( (TITLE (FRAG (NP (NP (DT A) (NN mouse) (NN model)) (PP (IN of) (NP (NN sitosterolemia)))) (: :) (S (NP-SBJ (NP (NN absence)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VBZ results) (PP (IN in) (NP (NN failure) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (JJ biliary) (NN cholesterol))))))))))) )
( (HEADING (NP (NN Abstract))) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ (NP (NNS Mutations)) (PP-LOC (IN in) (NP (NP (NP (DT either)) (PP (IN of) (NP (NP (CD two) (NNS genes)) (VP (VBG comprising) (NP (DT the) (NN STSL) (NN locus)))))) (, ,) (NP (NP (NP (NML (NML (NML (ADJP (NN ATP) (HYPH -) (VBG binding)) (NN cassette)) (-LRB- -LRB-) (NML (NN ABC))) (-RRB- -RRB-) (HYPH -) (NNS transporters)) (NN ABCG5)) (-LRB- -LRB-) (VP (VBG encoding) (NP (NN sterolin) (HYPH -) (CD 1))) (-RRB- -RRB-)) (CC and) (NP (NP (NN ABCG8)) (-LRB- -LRB-) (VP (VBG encoding) (NP (NN sterolin) (HYPH -) (CD 2))) (-RRB- -RRB-)))))) (, ,) (VP (VBP result) (PP (IN in) (NP (NP (NN sitosterolemia)) (, ,) (NP (NP (NP (DT a) (JJ rare) (ADJP (JJ autosomal) (JJ recessive)) (NN disorder)) (PP (IN of) (NP (NN sterol) (NN trafficking)))) (VP (VBN characterized) (NP (-NONE- *)) (PP (IN by) (NP-LGS (VBN increased) (NN plasma) (NML (NN plant) (NN sterol)) (NNS levels)))))))) (. .)) )
( (S (PP (VBN Based) (PP (IN upon) (NP (NP (DT the) (NN genetics)) (PP (IN of) (NP (NN sitosterolemia)))))) (, ,) (NP-SBJ-1 (NP (NN ABCG5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (CC and) (NP (NN ABCG8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))) (VP (VBP are) (VP (VBN hypothesized) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB function) (PP (IN as) (NP (JJ obligate) (NNS heterodimers)))))))) (. .)) )
( (S (NP-SBJ-1 (DT No) (JJ phenotypic) (NN difference)) (VP (VBZ has) (ADVP-TMP (RB yet)) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS humans)) (PP (IN with) (NP (NP (JJ complete) (NNS defects)) (PP-LOC (IN in) (NP (CC either) (NN ABCG5) (CC or) (NN ABCG8)))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NN proteins)) (, ,) (PP (VBN based) (PP (IN upon) (NP (NP (DT the) (NNS defects)) (PP-LOC (IN in) (NP (NNS humans)))))) (, ,) (VP (VBP are) (ADJP-PRD (JJ responsible) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG regulating) (NP (NP (JJ dietary) (NN sterol) (NN entry)) (CC and) (NP (JJ biliary) (NN sterol) (NN secretion)))))))) (. .)) )
( (HEADING (NP (NNS Methods))) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB mimic) (NP (DT the) (JJ human) (NN disease))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD created) (, ,) (PP-MNR (IN by) (NP (DT a) (VBN targeted) (NN disruption))) (, ,) (NP (NP (NP (DT a) (NN mouse) (NN model)) (PP (IN of) (NP (NN sitosterolemia)))) (VP (VBG resulting) (PP (IN in) (NP (NP (NML (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (NN deficiency)) (ADVP (RB alone))))))) (. .)) )
( (S (NP-SBJ (JJ Homozygous) (NN knockout) (NNS mice)) (VP (VP (VBP are) (ADJP-PRD (JJ viable))) (CC and) (VP (VBP exhibit) (NP (NN sitosterolemia)))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (S (NP-SBJ (NP (NNS Mice) (JJ deficient)) (PP (IN in) (NP (NN Abcg8)))) (VP (VBP have) (NP (NP (NP (NP (ADJP (RB significantly) (VBN increased)) (NN plasma)) (CC and) (NP (NML (NN tissue) (NML (NN plant) (NN sterol))) (NNS levels))) (-LRB- -LRB-) (NP (NN sitosterol) (CC and) (NN campesterol))) (-RRB- -RRB-) (ADJP (JJ consistent) (PP (IN with) (NP (NN sitosterolemia)))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ-1 (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (VP (VP (VBD was) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (CC both) (NN liver) (CC and) (NN intestine))) (PP-LOC (IN in) (NP (ADJP (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (JJ deficient)) (NNS mice))))) (CC and) (VP (VBD continued) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB show) (NP (DT an) (JJ apical) (NN expression))))))) (. .)) )
( (S (ADVP (RB Remarkably)) (, ,) (NP-SBJ (ADJP (NN Abcg8) (JJ deficient)) (NNS mice)) (VP (VP (VBD had) (NP (DT an) (JJ impaired) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN cholesterol)) (PP-DIR (IN into) (NP (NN bile)))))))) (, ,) (CC but) (VP (ADVP (RB still)) (VBD maintained) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN sitosterol)))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBP report) (NP (NP (DT an) (JJ intermediate) (NN phenotype)) (PP-LOC (IN in) (NP (NP (DT the) (JJ heterozygous) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VP (VBP are) (RB not) (ADJP-PRD (JJ sitosterolemic))) (, ,) (CC but) (VP (VBP have) (NP (NP (DT a) (VBN decreased) (NN level)) (PP (IN of) (NP (JJ biliary) (NN sterol) (NN secretion)))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ relative) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))))))))))) (. .)) )
( (HEADING (NP (NN Conclusion))) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP-SBJ (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (VP (VBZ is) (ADJP-PRD (JJ necessary) (PP (IN for) (NP (JJ biliary) (NN sterol) (NN secretion))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VBZ has) (NP (NP (DT a) (ADJP (RBR more) (JJ profound)) (NN effect)) (PP (IN upon) (NP (JJ biliary) (NN cholesterol) (NN secretion))) (PP (IN than) (NP (NN sitosterol))))))))) (. .)) )
( (S (SBAR-PRP (IN Since) (S (NP-SBJ-1 (JJ biliary) (NN sitosterol) (NN secretion)) (VP (VBZ is) (VP (VBN preserved) (NP-1 (-NONE- *)) (, ,) (SBAR-ADV (IN although) (FRAG (RB not) (ADJP-PRD (JJ elevated)) (PP-LOC (IN in) (NP (DT the) (JJ sitosterolemic) (NNS mice))))))))) (, ,) (NP-SBJ (DT this) (NN observation)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NP (NNS mechanisms)) (ADJP (JJ other) (PP (IN than) (PP (IN by) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))))) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NP (PRP$ its) (NN secretion)) (PP (IN into) (NP (NN bile))))))))))) (. .)) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ (NP (NN Absorption)) (PP (IN of) (NP (JJ dietary) (NN cholesterol))) (PP (IN from) (NP (DT the) (NN intestine)))) (VP (VP (VBZ is) (NP-PRD (NP (DT an) (JJ important) (NN part)) (PP (IN of) (NP (NN cholesterol) (NN homeostasis))))) (CC and) (VP (VBZ represents) (NP (NP (DT the) (JJ initial) (NN step)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ allows) (S (NP-SBJ (JJ dietary) (NN cholesterol)) (VP (TO to) (VP (VB exert) (NP (PRP$ its) (JJ metabolic) (NNS effects))))))))))) (. .)) )
( (S (NP-SBJ (DT A) (JJ typical) (NNP western) (NN diet)) (VP (VBZ contains) (NP (NP (NP (ADJP (RB relatively) (JJ equal)) (NNS amounts)) (PP (IN of) (NP (NP (NML (NN cholesterol) (CC and) (JJ non-cholesterol)) (NNS sterols)) (, ,) (NP (RB mainly) (NN plant) (NNS sterols))))) (, ,) (SBAR (WHPP-1 (IN of) (WHNP (WDT which))) (S (NP-SBJ-2 (NP (QP (IN about) (CD 55)) (NN %)) (PP (IN of) (NP (NP (DT the) (JJ dietary) (NN cholesterol)) (PP-1 (-NONE- *T*))))) (VP (VBZ is) (VP (VBN absorbed) (CC and) (VBN retained) (NP-2 (-NONE- *)) (PP (VBN compared) (PP (IN to) (NP (NP (QP (SYM ~) (CD 1)) (NN %)) (PP (IN of) (NP (DT the) (JJ dietary) (JJ non-cholesterol) (NNS sterols))))))))))) (PRN (-LRB- [) (NP (NP (CD 1)) (PP (SYM -) (NP (CD 3)))) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NNP Schoenheimer)) (VP (VBD recognized) (ADVP-TMP (NP (QP (JJR more) (IN than) (CD 75)) (NNS years)) (RB ago)) (SBAR (IN that) (S (NP-SBJ-1 (NP (RB only) (NN cholesterol)) (, ,) (CC not) (NP (JJ non-cholesterol) (NNS sterols))) (, ,) (VP (VBZ is) (VP (VBN absorbed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN intestine))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-3 (NP (DT the) (JJ exact) (JJ molecular) (NNS mechanisms)) (SBAR (WHPP-2 (IN by) (WHNP (WDT which))) (S (NP-SBJ (JJ preferential) (NN cholesterol) (NN absorption)) (VP (VBZ occurs) (PP-MNR-2 (-NONE- *T*)))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN elucidated) (NP-3 (-NONE- *)) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ])))))))))))) (. .)) )
( (S (S (ADVP (RB Similarly)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (DT the) (NN liver)) (VP (VBZ secretes) (NP (JJ free) (NN cholesterol)) (PP-DIR (IN into) (NP (NN bile)))))) (, ,) (NP-SBJ (PRP it)) (VP (MD can) (ADVP (RB preferentially)) (VP (VB excrete) (NP (JJ non-cholesterol) (NNS sterols)) (PP-DIR (IN into) (NP (NN bile)))))) (CC and) (S (NP-SBJ (NP (DT the) (NN mechanism) (-LRB- -LRB-) (AFX s) (-RRB- -RRB-)) (PP (IN of) (NP (DT this) (NN process)))) (VP (VBZ has) (ADVP-TMP (RB yet)) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN elucidated) (NP-1 (-NONE- *)) (ADVP-TMP (RB as) (RB well)))))))) (. .)) )
( (SINV (ADVP-TMP (RB Only) (RB recently)) (, ,) (PP-MNR (IN through) (NP (NP (DT the) (NN study)) (PP (IN of) (NP (DT a) (JJ rare) (JJ human) (NN disease))))) (, ,) (VB have) (NP-SBJ-1 (NP (NNS clues)) (PP (IN to) (NP (DT this) (NN process)))) (VP (VBN been) (VP (VBN revealed) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (NP (NN Sitosterolemia)) (-LRB- -LRB-) (NP (NP (NN MIM) (CD 210250)) (, ,) (VP (ADVP (RB also)) (VBN known) (NP (-NONE- *)) (PP (IN as) (NP (NN phytosterolemia))))) (-RRB- -RRB-)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ rare) (ADJP (JJ autosomal)) (, ,) (ADJP (RB recessively) (VBN inherited)) (NN disorder)) (VP (VBN characterized) (NP (-NONE- *)) (PP (IN by) (NP-LGS (VBN elevated) (NML (NN blood) (CC and) (NN tissue)) (NML (NN plant) (NN sterol)) (NNS levels))))) (PRN (-LRB- [) (NP (CD 5)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (VBN Affected) (NNS individuals)) (VP (MD can) (VP (VB develop) (NP (NP (UCP (NN tendon) (CONJP (CC and) (HYPH /) (CC or)) (JJ tuberous)) (NNS xanthomas)) (, ,) (NP (JJ hemolytic) (NNS episodes)) (, ,) (NP (NNS arthralgias)) (, ,) (NP (NN arthritis)) (, ,) (CC and) (NP (JJ premature) (NN atherosclerosis))) (-LRB- [) (NP (CD 6) (, ,) (CD 7)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (JJ Sitosterolemic) (NNS patients)) (VP (VBP have) (NP (NP (NP (ADJP (RB diagnostically) (VBN elevated)) (NML (NN plasma) (NML (NN plant) (NN sterol))) (NNS levels)) (-LRB- -LRB-) (NP (PP (IN for) (NP (NN example))) (, ,) (NP (NN sitosterol)) (, ,) (NP (NN campesterol)) (, ,) (NP (NN stigmasterol)) (, ,) (CC and) (NP (NN avenosterol)) (, ,) (ADVP-ETC (FW etc.)))) (-RRB- -RRB-) (CC and) (NP (NP (NP (PRP$ their) (ADJP (CD 5) (HYPH -) (VBN saturated)) (NN stanol) (NNS metabolites)) (, ,) (NP (ADVP (RB particularly)) (NN sitostanol))) (, ,) (PP (IN with) (NP (ADJP (ADJP (JJ normal)) (CC or) (ADJP (ADVP (RB only) (RB moderately)) (VBN increased))) (NN cholesterol) (NNS levels)))))) (. .)) )
( (S (NP-SBJ (JJ Clinical) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (VBN affected) (NNS individuals)) (VP (VP (VBP hyperabsorb) (NP (DT all) (JJ dietary) (NNS sterols) (PRN (-LRB- -LRB-) (S (ADVP (RB thus)) (NP-SBJ (-NONE- *PRO*)) (VP (VBP have) (VP (VBN lost) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB restrict) (NP (NP (DT the) (NN sterol) (NNS species)) (VP (VBN absorbed) (NP (-NONE- *))))))))))) (-RRB- -RRB-)))) (CC and) (VP (VBP have) (VP (VBN lost) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB excrete) (NP (NNS sterols)) (PP-DIR (IN into) (NP (NN bile)))))))))))) (PRN (-LRB- [) (NP (CD 8) (, ,) (CD 9)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ (NP (NN Infusion)) (PP (IN of) (NP (NN sitosterol) (CC and) (NN cholesterol))) (PP (IN into) (NP (JJ normal) (NNS individuals)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT a) (ADJP (JJ rapid) (CC and) (JJ preferential)) (NN excretion)) (PP (IN of) (NP (NN sitosterol))) (PP (IN into) (NP (NN bile))))))) (, ,) (CC but) (S (PP-LOC (IN in) (NP (JJ sitosterolemic) (NNS individuals))) (NP-SBJ (NML (JJ biliary) (NN sterol)) (NN secretion)) (VP (VBZ is) (ADJP-PRD (RB almost) (JJ absent)))) (PRN (-LRB- [) (NP (CD 7) (, ,) (CD 9)) (-RRB- ])) (. .)) )
( (S (NP-SBJ (NP (JJ Previous) (NNS studies)) (PP (IN on) (NP (NN sitosterolemia)))) (VP (VBP have) (VP (VBN suggested) (NP (NP (DT a) (NN defect)) (VP (VBG involving) (NP (NP (DT a) (JJ putative) (NN sterol) (`` ') (NN transporter) ('' ')) (VP (VBN expressed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (JJ intestinal) (NN brush) (NN border)) (CONJP (CC and) (HYPH /) (CC or)) (NP (DT the) (JJ hepatic) (JJ canalicular) (NN membrane)))))))) (PRN (-LRB- [) (NP (CD 10) (, ,) (CD 11)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (JJ Genetic) (NNS analyses)) (PP (IN of) (NP (NN sitosterolemia) (NNS pedigrees)))) (VP (VBD allowed) (NP (NP (DT the) (NN mapping)) (PP (IN of) (NP (DT the) (NN STSL) (NN locus))) (PP (IN to) (NP (NP (JJ human) (NN chromosome) (NN 2p21)) (, ,) (PP-LOC (IN between) (NP (NN D2S2294) (CC and) (NN D2S2298)))))) (PRN (-LRB- [) (NP (CD 12) (, ,) (CD 13)) (-RRB- ]))) (. .)) )
( (S (PP-MNR (PP (IN By) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (JJ positional) (NN cloning)) (NNS procedures))))) (CC or) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG screening) (PP (IN for) (NP (NP (NNS genes)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN exposure)) (PP (IN to) (NP (NN LXR) (NNS agonists)))))))))))) (, ,) (NP-SBJ (CD two) (NNS groups)) (VP (VBD identified) (NP (NP (NP (NML (CC not) (CD one) (CC but) (CD two)) (NNS genes)) (, ,) (NP (NN ABCG5) (CC and) (NN ABCG8))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP encode) (NP (NP (DT the) (NN proteins) (NML (NML (NN sterolin) (HYPH -) (CD 1)) (CC and) (NML (NN sterolin) (HYPH -) (CD 2)))) (, ,) (SBAR (WHNP-2 (NP (NNS mutations)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP cause) (NP (NN sitosterolemia)))))))))) (PRN (-LRB- [) (NP (NP (CD 14)) (PP (SYM -) (NP (CD 16)))) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ-1 (NP (JJ complete) (NN mutation)) (PP-LOC (IN in) (NP (CC either) (NP (NP (NN ABCG5)) (ADVP (RB alone))) (CC or) (NP (NP (NN ABCG8)) (ADVP (RB alone)))))) (VP (VBZ is) (ADJP-PRD (CONJP (RB not) (RB only)) (ADJP (JJ necessary)) (, ,) (CC but) (ADJP (JJ sufficient) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB cause) (NP (DT the) (NN disease))))))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))) (. .)) )
( (S (PP-TMP (IN To) (NP (NN date))) (, ,) (NP-SBJ-2 (NP (DT no) (NN patient)) (PP (IN with) (NP (NN sitosterolemia))) (PP-1 (-NONE- *ICH*))) (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (NP-2 (-NONE- *)) (PP-1 (IN with) (NP (NP (NNS mutations)) (PP-LOC (IN in) (NP (DT both) (NNS genes)))))))) (. .)) )
( (S (PP (VBN Based) (PP (IN upon) (NP (NP (DT these) (NNS data)) (, ,) (CC and) (NP (NP (DT the) (NN similarity)) (PP (IN of) (NP (DT the) (ADJP (JJ clinical) (CC and) (JJ biochemical)) (NN phenotype))))))) (, ,) (NP-SBJ-1 (NP (NN sterolin) (HYPH -) (CD 1)) (CC and) (NP (NN sterolin) (HYPH -) (CD 2))) (VP (VBP are) (VP (VBN hypothesized) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB function) (PP (IN as) (NP (JJ obligate) (NNS heterodimers)))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN fact) (SBAR (IN that) (S (NP-SBJ (NP (DT each)) (PP (IN of) (NP (DT these) (NN proteins)))) (VP (VBZ is) (NP-PRD (NP (DT a) (`` ') (NN half) (HYPH -) (NN transporter)) ('' ') (, ,) (VP (VBG containing) (NP (NP (CD six) (NN transmembrane) (NNS domains)) (, ,) (CONJP (CC and) (RB not)) (NP (NP (DT the) (JJ classical) (CD 12) (NN transmembrane)) (ADJP (JJ characteristic) (PP (IN of) (NP (JJ functional) (NN ABC) (NNS transporters))))))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (DT The) (JJ exact) (NN function)) (PP (IN of) (NP (DT these) (CD two) (NN proteins)))) (ADVP-TMP (RB still)) (VP (VBZ remains) (ADJP-PRD (JJ unknown)))) (CC but) (S (NP-SBJ (JJ recent) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NP (NN overexpression)) (PP (IN of) (NP (NN ABCG5) (HYPH /) (NN ABCG8))) (PP-LOC (IN in) (NP (DT a) (NML (JJ transgenic) (NN mouse)) (NN model)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (VBN increased) (NML (JJ biliary) (NN cholesterol)) (NN concentration)) (CC and) (NP (NP (DT a) (NML (CD 50) (NN %)) (NN reduction)) (PP (IN in) (NP (NP (DT the) (JJ fractional) (NN absorption)) (PP (IN of) (NP (JJ dietary) (NN cholesterol)))))))))))))) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ])) (. .)) )
( (S (NP-SBJ-1 (NP (PRP It)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ (NN ABCG5) (CC and) (NN ABCG8)) (VP (VBP act) (PP (IN as) (NP (NP (JJ mutual) (NNS chaperones)) (PP (IN for) (NP (CC both) (NP (NN maturation)) (CC and) (NP (JJ correct) (JJ apical) (NN targeting)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Co-expression)) (PP (IN of) (NP (DT both)))) (VP (VBD was) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (JJ apical) (NN trafficking)) (UCP (PP-LOC (IN in) (NP (DT a) (VBN polarized) (NN cell) (NN line))) (, ,) (CONJP (RB as) (RB well)) (ADVP (FW in) (FW vivo))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NML (NN Abcg5) (HYPH /) (NN Abcg8)) (RB double) (HYPH -) (NN knockout)) (NNS mice)))) (PRN (-LRB- [) (NP (CD 18) (, ,) (CD 19)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (DT no) (JJ functional) (NN assay)) (VP (VBZ has) (ADVP-TMP (RB yet)) (VP (VBN been) (VP (VBN developed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB demonstrate) (SBAR (SBAR (IN whether) (CC or) (RB not) (S (NP-SBJ (DT the) (CD two) (NN half) (HYPH -) (NNS transporters)) (VP (VBP function) (PP (IN as) (NP (AFX homo) (HYPH -) (CC or) (NNS heterodimers)))))) (CC and) (SBAR (IN whether) (S (NP-SBJ (PRP they)) (ADVP (RB selectively)) (VP (VB pump) (NP (NNS sterols)))))))))))) (. .)) )
( (S (ADVP (RB Likewise)) (, ,) (NP-SBJ (NP (DT the) (JJ cellular) (NN localization)) (PP (IN of) (NP (DT these) (CD two) (NN proteins)))) (VP (VBZ has) (ADVP-TMP (RB yet)) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN shown) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (NN model)) (ADJP (JJ deficient) (PP (IN in) (NP (NP (CC either) (NN Abcg5) (CC or) (NN Abcg8)) (ADVP (RB alone)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (NN mouse) (NN model)) (VP (VBG disrupting) (NP (CC both) (NN Abcg5) (CC and) (NN Abcg8)) (ADVP-TMP (RB simultaneously)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (NN phenotype)) (ADJP (JJ similar) (PP (IN to) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (JJ human) (NN disease)))))))) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (PRP it)) (S-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ important)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB point) (PRT (RP out)) (SBAR (IN that) (S (NP-SBJ-2 (DT the) (JJ human) (NN disease)) (VP (VBZ is) (VP (VBN caused) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ complete) (NN mutation)) (PP-LOC (IN in) (NP (NP (NP (CD one) (NML-3 (-NONE- *RNR*))) (CC or) (NP (DT the) (JJ other) (NML-3 (-NONE- *RNR*))) (NML-3 (NN gene))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT both)) (ADVP (RB simultaneously))))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD hypothesized) (SBAR (IN that) (S (S (NP-SBJ (NP (NN disruption)) (PP (IN of) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (DT the) (NN half) (HYPH -) (NNS transporters)))))) (VP (MD would) (VP (VB result) (PP (IN in) (NP (NN sitosterolemia)))))) (CC and) (S (NP-SBJ (NP (JJ selective) (NN loss)) (PP (IN of) (NP (DT either) (NN sterolin)))) (VP (MD may) (VP (VB show) (NP (NP (DT a) (JJ differential) (NN effect)) (PP (IN on) (NP (NP (NP (DT the) (JJ biliary) (NN secretion)) (PP (IN of) (NP (NNS sterols)))) (CC or) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NNS sterols))))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS studies)) (VP (VBP are) (ADJP-PRD (JJ difficult) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB test) (NP-1 (-NONE- *T*)) (PP-LOC (IN in) (NP (NNS humans)))))))) (, ,) (SBAR-PRP (IN as) (S (NP-SBJ (DT the) (NN target) (NNS organs)) (VP (VBP are) (ADJP-PRD (RB relatively) (JJ inaccessible)))))) (. .)) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB test) (NP (DT this) (NN hypothesis))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP report) (NP (NP (DT a) (NN mouse) (NN model)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ has) (NP (NP (DT a) (JJ selective) (JJ genetic) (NN mutation)) (PP (IN of) (NP (NN Abcg8))))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Mice)) (ADJP (JJ homozygous) (PP (IN for) (NP (NN Abcg8) (NN loss))))) (VP (VBP exhibit) (NP (NP (JJ many)) (PP (IN of) (NP (NP (DT the) (NNS characteristics)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN disease)) (NP (NN sitosterolemia)))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (PRP we)) (VP (VBP report) (NP (NP (NP (NNS studies)) (PP (IN of) (NP (JJ biliary) (NN sterol) (NN secretion)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP show) (SBAR (IN that) (S (PP (IN despite) (NP (JJ forced) (NN secretion))) (, ,) (NP-SBJ (ADJP (NN Abcg8) (HYPH -) (JJ deficient)) (NNS animals)) (VP (MD can) (RB not) (VP (VB secrete) (NP (NN cholesterol)) (PP-DIR (IN into) (NP (NN bile))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-2 (NN sitosterol) (NN secretion)) (VP (VBD seemed) (S (NP-SBJ-2 (-NONE- *)) (ADJP-PRD (JJ unaffected))))))))))))))) (. .)) )
( (HEADING (NP (NNS Methods))) )
( (HEADING (NP (NP (NML (NN Targeting) (NN vector)) (NN construction)) (CC and) (NP (NP (NN generation)) (PP (IN of) (NP (NN knockout) (NNS mice)))))) )
( (S (NP-SBJ-2 (DT A) (ADJP (NN mouse) (JJ genomic)) (NML (NML (JJ bacterial) (JJ artificial) (NN chromosome)) (-LRB- -LRB-) (NML (NN BAC))) (-RRB- -RRB-) (NN library) (PRN (-LRB- -LRB-) (NP (NN CitbCJ7)) (, ,) (NP (NML (NN ES) (NN cell)) (NN line) (HYPH /) (NN 129Sv)) (, ,) (NP (NP (NNP Research) (NNP Genetics)) (, ,) (ADJP (NNP Inc.))) (, ,) (NP (NP (NNP Huntsville)) (, ,) (NP-LOC (NNP AL)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN screened) (NP-2 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NNS primers)) (VP (VBN designed) (NP (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NNS sequences)) (PP (IN of) (NP (NN mouse) (NML (NN Abcg5) (CC and) (NN Abcg8)) (NN cDNA))))))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (ADVP (RB previously)) (VP (VBN reported) (NP-1 (-NONE- *)))))))) (PRN (-LRB- [) (NP (CD 21)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (DT A) (JJ positive) (NN BAC) (NN clone)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP-MNR (IN as) (NP (DT a) (NN template))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (NP (NP (JJ genomic) (NN DNA) (NNS fragments)) (PP (IN of) (NP (NN Abcg8))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (JJ Long) (HYPH -) (NN fragment)) (NML (NML (NN polymerase) (NN chain) (NN reaction)) (-LRB- -LRB-) (NML (NN PCR)))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NN Expanded) (NML (JJ Long) (NN Template) (NN PCR)) (NN system)) (NN kit) (PRN (-LRB- -LRB-) (NP (NP (NNP Roche) (NNP Applied) (NNP Science)) (, ,) (NP-LOC (NNP Indianapolis)) (, ,) (NP-LOC (NNP IA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT An) (NML (QP (RB approximately) (CD 4.5)) (NN kb)) (`` ') (NML (JJ long) (HYPH -) (NN arm)) ('' ') (JJ genomic) (NN fragment)) (VP (VBG containing) (NP (NP (JJ partial) (NN exon) (CD 1)) (PP (IN to) (NP (JJ partial) (NN exon) (CD 3)))))) (VP (VBD was) (VP (VBN inserted) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (NP (DT the) (NML (NN Pml) (CD I)) (ADJP (NN restriction) (HYPH -) (VBG cloning)) (NN site) (NN A)) (PP (IN of) (NP (NN OSDUPDEL) (NN vector))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (`` ') (NML (NN short) (HYPH -) (NN arm)) ('' ') (JJ genomic) (NN fragment)) (, ,) (VP (VBG containing) (NP (NP (JJ partial) (NN exon) (CD 4)) (PP (IN to) (NP (JJ partial) (NN exon) (CD 6)))))) (, ,) (VP (VBD was) (VP (VBN cloned) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (NP (DT the) (NML (NN Not) (NN I)) (HYPH -) (NN Kpn) (CD I)) (PP (IN of) (NP (VBG cloning) (NN site) (NN B))))))) (. .)) )
( (S (NP-SBJ (JJ Homologous) (NN targeting)) (VP (MD would) (VP (VB result) (PP (IN in) (NP (NP (NP (JJ complete) (NML (NN intron) (CD 3)) (NML-1 (-NONE- *RNR*))) (, ,) (NP (JJ partial) (NML (NN exon) (CD 3)) (NML-1 (-NONE- *RNR*))) (CC and) (NP (JJ partial) (NML (NN exon) (CD 4)) (NML-1 (-NONE- *RNR*))) (NML-1 (NN replacement))) (PP (IN by) (NP (DT the) (NML (NN neomycin) (HYPH -) (JJ resistance)) (NN cassette))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (NN disruption)) (PP (IN of) (NP (DT the) (NML (NN ABC) (NN Walker) (NN A)) (NN motif))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1a)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NN ES) (NNS cells) (PRN (-LRB- -LRB-) (NP (NML (CD 129) (HYPH /) (NN SvEvTac)) (HYPH -) (NN cell) (NN line)) (-RRB- -RRB-))) (VP (VP (VBD were) (VP (VBN electroporated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT the) (NML (VBN linearized) (NN targeting) (NN vector)) (NN DNA))))) (CC and) (VP (VBN cultured) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (JJ sub-confluent) (JJ embryonic) (NNS fibroblasts))))) (. .)) )
( (S (NP-SBJ-1 (VBN Transfected) (NN cell) (NNS colonies)) (VP (VBD were) (VP (VBN selected) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM-LGS (NP-SBJ (-NONE- *PRO*)) (VP (VBG culturing) (NP (NNS cells)) (PP-LOC (IN in) (NP (NP (NN medium)) (VP (VBG containing) (NP (NML (NML (CD 200) (NN μg)) (PP (SYM /) (NP (NN mL)))) (NN G418) (PRN (-LRB- -LRB-) (NP (NP (NNP Life) (NNP Technologies)) (, ,) (NP-LOC (NNP Rockville)) (, ,) (NP-LOC (NNP MD)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN ES) (NNS cells)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (JJ homologous) (NN recombination))) (PP-MNR (IN by) (NP (NN PCR))) (PP-MNR (IN with) (NP (NP (NP (DT the) (JJ forward) (NN primer)) (, ,) (NP (NP (NP (NN neoF)) (-LRB- -LRB-) (NP (NML (CD 5)) (SYM ') (HYPH -) (NN GGGTCGTTTGTTCGGATCAA) (HYPH -) (CD 3) (SYM '))) (-RRB- -RRB-) (PP (IN from) (NP (NN neo) (NN cassette))))) (, ,) (CC and) (NP (NP (NP (NML (JJ reverse) (NN primer)) (NN intron) (NN 6R)) (-LRB- -LRB-) (NP (NML (CD 5) (SYM ')) (HYPH -) (NN ACCAGTTGGTCCTAGCTCGA) (HYPH -) (CD 3) (SYM '))) (-RRB- -RRB-) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ is) (VP (VBN located) (NP-2 (-NONE- *)) (PP-LOC (IN outside) (NP (DT the) (VBG targeting) (NN construct))) (PP-LOC (IN in) (NP (NN mouse) (NN Abcg8) (NN intron) (CD 6)))))))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (RB Positively) (VBN targeted)) (NML (NN ES) (NN cell)) (NNS clones)) (VP (VBD were) (VP (VBN confirmed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NNP Southern) (NN blotting))) (, ,) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NML (NN ES) (NN cell)) (NN DNA)) (VP (VBN digested) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN BamHI)) (CC and) (NP (NP (DT a) (NN probe)) (VP (VBZ comprising) (PP (IN of) (NP (NP (DT a) (NML (CD 562) (NN bp)) (NN PCR) (NN fragment)) (PP (IN from) (NP (NP (NP (JJ partial) (NN intron) (CD 2)) (CC and) (NP (NN exon) (CD 3))) (PP (IN of) (NP (NN Abcg8) (NN gene))))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (RB Positively) (VBN targeted)) (NN ES) (NNS cells)) (VP (VBD were) (VP (VP (VBN microinjected) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (NN C57BL6) (NNS blastocysts)))) (CC and) (VP (VBN transplanted) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (JJ pseudopregnant) (NNS recipients)))))) (. .)) )
( (S (NP-SBJ-1 (CD Five) (ADJP (RB highly) (JJ chimeric)) (NNS mice) (PRN (-LRB- -LRB-) (NP (JJ agouti) (NN coat) (NN color)) (, ,) (NP (NP (CD three) (NNS males)) (CC and) (NP (CD two) (NNS females))) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN isolated) (NP-1 (-NONE- *))) (CC and) (VP (VBN bred) (NP-1 (-NONE- *)) (PP (IN with) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS mice))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (NP (ADJP (NP (NML (NN germ) (HYPH -) (NN line)) (NN transmission)) (JJ heterozygous)) (NNS mice)) (PP (IN of) (NP (NML (NN Abcg8) (NN gene)) (NN disruption)))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Heterozygous) (NN offspring) (NNS mice)) (VP (VBD were) (VP (RB back) (HYPH -) (VBN crossed) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS mice) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM >) (NP (CD 5)))) (-RRB- -RRB-)))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (VBN disrupted) (NN line)))))) (CC and) (VP (VBN inter-crossed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (NN knockout) (NNS mice))))))) (. .)) )
( (HEADING (NP (NNS Animals) (CC and) (NNS diets))) )
( (S (NP-SBJ-1 (DT All) (NNS mice)) (VP (VBD were) (VP (VP (VBN maintained) (NP-1 (-NONE- *)) (PP (IN on) (NP (NP (NP (DT a) (JJ standard) (NN rodent) (NN chow)) (-LRB- -LRB-) (NP (NML (NNP Harlan) (NNP Teklad)) (NML (NN mouse) (HYPH /) (NN rat)) (NN diet) (NN LM) (HYPH -) (CD 485))) (-RRB- -RRB-) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD contained) (NP (NP (NML (NML (CD 61) (NN mg)) (PP (SYM /) (NP (NN kg)))) (NN cholesterol)) (, ,) (NP (NML (NML (CD 31) (NN mg)) (PP (SYM /) (NP (NN kg)))) (NN campesterol)) (, ,) (CC and) (NP (NML (NML (CD 105) (NN mg)) (PP (SYM /) (NP (NN kg)))) (NN sitosterol))))))))) (, ,) (VP (VBN given) (NP-1 (-NONE- *)) (NP (NP (JJ free) (NN access)) (PP (IN to) (NP (NN water))))) (CC and) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP (IN at) (NP (CD 25) (NN °C))) (PP (IN with) (NP (DT a) (NML (NML (NML (CD 12) (HYPH -) (NN h)) (JJ light)) (, ,) (NML (NML (CD 12) (HYPH -) (NN h)) (JJ dark))) (NN cycle)))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS animals)) (VP (VBD were) (VP (VBN housed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (DT the) (NNS facilities)) (PP (IN for) (NP (NN laboratory) (NNS animals)))) (VP (VBN provided) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT the) (NNP Division)) (PP (IN of) (NP (NML (NNP Laboratory) (NNP Animal)) (NNPS Resources)))) (NP (NNP ACLAM))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NML (NML (NNP Institutional) (NNP Animal)) (NML (NNP Care) (CC and) (NNP Research))) (NNP Advisory) (NNP Committee)) (PP-LOC (IN at) (NP (NP (NNP Medical) (NNP University)) (PP (IN of) (NP (NNP South) (NNP Carolina)))))) (VP (VBD approved) (NP (DT all) (NNS experiments))) (. .)) )
( (HEADING (NP (NP (NN Genotyping)) (PP (IN by) (NP (NN PCR))))) )
( (S (NP-SBJ-1 (NML (NN Mouse) (NN tail)) (NN DNA)) (VP (VBD was) (VP (VBN isolated) (CC and) (VBN purified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG cutting) (NP (NP (QP (RB approximately) (CD 0.5)) (NN cm)) (PP (IN of) (NP (NN mouse) (NN tail))))) (CC and) (VP (VBG digesting) (NP (PRP it)) (PP-LOC (IN in) (NP (NML (CD 500) (NN μl)) (NN lysis) (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NP (NML (CD 50) (NN mM)) (NN Tris) (HYPH -) (NN HCl)) (, ,) (NP-ADV (NN pH) (CD 8.0))) (, ,) (NP (NML (CD 100) (NN mM)) (NN EDTA)) (, ,) (NP (NML (CD 125) (NN mM)) (NN NaCl)) (, ,) (NP (NML (CD 1) (NN %)) (NN SDS)) (, ,) (NP (NML (CD 200) (NN μg)) (NN Proteinase) (NN K))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (VBG rocking)) (ADVP-TMP (RB overnight)) (PP (IN at) (NP (CD 55) (NN °C))))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (CD 200) (NN μl)) (VBN saturated) (NN NaCl)) (VP (VBD was) (VP (VBN added) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (JJ digested) (NN solution))) (PP (IN with) (NP (NP (JJ vigorous) (VBG shaking)) (PP-TMP (IN for) (NP (QP (QP (RB at) (RBS least)) (CD 60)) (NNS seconds))))))) (. .)) )
( (S (NP-SBJ-1 (VBN Mixed) (NN solution)) (VP (VBD was) (VP (VBN spun) (NP-1 (-NONE- *)) (PRT (RP down)) (PP (IN at) (NP (JJ maximum) (NN speed))) (PP-LOC (IN in) (NP (JJ top) (NN micro) (HYPH -) (NN centrifuge))) (PP-TMP (IN for) (NP (CD 20) (NN min))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN supernatant)) (VP (VBD was) (VP (VP (VBN transferred) (NP-1 (-NONE- *)) (PP-DIR (IN to) (NP (DT a) (JJ new) (NN tube))) (PP (IN with) (NP (JJ equal) (NN volume) (NML (CD 100) (NN %)) (NN EtOH)))) (CC and) (VP (VBN mixed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN inversion)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN DNA) (NN pellet)) (VP (VBD was) (VP (VP (VBN washed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 70) (NN %)) (NN EtOH)))) (CC and) (VP (VBD resuspended) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (QP (CD 100) (SYM –) (CD 150)) (NN μl)) (NN TE) (NN buffer)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN UV) (NN spectrophotometry)) (CC and) (NP (NN electrophoresis))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB analyze) (NP (NP (DT the) (NML (NN quality) (CC and) (NN quantity))) (PP (IN of) (NP (DT the) (JJ genomic) (NN DNA))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Genotyping)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP-LGS (JJ multiplex) (NN PCR) (NN reaction))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (CD three) (JJ separate) (NNS primers)) (-LRB- -LRB-) (NP (NP (CD two) (NN Abcg8) (ADJP (NN gene) (JJ specific)) (NNS primers)) (, ,) (NP (NP (NML (NN mg8) (HYPH -) (NN in3F)) (NML (CD 5) (SYM ')) (HYPH -) (NN CCCAATGATGAATGAGACGCT) (HYPH -) (CD 3) (SYM ')) (, ,) (NP (NML (NN mg8) (HYPH -) (NN R9)) (NML (CD 5) (SYM ')) (HYPH -) (NN TTTGTCACGCTGGGCCTGG) (HYPH -) (CD 3) (SYM '))) (CC and) (NP (NP (NN neoF)) (PP (IN for) (NP (NP (NN identification)) (PP (IN of) (NP (NN Abcg8) (NN target) (NN status)))))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ (DT The) (NN PCR) (NN reaction)) (VP (VBD consisted) (PP (IN of) (NP (NP (NN 1x) (NN PCR) (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 1.5) (NN mM)) (NN MgCl2)) (, ,) (NP (NML (CD 16) (NN mM)) (PRN (-LRB- -LRB-) (NP (NN NH4)) (-RRB- -RRB-)) (NN 2SO4)) (, ,) (NP (NML (CD 0.1) (NN mM)) (NNS dNTPs)) (, ,) (NP (NML (CD 67) (NN mM)) (NN Tris) (HYPH -) (NN HCl) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 8.8)) (-RRB- -RRB-)))) (-RRB- -RRB-))) (NP (NP (CD 1) (NN μM)) (PP (IN of) (NP (DT each) (NN primer)))) (, ,) (NP (NN water)) (CC and) (NP (NP (CD 1.0) (NNS units)) (PP (IN of) (NP (NN Taq) (NN polymerase))))))) (. .)) )
( (FRAG (S (NP-SBJ-1 (DT The) (NNS reactions)) (VP (VBD were) (VP (VBN cycled) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBZ follows))))))) (: :) (NP (NP (NP (NP (CD 94) (NN °C)) (PP-TMP (IN for) (NP (CD 30) (NN sec)))) (, ,) (NP (NP (CD 60) (NN °C)) (PP-TMP (IN for) (NP (CD 30) (NN sec)))) (, ,) (NP (NP (CD 72) (NN °C)) (PP-TMP (IN for) (NP (CD 1) (NN min))))) (PP-TMP (IN for) (NP (CD 35) (NNS cycles)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN PCR) (NNS products)) (VP (VBD were) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN electrophoresis))))) (. .)) )
( (HEADING (NP (NML (NNP Southern) (NN blot)) (NN analysis))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB confirm) (NP (NN PCR) (NNS results))))) (, ,) (NP-SBJ-1 (NNS DNAs)) (VP (VBD were) (VP (VP (VBN digested) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN Bam) (NN HI)))) (, ,) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN electrophoresis))) (PP-LOC (IN in) (NP (DT a) (NML (CD 0.6) (NN %)) (NN agarose) (NN gel)))) (CC and) (VP (VBN transferred) (NP-1 (-NONE- *)) (PP-DIR (IN to) (NP (NN nylon) (NN membrane)))))) (. .)) )
( (S (NP-SBJ-1 (NML (NNP Southern) (NN blot)) (NNS filters)) (VP (VBD were) (VP (VBN hybridized) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT a) (NML (CD 562) (NN bp)) (NN PCR) (NN fragment)) (PP (IN from) (NP (NP (NP (JJ partial) (NN intron) (CD 2)) (CC and) (NP (NN exon) (CD 3))) (PP (IN of) (NP (NN Abcg8) (ADJP (NN 32P) (HYPH -) (RB randomly) (HYPH -) (VBN labeled)) (NN probe))))))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *))))) (PRN (-LRB- [) (NP (CD 22)) (-RRB- ])))) (. .)) )
( (HEADING (NP (NML (NNP Northern) (NN blot)) (NN analysis))) )
( (S (NP-SBJ-1 (NP (NP (NN Isolation)) (PP (IN of) (NP (NP (ADJP (NN liver) (CC and) (JJ intestinal)) (JJ total) (NN RNA)) (PP (IN from) (NP (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +)) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NNS mice)))))) (CC and) (NP (NML (NNP Northern) (NN blot)) (NNS analyses))) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *))))) (PRN (-LRB- [) (NP (CD 23)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN probe)) (PP (IN for) (NP (NN Abcg5)))) (VP (VBD was) (NP-PRD (CD 1964) (NN bp)) (PRN (-LRB- -LRB-) (NP (NN nt) (NML (NML (CD 136)) (PP (SYM –) (NP (CD 2099))))) (, ,) (NP (NNP GeneBank™) (NN accession) (NN no.) (NN AH011511)) (-RRB- -RRB-)))) (CC and) (S (NP-SBJ (NP (DT the) (NN probe)) (PP (IN for) (NP (NN Abcg8)))) (VP (VBD was) (NP-PRD (CD 2019) (NN bp)) (PRN (-LRB- -LRB-) (NP (NN nt) (NML (NML (CD 103)) (PP (SYM –) (NP (CD 2126))))) (, ,) (NP (NNP GeneBank™) (NN accession) (NN no.) (NN AH011518)) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NML (NML (JJ Reverse) (NN Transcription)) (-LRB- -LRB-) (NML (NN RT))) (-RRB- -RRB-) (HYPH -) (NN PCR))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB confirm) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT no) (JJ alternative) (NN splicing)) (PP (IN of) (NP (DT the) (VBN disrupted) (NN allele)))))))))) (, ,) (NP-SBJ-1 (NN RT) (HYPH -) (NN PCR)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN on) (NP (NP (NNS cDNAs)) (PP (IN of) (NP (VBN pooled) (NN mouse) (NN liver))))))) (. .)) )
( (S (ADVP (RB Briefly)) (, ,) (NP-SBJ-1 (NP (NNS samples)) (PP (IN of) (NP (NP (JJ total) (NN RNA) (PRN (-LRB- -LRB-) (NP (CD 0.5) (NN μg)) (-RRB- -RRB-))) (PP (IN from) (NP (VBN pooled) (NN mouse) (NNS livers))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 4)))) (-RRB- -RRB-))) (VP (VBD were) (VP (RB reverse) (VBN transcribed) (NP-1 (-NONE- *)) (PP (VBG according) (PP (IN to) (NP (DT the) (NNP SuperScript™) (NML (NML (JJ First) (HYPH -) (NN Strand)) (NN Synthesis)) (NN System) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen)) (, ,) (NP-LOC (NNP Carlsbad)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ random) (NNS hexamers)) (PP-LOC (IN in) (NP (NP (DT a) (JJ final) (NML (JJ total) (NN reaction)) (NN volume)) (PP (IN of) (NP (CD 20) (NN μl))))))))) (. .)) )
( (S (NP-SBJ-1 (NN RT) (HYPH -) (NN PCR)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NP (NNS primers)) (VP (VBN located) (NP (-NONE- *)) (PP-LOC (IN outside) (PP (IN of) (NP (DT the) (VBN targeted) (NN region)))))) (: :) (NP (NP (NP (NP (NN F1)) (-LRB- -LRB-) (NP (NN CCTCAGCTGGTGAGGAGGTG))) (-RRB- -RRB-) (PP (IN with) (NP (NP (NN R1)) (-LRB- -LRB-) (NP (NN GATGGAGAAGGTGAAGTTGCC))))) (-RRB- -RRB-) (, ,) (NP (NP (NP (NN F2)) (-LRB- -LRB-) (NP (NN ATTTCCAATGACTTCCGGGAC))) (-RRB- -RRB-) (PP (IN with) (NP (NN R1)))) (CC and) (NP (NP (NP (NN F3)) (-LRB- -LRB-) (NP (NN CTGGAAGACGGGCTGTACACT))) (-RRB- -RRB-) (PP (IN with) (NP (NN R1)))))) (, ,) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (NP (VBN expected) (NN product) (NNS lengths)) (PP (IN of) (NP (NP (NML (CD 1449) (, ,) (CD 654) (CC and) (CD 429)) (NN bp)) (ADVP (RB respectively))))) (PP-LOC (IN in) (NP (NML (JJ wild) (HYPH -) (NN type)) (NN cDNA)))))))))) (. .)) )
( (HEADING (NP (JJ Quantitative) (NN RT) (HYPH -) (NN PCR))) )
( (S (NP-SBJ-1 (NP (NNS Primers)) (SBAR-2 (-NONE- *ICH*))) (VP (VBD were) (VP (VP (VBN based) (NP-1 (-NONE- *)) (PP (IN upon) (NP (ADJP (RB previously) (VBN published)) (NN primer) (NNS sets))) (PRN (-LRB- [) (NP (NP (CD 24)) (PP (SYM -) (NP (CD 26)))) (-RRB- ]))) (CC or) (VP (VBN designed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNP MacVector))))) (, ,) (SBAR-2 (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD were) (VP (VBN designed) (NP-3 (-NONE- *)) (PP (IN from) (NP (CC either) (NN mRNA) (CC or) (NN cDNA))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB avoid) (NP (NP (DT the) (NN amplification)) (PP (IN of) (NP (ADJP (RB potentially) (VBG contaminating)) (JJ genomic) (NN DNA))) (PP-LOC (IN in) (NP (DT the) (JJ total) (NN RNA) (NN sample))))))))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Samples)) (PP (IN of) (NP (NP (JJ total) (NN RNA) (PRN (-LRB- -LRB-) (NP (CD 0.5) (NN μg)) (-RRB- -RRB-))) (PP (IN from) (NP (VBN pooled) (NN mouse) (NNS livers))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 4)))) (-RRB- -RRB-))) (VP (VBD were) (VP (RB reverse) (VBN transcribed) (NP-1 (-NONE- *)) (PP-MNR (VBG according) (PP (IN to) (NP (DT the) (NNP SuperScript™) (NML (NML (JJ First) (HYPH -) (NN Strand)) (NN Synthesis)) (NN System) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen)) (, ,) (NP-LOC (NNP Carlsbad)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (JJ random) (NNS hexamers)) (PP (IN with) (NP (NP (DT a) (JJ final) (NML (JJ total) (NN reaction)) (NN volume)) (PP (IN of) (NP (CD 20) (NN μl)))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Quantitative) (NN RT) (HYPH -) (NN PCR)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (NN PE) (NNP Biosystems)) (NNP GeneAmp®) (CD 5700) (NML (NN sequence) (NN Detection)) (NN System) (PRN (-LRB- -LRB-) (NP (NP (NNP Forest) (NNP City)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (JJ Standard) (NN reaction) (NN volume)) (VP (VBD was) (NP-PRD (NP (NP (CD 10) (NN μl)) (VP (VBG containing) (NP (QP (CD 1) (SYM ×)) (NNP QuantiTect) (NNP SYBR) (NNP Green) (NN PCR) (NN master) (NN mix))) (PRN (-LRB- -LRB-) (NP (NP (NNP Qiagen)) (, ,) (NP-LOC (NNP Valencia)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))) (, ,) (NP (NML (CD 0.002) (NN U)) (NN AmpErase) (NN UNG) (NN enzyme) (PRN (-LRB- -LRB-) (NP (NP (NN PE) (NNP Biosystems)) (, ,) (NP-LOC (NNP Forest) (NNP City)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))) (, ,) (NP (NP (CD 0.7) (NN μl)) (PP (IN of) (NP (NN cDNA) (NN template))) (PP (IN from) (NP (NML (JJ reverse) (NN transcription)) (NN reaction))) (PP (IN as) (ADVP-LOC (RB above)))) (CC and) (NP (NP (QP (CD 100) (SYM –) (CD 500)) (NN nM)) (PP (IN of) (NP (NN oligonucleotide) (NNS primers)))))) (. .)) )
( (S (NP-SBJ (NP (JJ Initial) (NNS steps)) (PP (IN of) (NP (NN RT) (HYPH -) (NN PCR)))) (VP (VBD were) (NP-PRD (NP (NP (CD two) (NNS minutes)) (PP (IN at) (NP (CD 50) (NN °C))) (PP (IN for) (NP (NN UNG) (NN activation)))) (, ,) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NML (CD 15) (NN minute)) (NN hold)) (PP (IN at) (NP (CD 95) (NN °C)))))))) (. .)) )
( (S (NP-SBJ (NNS Cycles) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 40)))) (-RRB- -RRB-))) (VP (VBD consisted) (PP (IN of) (NP (NP (NP (DT a) (NML (CD 15) (JJ second)) (NN melt)) (PP (IN at) (NP (CD 95) (NN °C)))) (, ,) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NML (CD 1) (NN minute)) (NML (NN annealing) (HYPH /) (NN extension))) (PP (IN at) (NP (CD 60) (NN °C))))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ final) (NN step)) (VP (VBD was) (NP-PRD (NP (DT a) (NML (CD 60) (NN °C)) (NN incubation)) (PP-TMP (IN for) (NP (CD 1) (NN minute))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN run))))) (, ,) (NP-SBJ-1 (NNS samples)) (VP (VBD were) (VP (VBN heated) (NP-1 (-NONE- *)) (PP (IN to) (NP (CD 95) (NN °C))) (PP-TMP (IN with) (NP (NP (DT a) (NN ramp) (NN time)) (PP (IN of) (NP (CD 20) (NNS minutes))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB construct) (NP (NN dissociation) (NNS curves)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB ensure) (SBAR (IN that) (S (NP-SBJ-2 (JJ single) (NN PCR) (NNS products)) (VP (VBD were) (VP (VBN obtained) (NP-2 (-NONE- *)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS reactions)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (NN triplicate))))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (NML (NN Threshold) (NN cycle)) (-LRB- -LRB-) (NML (NN CT))) (-RRB- -RRB-) (NN analysis)) (PP (IN of) (NP (DT all) (NNS samples)))) (VP (VBD was) (VP (VBN set) (NP-1 (-NONE- *)) (PP (IN at) (NP (CD 0.5) (NML (JJ relative) (NN fluorescence)) (NNS units))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ relative) (NNS quantities)) (PP (IN of) (NP (NN message))) (PP (IN of) (NP (NP (NNS genes)) (PP (IN of) (NP (NN interest))))) (PP (IN from) (NP (NP (DT the) (NML (NN mouse) (NN liver)) (NNS samples)) (VP (VBN used) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (JJ real) (HYPH -) (NN time)) (NN RT) (HYPH -) (NN PCR))))))) (VP (VBD were) (VP (VBN normalized) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN cyclophilin))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB compensate) (PP (IN for) (NP (NP (NNS variations)) (PP (IN in) (NP (NML (NN input) (NN RNA)) (NNS amounts)))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS data)) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (JJ comparative) (NML (NN threshold) (NN cycle)) (NN method)) (-LRB- -LRB-) (NP (NN CT))))))) (-RRB- -RRB-) (. .)) )
( (S (ADVP (RB Briefly)) (, ,) (NP-SBJ-1 (DT the) (NN CT) (NNS values)) (VP (VBP are) (VP (VBN averaged) (NP-1 (-NONE- *)) (, ,) (PP (IN from) (NP (NP (DT the) (NNS triplicates)) (VP (VBG defining) (NP (NP (DT a) (NML (NN Δ) (HYPH -) (NN CT)) (NN value)) (VP (VBN calculated) (NP (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG taking) (NP (NP (DT the) (JJ average) (NN CT)) (PP (IN of) (NP (NP (DT the) (NN gene)) (PP (IN of) (NP (NN interest))))))) (CC and) (VP (VBG subtracting) (NP (PRP it)) (PP (IN from) (NP (NP (DT the) (JJ average) (NN CT)) (PP (IN of) (NP (NN cyclophilin)))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN ΔΔ) (HYPH -) (NN CT)) (VP (VBD was) (VP (VBN calculated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG subtracting) (NP (DT the) (JJ average) (NML (NN Δ) (HYPH -) (NN CT) (PRN (-LRB- -LRB-) (NP (NN calibrator)) (-RRB- -RRB-))) (NNS values)) (PP (IN from) (NP (DT the) (NN Δ) (HYPH -) (NN CT) (PRN (-LRB- -LRB-) (NP (NN sample)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ relative) (NN quantification)) (VP (VBD was) (ADVP-TMP (RB then)) (VP (VBN calculated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP-LGS (DT the) (NN expression) (CD 2) (SYM -) (NN AverageΔΔ) (SYM -) (NN CT))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (DT The) (NN mRNA) (NN quantity)) (PP (IN for) (NP (DT the) (NN calibrator) (PRN (-LRB- -LRB-) (NP (JJ wild) (NN type)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN as) (NP (CD 1)))))) (CC and) (S (NP-SBJ-2 (DT all) (JJ other) (NNS quantities)) (VP (VBD were) (VP (VBN expressed) (NP-2 (-NONE- *)) (PP (IN as) (NP (NP (DT a) (NN fold) (NN difference)) (ADJP (JJ relative) (PP (IN to) (NP (DT the) (NN calibrator) (PRN (-LRB- -LRB-) (NP (JJ wild) (NN type)) (-RRB- -RRB-)))))))))) (. .)) )
( (HEADING (NP (NP (NML (NN Plasma) (NN lipid)) (NN analysis)) (PP (IN by) (NP (NML (JJ fast) (NN protein)) (NN liquid) (NN chromatography))))) )
( (S (PP-TMP (VBG Following) (NP (NP (CD 16) (NNS hrs)) (PP (IN of) (NP (NN fasting))))) (, ,) (NP-SBJ-1 (NP (NN blood) (NNS samples) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 3)))) (-RRB- -RRB-))) (PP (IN from) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +)) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NNS mice)))))) (VP (VBD were) (VP (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (ADJP (JJ retro) (HYPH -) (JJ orbital)) (NN venous) (NN plexus))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (VBN heparinized) (JJ capillary) (NNS tubes)))) (PP (IN under) (NP (NN isoflurane) (NN anesthesia)))) (, ,) (CC and) (VP (VBN placed) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (NP (JJ precooled) (NNS tubes)) (VP (VBG containing) (NP (NP (CD 10) (NN μl)) (PP (IN of) (NP (NML (CD 0.5) (NN M)) (NN EDTA)))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (JJ Equal) (NNS volumes)) (PP (IN of) (NP (NP (NN plasma)) (PP (IN from) (NP (DT each) (NN genotype)))))) (VP (VBD were) (VP (VBN pooled) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (NP (CD 100) (NN μL)) (PP (IN of) (NP (DT the) (VBN pooled) (NN sample)))) (VP (VBD were) (VP (VP (VBN injected) (CC and) (VBN fractionated) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NML (JJ fast) (NN protein)) (NN liquid) (NN chromatography)) (-LRB- -LRB-) (NP (NN FPLC)))) (-RRB- -RRB-) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NML (NN Superose) (CD 6)) (NML (NN HR10) (HYPH /) (CD 30)) (NN column) (PRN (-LRB- -LRB-) (NP (NP (NNP Pharmacia) (NNP Biotech) (NNP Inc.)) (, ,) (NP-LOC (NNP Piscataway)) (, ,) (NP-LOC (NNP NJ)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-)))))) (CC and) (VP (VBN analyzed) (NP-2 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN described) (NP-3 (-NONE- *))))))))) (PRN (-LRB- [) (NP (CD 27)) (-RRB- ])) (. .)) )
( (HEADING (NP (NP (NN Sterol) (NN composition)) (PP (IN of) (NP (NN plasma) (CC and) (NNS tissues))))) )
( (S (PP-TMP (VBG Following) (NP (NP (DT a) (NML (CD four) (HYPH -) (NN hour)) (NN fast)) (PP (IN of) (NP (NP (ADJP (NP (CD 12) (HYPH -) (NN week)) (HYPH -) (JJ old)) (NNS mice)) (VP (VBN fed) (NP (-NONE- *)) (PP (IN on) (NP (JJ regular) (NML (NN rodent) (NN chow)) (NN diet)))))))) (: ;) (NP-SBJ-1 (NN blood) (CC and) (NNS tissues)) (VP (VBD were) (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN under) (NP (NN isofluorane) (NN anesthesia))) (PP (IN from) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +)) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NNS mice) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 3)) (PP (IN for) (NP (DT each) (NN group))))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NN Blood)) (VP (VBD was) (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (ADJP (JJ retro) (HYPH -) (JJ orbital)) (NN venous) (NN plexus))) (PP-MNR (IN by) (NP (VBN heparinized) (NN glass) (NN tube))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS animals)) (VP (VBD were) (VP (VBN sacrificed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ cervical) (NN dislocation))) (PP-PRP (IN for) (NP (NN tissue) (NN collection))))) (. .)) )
( (S (S (NP-SBJ-1=4 (NN Plasma) (PRN (-LRB- -LRB-) (NP (CD 100) (NN μl)) (-RRB- -RRB-))) (VP (VBD was) (VP=5 (VBN saponified) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 1) (NN N)) (NN NaOH))) (PP-TMP (IN for) (NP (CD one) (NN hour)))))) (, ,) (S (NP-SBJ-2=4 (NP (CD 1.5) (NN mL)) (NN water)) (VP=5 (VBD added) (NP-2 (-NONE- *)))) (CC and) (S (NP-SBJ-3=4 (NNS sterols)) (VP=5 (VP (VBN extracted) (NP-3 (-NONE- *)) (PP (IN with) (NP (NP (CD three) (JJ sequential) (NNS portions)) (PP (IN of) (NP (NP (NML (CD 1.5) (NN mL)) (NN ethyl) (NN acetate)) (, ,) (VP (VBG containing) (NP (NP (NML (CD 70) (NN μg)) (NN 5α) (HYPH -) (NN cholestane)) (PP (IN as) (NP (DT an) (JJ internal) (NN standard)))))))))) (, ,) (VP (VBN pooled) (NP-3 (-NONE- *))) (CC and) (VP (VBN dried) (NP-3 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (NN Mouse) (NML (NML (NNS tissues)) (-LRB- -LRB-) (NML (NN liver) (, ,) (NN spleen) (CC and) (NN brain)))) (-RRB- -RRB-) (VP (VBD were) (VP (VP (VBN weighed) (NP-1 (-NONE- *))) (, ,) (VP (VBN homogenized) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NML (CD 1) (NN mL)) (NML (NML (NML (NN phosphate) (NN buffer)) (NN saline)) (-LRB- -LRB-) (NML (NN PBS)))) (-RRB- -RRB-) (PP (IN with) (NP (NP (DT a) (NN dounce) (NN homogenizer) (PRN (-LRB- -LRB-) (NP (NP (CD 15) (NNS strokes)) (PP (IN at) (NP (CD 500) (NN rpm)))) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (JJ small) (NN aliquot)) (PP (IN of) (NP (NP (DT the) (JJ whole) (NN homogenate)) (VP (VBN assayed) (NP (-NONE- *)) (PP (IN for) (NP (NN protein) (NN concentration)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Aliquots)) (PP (IN for) (NP (NN sterol) (NN analysis))) (PP (IN from) (NP (JJ whole) (NN tissue) (NNS homogenates)))) (VP (VBD were) (VP (VBN extracted) (NP-1 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-LOC (RB above))))))) (. .)) )
( (S (S (NP-SBJ-1 (VBN Dried) (NN sterol) (NNS samples)) (VP (VBD were) (VP (VP (VBN derivatized) (NP-1 (-NONE- *)) (PP (IN as) (NP (NNS trimethylsilylethers)))) (, ,) (VP (VBN redissolved) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 10) (NN μL)) (NN hexane))))))) (CC and) (S (NP-SBJ-2 (NML (CD 2) (NN μL)) (NNS samples)) (VP (VBD were) (VP (VBN injected) (NP-2 (-NONE- *)) (PP-DIR (IN into) (NP (NP (NP (DT a) (JJ capillary) (NN column) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 26) (NN m)) (NN length)) (, ,) (NP (NML (CD 0.32) (NN mm)) (NN ID)) (, ,) (NP (NML (CD 0.45) (NN mm)) (NN OD))) (-RRB- -RRB-))) (VP (VBN coated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (JJ liquid) (NN CpWAX) (NML (CD 57) (NN CB)) (PRN (-LRB- -LRB-) (NP (NP (NNP Chrompak)) (, ,) (NP-LOC (NNP Bridgewater)) (, ,) (NP-LOC (NNP NJ)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-)))))) (PP-LOC (IN in) (NP (NP (DT a) (NML (NNP Hewlett) (HYPH -) (NNP Packard)) (NNP Gas) (NNP Chromatograph)) (VP (VBN equipped) (NP (-NONE- *)) (PP (IN with) (NP (DT a) (NML (NN flame) (NN ionization)) (NN detector))))))))))) (PRN (-LRB- [) (NP (CD 28)) (-RRB- ])) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Concentrations)) (PP (IN of) (NP (NML (NN plasma) (CC and) (NN tissue)) (NNS sterols)))) (VP (VBD were) (VP (VBN reported) (NP-1 (-NONE- *)) (PP (IN as) (NP (NML (NML (NML (NN mg)) (PP (SYM /) (NP (NN dL)))) (CC and) (NML (NML (NN μg)) (PP (SYM /) (NP (NN g))))) (NML (JJ wet) (NN weight)) (NN tissue))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (HEADING (NP (JJ Polyclonal) (NN antibody) (NN production))) )
( (S (NP-SBJ-1 (CD Three) (JJ separate) (JJ polyclonal) (UCP (ADJP (JJ anti-Abcg5)) (HYPH /) (NML (NN sterolin) (HYPH -) (CD 1))) (NNS antibodies)) (VP (VBP have) (VP (VBN been) (VP (VBN raised) (NP-1 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *))))) (PRN (-LRB- [) (NP (CD 20) (, ,) (CD 29) (, ,) (CD 30)) (-RRB- ]))))) (. .)) )
( (S (PP-LOC (IN In) (NP (NNS experiments))) (, ,) (NP-SBJ-1 (UCP (ADJP (JJ anti-Abcg5)) (HYPH /) (NML (NN sterolin) (HYPH -) (CD 1))) (NNS antibodies)) (VP (VBP are) (VP (VBN labelled) (NP-1 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBZ follows)))))) (: :)) )
( (FRAG (FRAG (LST (LS 1) (-RRB- -RRB-)) (NP (NN SC)) (: –) (PP (IN from) (NP (DT the) (NNP Patel) (NN group)))) (, ,) (FRAG (LST (LS 2) (-RRB- -RRB-)) (NP (NN AMC)) (: –) (PP (IN from) (NP (DT the) (NML (NNP AMC) (NNP Liver) (NNP Center)) (NN group)))) (, ,) (CC and) (FRAG (LST (LS 3) (-RRB- -RRB-)) (NP (NN UTSW)) (: –) (PP (IN from) (NP (DT the) (NNP Hobbs) (NN group)))) (. .)) )
( (HEADING (NP (NML (NN Membrane) (NN protein)) (NNS preparations))) )
( (S (NP-SBJ-1 (JJ Total) (NNS membranes)) (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG taking) (NP (NP (QP (RB approximately) (CD 500)) (NN mg)) (PP (IN of) (NP (NP (NN liver) (NN tissue)) (VP (VP (VBD cut) (NP (-NONE- *)) (PP (IN into) (NP (JJ small) (NNS pieces)))) (CC and) (VP (VBN homogenized) (NP (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NN ice) (JJ cold)) (NN lysis) (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NML (CD 5) (NN mM)) (NN Tris)) (HYPH -) (NP-ADV (NN pH) (CD 7.5))) (, ,) (NP (NML (CD 250) (NN mM)) (NN sucrose))) (PP (IN with) (NP (NN protease) (NNS inhibitors)))) (-RRB- -RRB-)))) (PP-MNR (IN by) (NP-LGS (NP (DT a) (NN dounce) (NN homogenizer)) (PP (IN times) (NP (CD 10) (NNS strokes))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Samples)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NN centrifugation)) (: –) (NP-ADV (NP (CD 1300) (NN g)) (PP-TMP (IN for) (NP (CD 10) (NNS minutes))) (PP (IN at) (NP (CD 4) (NN °C)))))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NN supernant)) (VP (VBD was) (VP (VBN saved) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (DT the) (NN pellet)) (VP (VBD was) (VP (VP (VBN resuspended) (NP-2 (-NONE- *))) (CC and) (VP (ADVP-TMP (RB again)) (VBN subjected) (NP-2 (-NONE- *)) (PP (IN to) (NP (NP (NN dounce) (NN homogenization)) (PP (IN times) (NP (CD 10) (NNS strokes)))))) (VP (ADVP-TMP (RB then)) (VBD centrifuged) (NP-2 (-NONE- *)) (NP-ADV (CD 1000) (NN g)) (PP-TMP (IN for) (NP (CD 10) (NNS minutes))) (PP (IN at) (NP (CD 4) (NN °C))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN step)) (VP (VBD was) (VP (VBN repeated) (NP-1 (-NONE- *)) (NP-TMP (ADVP-TMP (RB twice)) (DT each) (NN time)) (PP (IN with) (S-NOM (NP-SBJ-2 (DT the) (NN supernant)) (VP (VBG being) (VP (VP (VBN collected) (NP-2 (-NONE- *))) (CC and) (VP (VBN kept) (NP-2 (-NONE- *)) (S-CLR (NP-SBJ-2 (-NONE- *PRO*)) (PP-LOC-PRD (IN on) (NP (NN ice))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS supernants)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VP (VBN pooled) (NP-1 (-NONE- *))) (CC and) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NN ultracentrifugation)) (PP (IN at) (NP (CD 100,000) (NN g))))) (PP-TMP (IN for) (NP (CD 60) (NNS minutes))) (PP (IN at) (NP (CD 4) (NN °C)))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NN supernant)) (VP (VBD was) (VP (VBN removed) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (DT the) (NN pellet)) (VP (VBD was) (VP (VBN resuspended) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NN lysis) (NN buffer)))))) (. .)) )
( (S (NP-SBJ-1 (NN Plasma) (NNS membranes)) (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-2 (-NONE- *))))) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Protein) (NN sample)) (NNS concentrations)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP-LGS (NML (NNP Bio) (HYPH -) (NNP Rad)) (ADJP (NN protein) (JJ colormetric)) (NN assay))) (PP (IN per) (NP (NP (NN manufacturer) (POS 's)) (NN protocol) (PRN (-LRB- -LRB-) (NP (NP (NNP BioRad)) (, ,) (NP-LOC (NNP Hercules)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NP (CD 50) (NN μg)) (PP (IN of) (NP (NN membrane) (NN proteins)))) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN resolved) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (NML (CD 7.5) (NN %)) (NN SDS) (NN acrylamide) (NN gel))))) (. .)) )
( (HEADING (NP (NN Immunoblotting))) )
( (S (NP-SBJ-2 (NP (NNS Proteins)) (VP (VBN resolved) (NP (-NONE- *)) (PP-MNR (IN by) (NP-LGS (NN SDS) (HYPH -) (NN PAGE))))) (VP (VBD were) (VP (VBN transferred) (NP-2 (-NONE- *)) (PP-DIR (IN to) (NP (NN nitrocellulose) (NNS membranes))))) (. .)) )
( (S (NP-SBJ-1 (NNS Membranes)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN blocked) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD one) (NN hour))) (PP-LOC (IN in) (NP (NML (CD 5) (NN %)) (JJ dry) (NN milk))) (PP-LOC (IN in) (NP (NP (NN PBS) (HYPH -) (NN T)) (-LRB- -LRB-) (NP (NP (ADJP (NN Phosphate) (VBN Buffered)) (NN saline)) (CC and) (NP (NML (CD 0.1) (NN %)) (NN Tween) (CD 20))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NNS Blots)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN probed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (JJ primary) (NN antibody)) (PP (IN against) (NP (NN Abcg5))))) (PP-LOC (IN in) (NP (NML (CD 5) (NN %)) (NN milk))) (PP-LOC (IN in) (NP (NN PBS) (HYPH -) (NN T))) (ADVP-TMP (RB overnight)) (PP-LOC (IN at) (NP (CD 4) (NN °C))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN blot)) (VP (VBD was) (VP (VP (ADVP-TMP (RB then)) (VBN washed) (NP-1 (-NONE- *)) (NP-TMP (CD three) (NNS times)) (PP-TMP (IN for) (NP (CD five) (NNS minutes))) (PP-LOC (IN in) (NP (NP (NN TBS) (HYPH -) (NN T)) (-LRB- -LRB-) (NP (NP (ADJP (NN Tris) (VBN Buffered)) (NN Saline)) (HYPH /) (NP (NML (CD 0.1) (NN %)) (NN Tween) (HYPH -) (NN 20))))) (-RRB- -RRB-) (PP-MNR (IN with) (NP (NML (CD 150) (NN mM)) (NN NaCl)))) (, ,) (CC and) (VP (ADVP (RB secondarily)) (VBN stained) (NP-1 (-NONE- *)) (PP (IN with) (NP (ADJP (NP (NN goat) (HYPH -) (NN anti-rabbit)) (VBN conjugated)) (NN HRP) (NML (NML (CD 1)) (PP (SYM :) (NP (CD 10,000)))) (NN dilution))) (PP-LOC (IN in) (NP (NML (CD 5) (NN %)) (NN milk))) (PP-LOC (IN in) (NP (NN PBS) (HYPH -) (NN T))) (PP-TMP (IN for) (NP (CD one) (NN hour)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN blot)) (VP (VBD was) (ADVP-TMP (RB again)) (VP (VP (VBN washed) (NP-1 (-NONE- *)) (NP-TMP (CD three) (NNS times)) (PP-TMP (IN for) (NP (CD five) (NNS minutes))) (PP-LOC (IN in) (NP (NN TBS) (HYPH -) (NN T))) (PP-MNR (IN with) (NP (NML (CD 150) (NN mM)) (NN NaCl)))) (VP (ADVP-TMP (RB then)) (VBN covered) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NNP Western) (NNP Lightning®)) (NNP Chemiluminescence) (NNP Reagent) (NNP Plus) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP PerkinElmer) (NNP Life) (NNPS Sciences)) (, ,) (ADJP (NNP Inc.))) (NP-LOC (NNP Boston)) (, ,) (NP-LOC (NNP MA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))))) (, ,) (VP (VBN wrapped) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN plastic)))) (, ,) (VP (VBN exposed) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN film)))) (CC and) (VP (VBN developed) (NP-1 (-NONE- *))))) (. .)) )
( (HEADING (NP (JJ Immunohistochemical) (NN analysis))) )
( (S (NP-SBJ-1 (ADJP (RB Snap) (HYPH -) (VBN frozen)) (NML (NN liver) (CC and) (NN intestine)) (NN tissue)) (VP (VP (VBD were) (VP (VBN cut) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (ADJP (NP (CD 8) (NN μm)) (JJ thick)) (JJ frozen) (NNS sections))))))) (, ,) (VP (NN air) (HYPH -) (VBN dried) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 30) (NNS minutes))) (PP-DIR (IN onto) (NP (NN glass) (NNS slides)))) (CC and) (VP (VBN stored) (NP-1 (-NONE- *)) (PP (IN at) (NP (QP (SYM -) (CD 80)) (NN °C))) (SBAR-TMP (IN until) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN required) (NP-2 (-NONE- *))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS slides)) (VP (VBD were) (VP (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN hematoxylin)))) (, ,) (VP (VBD rinsed) (NP-1 (-NONE- *)) (NP-TMP (CD three) (NNS times)) (PP-MNR (IN with) (NP (NN PBS)))) (, ,) (VP (VBN fixed) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 10) (NN min))) (PP-MNR (IN with) (NP (VBN cooled) (NN methanol))) (PP (IN at) (NP (QP (SYM -) (CD 20)) (NN °C)))) (CC and) (VP (ADVP-TMP (RB then)) (VBD rinsed) (NP-1 (-NONE- *)) (NP-TMP (CD three) (NNS times)) (PP-MNR (IN with) (NP (NN PBS)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Slides)) (PP (IN for) (NP (NN antibody) (NN staining)))) (VP (VBD were) (ADVP-TMP (RB initially)) (VP (VP (VBN blocked) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN PBS) (HYPH /) (CD 0.1) (NN M)) (NML (NN glycine) (HYPH /) (CD 10) (NN %)) (NN goat) (NN serum))) (PP-TMP (IN for) (NP (CD 60) (NN min))) (PP (IN at) (NP (NN room) (NN temperature)))) (VP (ADVP-TMP (RB then)) (VBN incubated) (NP-1 (-NONE- *)) (PP (IN with) (NP (ADJP (JJ anti-sterolin) (HYPH -) (CD 1)) (NN antibody) (PRN (-LRB- -LRB-) (NP (NML (NML (CD 1)) (PP (SYM :) (NP (CD 15)))) (NN dilution)) (-RRB- -RRB-)))) (ADVP-TMP (RB overnight)) (PP (IN at) (NP (CD 4) (NN °C)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS slides)) (VP (VBD were) (VP (VP (VP (VBN washed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (QP (CD 1) (SYM ×)) (NN PBS)))) (CC and) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP (IN with) (NP (JJ secondary) (NN antibody) (PRN (-LRB- -LRB-) (NP (NP (NML (NN goat) (HYPH -) (NN anti-rabbit)) (NN IgG)) (VP (VBN conjugated) (NP (-NONE- *)) (PP (IN with) (NP (NN rhodamine))))) (, ,) (NP (NML (NML (CD 1)) (PP (SYM :) (NP (CD 1000)))) (NN dilution)) (-RRB- -RRB-)))) (PP-TMP (IN for) (NP (CD 30) (NN min))) (PP (IN at) (NP (NN room) (NN temperature))))) (, ,) (VP (VP (VBD washed) (NP-1 (-NONE- *))) (CC and) (VP (ADVP-TMP (RB then)) (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN under) (NP (NP (DT an) (NNP Olympus) (NML (NN BX) (HYPH -) (CD 5)) (JJ confocal) (NN microscope)) (PP (IN with) (NP (NNP Fluoview))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNS sections)) (VP (VBN stained) (NP (-NONE- *)) (PP-LOC (IN at) (NP (DT the) (NNP AMC) (NNP Liver) (NNP Center))))) (VP (VBD were) (VP (VP (VBN fixed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 100) (NN %)) (NN acetone))) (PP-TMP (IN for) (NP (CD 30) (NN min))) (PP (IN at) (NP (NN room) (NN temperature)))) (, ,) (VP (VBD blocked) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (NN solution)) (PP (IN of) (NP (NML (NN PBS) (HYPH /) (CD 0.05) (NN %)) (NML (NML (NNP Tween) (HYPH -) (CD 20)) (HYPH /) (CD 5) (NN %)) (NML (NML (NN goat) (NN serum)) (-LRB- -LRB-) (NML (NN GS)) (-RRB- -RRB-)))))) (PP-TMP (IN for) (NP (CD one) (NN hour)))) (, ,) (VP (ADVP-TMP (RB then)) (VBN incubated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NP (NN Anti-sterolin) (HYPH -) (CD 1) (PRN (-LRB- -LRB-) (NP (NML (NML (CD 1)) (PP (SYM :) (NP (CD 40)))) (NN dilution)) (-RRB- -RRB-))) (CC and) (NP (JJ anti-Bsep) (PRN (-LRB- -LRB-) (NP (NML (NML (CD 1)) (PP (SYM :) (NP (CD 200)))) (NN dilution)) (-RRB- -RRB-)))) (VP (VBN diluted) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN PBS) (HYPH /) (NN Tween) (HYPH /) (NN GS))) (, ,) (PP-TMP (IN for) (NP (CD one) (NN hour))))))))) (. .)) )
( (S (ADVP-TMP (RB Thereafter)) (, ,) (S (NP-SBJ-1 (NNS slides)) (VP (VBD were) (VP (VBN washed) (NP-1 (-NONE- *)) (NP-TMP (QP (CD 3) (SYM ×)) (CD 10) (NN min)) (PP-LOC (IN in) (NP (NN PBS) (HYPH /) (NN Tween)))))) (CC and) (S (NP-SBJ-2 (NP (DT the) (JJ secondary) (NN antibody)) (-LRB- -LRB-) (NP (NML (NN goat) (HYPH -) (NN anti-rabbit)) (NNP Alexa) (CD 488))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN applied) (NP-2 (-NONE- *)) (PP (IN in) (NP (NML (NML (CD 1)) (PP (SYM :) (NP (CD 1000)))) (NN dilution))) (PP-LOC (IN in) (NP (NN PBST) (HYPH /) (NN GS))) (PP-TMP (IN for) (NP (CD one) (NN hour))) (PP (IN at) (NP (NN room) (NN temperature)))))) (. .)) )
( (S (PP-TMP (IN After) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG washing) (PP-TMP (IN for) (NP (QP (CD 3) (SYM ×)) (CD 10) (NN min)))))) (NP-SBJ-1 (DT the) (NNS sections)) (VP (VBD were) (VP (VBN mounted) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Dapi) (HYPH /) (NN Dapco)) (NN solution))))) (. .)) )
( (S (NP-SBJ-1 (NN Fluorescence) (NN microscopy)) (VP (VBD was) (VP (VBN done) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT a) (NNP Leica) (NML (NN DM) (NN RA2)) (NN microscope)) (VP (VBN equipped) (NP (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NNP Leica) (NN DC350F) (NN photo) (NN camera)))))))) (. .)) )
( (S (S (PP-PRP (IN For) (NP (NNP Dapi) (NN staining))) (, ,) (NP-SBJ-1 (CD 359) (NN nm) (PRN (-LRB- -LRB-) (NP (NML (CD 30.38) (NN ms)) (NN exposure)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *))))) (CC and) (S (PP-PRP (IN for) (NP (NML (NN Abcg5) (CC and) (NN Bsep)) (NN staining))) (, ,) (NP-SBJ-2 (CD 514) (NN nm) (PRN (-LRB- -LRB-) (PP (IN for) (NP (DT both))) (: :) (NP (NML (CD 1654.34) (NN ms)) (NN exposure)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (NP-2 (-NONE- *))))) (CC and) (S (NP-SBJ-3 (DT the) (NNS pictures)) (VP (VBD were) (VP (VBN analyzed) (CC and) (VBN overlaid) (NP-3 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN FW4000) (NN software) (PRN (-LRB- -LRB-) (NP (NNP Leica)) (-RRB- -RRB-)))))))) (. .)) )
( (HEADING (NP (NP (NN Transfection) (CC and) (NN immunostaining)) (PP (IN of) (NP (NML (NN COS) (HYPH -) (CD 1)) (NNS cells))))) )
( (S (NP-SBJ-1 (NML (NN COS) (HYPH -) (CD 1)) (NNS cells)) (VP (VBD were) (ADVP (RB transiently)) (VP (VBN transfected) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (NML (NML (NN pCMV) (HYPH -) (NN mouse)) (NN Abcg5)) (CC and) (NML (NML (NN pCMV) (HYPH -) (NN mouse)) (NN Abcg8))) (NN expression) (NNS constructs))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NNP Qiagen) (NN SuperFect) (NN reagent)))) (PP (IN per) (NP (NN protocol))) (PRN (-LRB- -LRB-) (NP (NP (NNP Valencia)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Briefly)) (, ,) (NP-SBJ-1 (NML (NN COS) (HYPH -) (CD 1)) (NNS cells)) (VP (VBD were) (VP (VBN seeded) (NP-1 (-NONE- *)) (PP-DIR (IN onto) (NP (DT a) (NML (CD six) (HYPH -) (NN well)) (NN plate))) (NP-TMP (NP (DT the) (NN day)) (PP (JJ prior) (PP (IN to) (NP (NN transfection))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (NML (CD 60) (NN %)) (NN confluence)) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN grown) (NP-2 (-NONE- *)) (PP (IN at) (NP (NP (CD 37) (NN °C)) (CC and) (NP (NML (CD 5) (NN %)) (NN CO2)))) (PP-LOC (IN in) (NP (NP (NN DMEM)) (VP (VBN supplemented) (NP (-NONE- *)) (PP (IN with) (NP (NP (NML (CD 10) (NN %)) (NN FBS)) (, ,) (NP (NML (NML (CD 100) (NN U)) (PP (SYM /) (NP (NN ml)))) (NN penicillin)) (, ,) (NP (NML (NML (CD 100) (NN μg)) (PP (SYM /) (NP (NN ml)))) (NN streptomycin)) (CC and) (NP (QP (CD 1) (SYM ×)) (NN glutamine))))))) (ADVP-TMP-3 (-NONE- *T*)))))))))) (. .)) )
( (S (PP-TMP (IN On) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (NN transfection))))) (, ,) (NP-SBJ-1 (NP (CD 2) (NN μg)) (PP (IN of) (NP (NN DNA)))) (VP (VBD was) (VP (VP (VBN mixed) (NP-1 (-NONE- *)) (PP (IN with) (NP (NML (NNP Qiagen) (NN SuperFect)) (NN reagent)))) (CC and) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 10) (NNS minutes)))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN mixture)) (VP (VBD was) (ADVP-TMP (RB then)) (VP (VP (VBN added) (NP-1 (-NONE- *)) (PP (IN to) (NP (ADJP (NN serum) (HYPH -) (JJ free)) (NNS media)))) (CC and) (VP (VBN placed) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (DT the) (NNS cells))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB incubate) (PP-TMP (IN for) (NP (CD two) (NNS hours))))))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NNS cells)) (VP (VBD were) (VP (VBN washed) (NP-1 (-NONE- *)) (ADVP-TMP (RB once)) (PP (IN with) (NP (NN 1x) (NNS PBS)))))) (CC and) (S (NP-SBJ-2 (JJ fresh) (NNS media)) (VP (VBD was) (VP (VBN added) (NP-2 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBN transfected) (NNS cells)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 48) (NNS hours))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB ensure) (NP (NN expression)))))) (CC and) (VP (ADVP (RB subsequently)) (VBN fixed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NML (NML (CD 1)) (PP (SYM :) (NP (CD 1)))) (NN mixture)) (PP (IN of) (NP (NP (NN acetone)) (PP (SYM :) (NP (NN methanol)))))))))) (. .)) )
( (S (PP-PRP (IN In) (NP (NP (NN preparation)) (PP (IN for) (NP (NN immunostaining))))) (, ,) (NP-SBJ-1 (NNS cells)) (VP (VBD were) (VP (VP (VBN blocked) (NP-1 (-NONE- *)) (PP (IN with) (NP (NML (CD 2) (NN %)) (NN goat) (NN serum))) (PP-LOC (IN in) (NP (NN PBS))) (PP-TMP (IN for) (NP (CD 30) (NNS minutes)))) (, ,) (VP (ADVP-TMP (RB then)) (VBN incubated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NML (NML (CD 1)) (PP (SYM :) (NP (CD 50)))) (NN dilution)) (PP (IN of) (NP (NML (JJ primary) (NN antibody)) (NN anti-Abcg5))))) (PP-LOC (IN in) (NP (NML (CD 2) (NN %)) (NML (NN goat) (NN serum)) (HYPH -) (NN PBS))) (PP-TMP (IN for) (NP (CD 1.5) (NNS hours)))) (, ,) (CC and) (VP (ADVP-TMP (RB subsequently)) (VBN incubated) (NP-1 (-NONE- *)) (PP (IN with) (NP (JJ secondary) (NN rhodamine) (NN anti-rabbit) (NN IgG) (NN antibody))) (PP-TMP (IN for) (NP (CD 30) (NNS minutes)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Cells)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN under) (NP (NP (DT an) (NNP Olympus) (NML (NN BX) (HYPH -) (CD 5)) (JJ confocal) (NN microscope)) (PP (IN with) (NP (NNP Fluoview))))))) (. .)) )
( (HEADING (NP (JJ Dynamic) (NML (JJ biliary) (NN lipid)) (NML (NN collection) (CC and) (NN analysis)))) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN anaesthetized) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ intraperitoneal) (NN injection)) (PP (IN of) (NP (NP (NML (NML (CD 1) (NN mL)) (PP (SYM /) (NP (NN kg)))) (NN fentanyl) (HYPH /) (NN fluanisone)) (CC and) (NP (NML (NML (CD 10) (NN mg)) (PP (SYM /) (NP (NN kg)))) (NN Diazepam)))))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (NN abdomen)) (VP (VBD was) (VP (VBN opened) (NP-1 (-NONE- *))))) (CC and) (, ,) (S (PP-TMP (IN after) (NP (NP (JJ distal) (NN ligation)) (PP (IN of) (NP (DT the) (NN bile) (NN duct))))) (, ,) (NP-SBJ-2 (DT the) (NN gallbladder)) (VP (VBD was) (VP (VBN cannulated) (NP-2 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (NN Bile) (NN sampling)) (VP (VP (VBD started) (PP-TMP (ADVP (RB directly)) (IN after) (NP (NN cannulation)))) (CC and) (VP (VBD was) (VP (VBN collected) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 10) (NN min)))))) (. .)) )
( (S (NP-SBJ-1 (NN Bile) (NN flow)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (ADVP-MNR (RB gravimetrically)))) (. .)) )
( (S (NP-SBJ-1 (NML (JJ Biliary) (NN bile)) (NML (NN salt) (, ,) (NN sterol) (CC and) (NN phospholipid)) (NNS concentrations)) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously))))) (PRN (-LRB- [) (NP (CD 32)) (-RRB- ])))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (NP (NP (JJ maximal) (NN secretion) (NNS rates)) (PP (IN of) (NP (NML (JJ biliary) (NN lipid)) (NN secretion))))))) (, ,) (NP-SBJ-1 (NN bile)) (VP (VBD was) (VP (VBN diverted) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 90) (NN min))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB deplete) (NP (DT the) (JJ endogenous) (NML (NN bile) (NN salt)) (NN pool))))))) (. .)) )
( (S (ADVP-TMP (RB Subsequently)) (, ,) (NP-SBJ-1 (NP (NN tauroursodeoxycholate) (PRN (-LRB- -LRB-) (NP (NP (NNP Sigma) (NNP Chemical) (NNP Co.)) (, ,) (NP-LOC (NNP MO)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-))) (VP (VBN dissolved) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN PBS))))) (VP (VBD was) (VP (VBN infused) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (DT the) (JJ jugular) (NN vein))) (PP (IN in) (NP (JJ stepwise) (VBG increasing) (NNS rates))) (PP (IN from) (NP (NP (QP (CD 600) (SYM –) (CD 1,800)) (NN nmol)) (PP (SYM /) (NP (NN min))) (PP (SYM /) (NP (NML (CD 100) (NN g)) (NN body) (NN weight))))))) (. .)) )
( (S (NP-SBJ-1 (NN Bile)) (VP (VBD was) (VP (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 10) (NN min)) (NNS fractions)))) (CC and) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN bile) (NML (NN salt) (CC and) (NN lipid)) (NN content)))))) (. .)) )
( (S (PP-LOC (IN In) (NP (JJ separate) (NNS experiments))) (, ,) (PP-TMP (VBG following) (NP (NP (NP (JJ distal) (NN ligation)) (PP (IN of) (NP (DT the) (NN bile) (NN duct)))) (CC and) (NP (NP (NN cannulation)) (PP (IN of) (NP (NN gallbladder)))))) (, ,) (NP-SBJ-1 (NN bile)) (VP (VBD was) (VP (VBN diverted) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 30) (NNS minutes))) (SBAR-TMP (IN while) (S (NP-SBJ-2 (NNS mice)) (VP (VBD were) (VP (VBN infused) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (JJ sterile) (NN PBS))))))))) (. .)) )
( (S (ADVP-TMP (RB Subsequently)) (, ,) (S (S (NP-SBJ-1 (DT the) (NNS mice)) (VP (VBD were) (VP (VBN infused) (NP-1 (-NONE- *)) (ADVP (RB continuously)) (PP (IN with) (NP (NP (CD 1,200) (NN nmol)) (PP (SYM /) (NP (NN min))) (PP (SYM /) (NP (NML (CD 100) (NN g)) (NN body) (NN weight))) (PP (IN of) (NP (NN tauroursodeoxycholate)))))))) (CC and) (S (NP-SBJ-2 (CD two) (NML (CD 30) (HYPH -) (NN minute)) (NNS fractions)) (VP (VBD were) (VP (VBN collected) (NP-2 (-NONE- *)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Sterol) (NNS analyses)) (PP (IN of) (NP (NN bile)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN GC) (NN analysis))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-LOC (RB above))))))) (. .)) )
( (HEADING (NP (NP (NP (NN Assay)) (PP (IN of) (NP (NN HMG) (HYPH -) (NN CoA)))) (CC and) (NP (NML (NN cholesterol) (NML (NML (CD 7) (NN α)) (HYPH -) (NN hydroxylase)) (NN enzyme)) (NN activity)))) )
( (S (NP-SBJ-1 (NML (NN Mouse) (NN liver)) (NNS microsomes)) (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ differential) (NN centrifugation))) (PRN (-LRB- [) (NP (CD 33)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB Briefly)) (, ,) (NP-SBJ-1 (NML (QP (CD 0.1) (SYM –) (CD 0.2)) (NN g)) (NN liver)) (VP (VBD was) (VP (VBN homogenized) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (NML (NNP Potter) (HYPH -) (NNP Elvjhem)) (NN homogenizer)) (PP (IN with) (NP (NP (CD five) (NNS volumes)) (PP (IN of) (NP (NP (NN buffer)) (-LRB- -LRB-) (NP (NP (NP (NML (CD 0.25) (NN M)) (NN sucrose)) (, ,) (NP (NML (CD 0.1) (NN M)) (NN Tris)) (, ,) (NP (NML (CD 0.1) (NN mM)) (NN disodium) (NN EDTA)) (, ,) (NP (NML (CD 0.1) (NN mM)) (NN DTT))) (, ,) (NP-ADV (NN pH) (CD 7.4))))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NNS Microsomes)) (VP (VBD were) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ differential) (NN centrifugation) (PRN (-LRB- -LRB-) (NP (NP (CD 10,000) (NN g)) (PP (IN to) (NP (CD 100,000) (NN g)))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS pellets)) (VP (VBD were) (VP (VP (VBN washed) (NP-1 (-NONE- *))) (CC and) (VP (VBN resuspended) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN storage) (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NP (NML (CD 0.1) (NN M)) (NN dipotassium) (NN phosphate)) (, ,) (NP (NML (CD 0.05) (NN M)) (NN KCl)) (, ,) (NP (NML (CD 1) (NN mM)) (NN DTT)) (, ,) (NP (NML (CD 5) (NN mM)) (NN disodium) (NN EDTA)) (, ,) (NP (NML (CD 20) (NN %)) (NN glycerol))) (, ,) (NP-ADV (NN pH) (CD 7.4))) (-RRB- -RRB-)))) (PP (IN at) (NP (NP (NML (QP (CD 25) (SYM –) (CD 30)) (NN mg)) (NN protein)) (PP (SYM /) (NP (NN ml)))))))) (. .)) )
( (S (NP-SBJ-1 (NN Protein) (NNS concentrations)) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (VBG according) (PP (IN to) (NP (NP (DT the) (NN method)) (PP (IN of) (NP (NP (NNP Lowry)) (ADVP-ETC (FW et) (FW al.))))))) (PRN (-LRB- [) (NP (CD 34)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN activity)) (PP (IN of) (NP (NN cholesterol) (NML (CD 7) (NN α)) (HYPH -) (NN hydroxylase) (PRN (-LRB- -LRB-) (NP (NN EC) (CD 1.14.12.17)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (DT an) (NML (NN isotope) (NN incorporation)) (NN method))) (PP-MNR (VBG according) (PP (IN to) (NP (NP (NP (NNP Shefer)) (ADVP-ETC (FW et) (FW al.))) (PRN (-LRB- [) (NP (CD 33)) (-RRB- ])) (PP (IN with) (NP (DT some) (NNS modifications)))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN reaction) (NN mixture) (PRN (-LRB- -LRB-) (NP (JJ final) (NN volume)) (NP (CD 0.5) (NN ml)) (-RRB- -RRB-))) (VP (VBD consisted) (PP (IN of) (NP (NP (NP (NML (NN potassium) (NN phosphate)) (NN buffer) (PRN (-LRB- -LRB-) (NP (NP (NP (NML (CD 100) (NN mM)) (NN K2HPO4)) (, ,) (NP (NML (CD 0.1) (NN mM)) (NN EDTA)) (, ,) (NP (NML (CD 5) (NN mM)) (NN DTT)) (, ,) (NP (NML (CD 30) (NN mM)) (NN nicotinamide))) (, ,) (NP-ADV (NN pH) (CD 7.4))) (-RRB- -RRB-)) (, ,) (PRN (-LRB- [) (NP (NN 14C)) (-RRB- ]))) (HYPH -) (NP (NN cholesterol) (PRN (-LRB- -LRB-) (NP (QP (CD 5) (SYM ×) (CD 105)) (NN dpm)) (-RRB- -RRB-)))) (VP (VBN solubilized) (NP (-NONE- *)) (PP (IN in) (NP (NP (NP (CD 50) (NN μl)) (PP (IN of) (NP (NML (CD 25) (NN %) (PRN (-LRB- -LRB-) (NP (NN wt) (HYPH /) (NN vol)) (-RRB- -RRB-))) (NN β) (HYPH -) (NN cyclodextrin) (PRN (-LRB- -LRB-) (NP (JJ final) (NN concentration)) (NP (CD 0.8) (NN %)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (QP (CD 50) (SYM –) (CD 200)) (NN μg)) (PP (IN of) (NP (JJ microsomal) (NN protein)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN reaction)) (VP (VP (VBD was) (VP (VBN initiated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (NN NADPH)) (CC or) (NP (NP (DT an) (ADJP (NN NADPH) (HYPH -) (VBG generating)) (NN system)) (-LRB- -LRB-) (NP (NP (NML (CD 3.4) (NN mM)) (NN NADP+)) (, ,) (NP (NML (CD 30) (NN mM)) (NML (NN glucose) (HYPH -) (CD 6)) (HYPH -) (NN phosphate)) (, ,) (NP (NP (CD 0.3) (NN U)) (PP (IN of) (NP (NML (NML (NN glucose) (HYPH -) (CD 6)) (HYPH -) (NN phosphate)) (NN dehydrogenase)))))))))))) (-RRB- -RRB-) (CC and) (VP (VBN continued) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 15) (NN min))) (PP (IN at) (NP (CD 37) (NN °C))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN reaction)) (VP (VBD was) (VP (VBN stopped) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NP (CD 0.5) (NN ml)) (PP (IN of) (NP (NML (CD 1) (NN N)) (NN KOH)))) (, ,) (NP (NP (CD 5) (NN μg)) (PP (IN of) (NP (VBN butylated) (NN hydroxytoluene)))) (, ,) (CC and) (NP (NP (CD 10) (NN μl)) (PP (IN of) (NP (JJ ethanolic) (NN potassium) (NN hydroxide)))))))) (. .)) )
( (S (PRN (-LRB- [) (NP (NN 3H)) (-RRB- ])) (NP-SBJ-1 (NML (CD 7) (NN α)) (HYPH -) (NN hydroxycholesterol) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (SYM ×) (CD 104)) (NN dpm) (HYPH /) (CD 5) (NN μg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN added) (NP-1 (-NONE- *)) (PP (IN as) (NP (DT an) (NML (JJ internal) (NN recovery)) (NN standard))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NP (NN saponification)) (PP (IN at) (NP (CD 37) (NN °C))) (PP-TMP (IN for) (NP (CD one) (NN hour))))) (, ,) (S (S (NP-SBJ-1 (NNS sterols)) (VP (VBD were) (VP (VBN extracted) (NP-1 (-NONE- *)) (ADVP-TMP (RB twice)) (PP-MNR (IN with) (NP (NP (CD 3) (NN ml)) (PP (IN of) (NP (NN n) (HYPH -) (NN hexane)))))))) (CC and) (S (NP-SBJ-2 (DT the) (NNS extracts)) (VP (VBD were) (VP (VBN evaporated) (NP-2 (-NONE- *)) (PP (IN to) (NP (NN dryness))) (PP (IN under) (NP (NN nitrogen))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN residue)) (VP (VBD was) (VP (VP (VBN dissolved) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (CD 0.3) (NN ml)) (PP (IN of) (NP (NP (NN n) (HYPH -) (NN hexane)) (: :) (NP (CD 2) (HYPH -) (NN propanol)))) (PRN (-LRB- -LRB-) (NP (CD 97.3) (NN vol) (HYPH /) (NN vol)) (-RRB- -RRB-))))) (CC and) (VP (VBN applied) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT a) (NN silica) (NN column) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mg)) (: ;) (NP (NN sep) (HYPH -) (NN pak)) (, ,) (PP (IN by) (NP (NP (CD 4) (NN ml)) (PP (IN of) (NP (NP (NN n) (HYPH -) (NN hexane)) (: :) (NP (CD 2) (HYPH -) (NN propanol)))) (PRN (-LRB- -LRB-) (NP (CD 97.3) (NN vol) (HYPH /) (NN vol)) (-RRB- -RRB-)))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NML (CD 7) (NN α)) (HYPH -) (NN hydroxycholesterol)) (VP (VBD was) (VP (VP (VBN eluted) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (CD 3) (NN ml)) (PP (IN of) (NP (NP (NN n) (HYPH -) (NN hexane)) (: :) (NP (CD 2) (HYPH -) (NN propanol)))) (PRN (-LRB- -LRB-) (NP (NP (CD 80)) (PP (SYM :) (NP (CD 20)))) (NP (NP (NN vol)) (PP (SYM :) (NP (NN vol)))) (-RRB- -RRB-))))) (CC and) (VP (ADVP (RB further)) (VBN isolated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN TLC))) (PP-LOC (IN on) (NP (NML (NN silica) (NN gel)) (NNS plates))) (PRN (-LRB- -LRB-) (NP (NML (NN Silica) (NN gel)) (CD 60)) (, ,) (NP (NP (NNP EM) (NNP Science)) (, ,) (NP-LOC (NNP Gibbestown)) (, ,) (NP-LOC (NNP NJ)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-)) (PP-MNR (IN with) (NP (NN diethyl) (NN ether)))) (, ,) (CC and) (VP (VBN quantified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN liquid) (NN scintillation) (NN counting))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NNP Ecolume) (PRN (-LRB- -LRB-) (NP (NP (NN ICN) (NNP Radiochemicals)) (NP-LOC (NNP Irvine)) (, ,) (NP-LOC (NNP CA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Assays)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP (IN in) (NP (NN duplicate))) (PP (IN with) (NP (NP (NN correction)) (PP (IN for) (NP (NML (NN zero) (HYPH -) (NN time)) (NNS controls))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NML (NN HMG) (HYPH -) (NN CoA)) (NN reductase) (PRN (-LRB- -LRB-) (NP (NN EC) (CD 1.1.1.3.4)) (-RRB- -RRB-))) (NN activity)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP (VBG according) (PP (IN to) (NP (NP (DT the) (NN method)) (PP (IN of) (NP (NP (NNP Xu)) (ADVP-ETC (FW et) (FW al.)) (PRN (-LRB- [) (NP (CD 35)) (-RRB- ]))))))) (PP (IN with) (NP (NNS modifications))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (PRN (-LRB- [) (NP (CD 36)) (-RRB- ]))))))) (. .)) )
( (HEADING (NP (JJ Statistical) (NN analysis))) )
( (S (NP-SBJ-1 (NNS Data)) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN as) (NP (NN means) (SYM ±) (NN SD))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNP Student) (POS 's)) (NN t) (NN test)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ statistical) (NN significance)) (PP (IN of) (NP (NP (NNS differences)) (PP (IN between) (NP (NP (DT the) (NNS groups)) (PP (IN of) (NP (NNS animals))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Significance)) (VP (VBD was) (VP (VBN set) (NP-1 (-NONE- *)) (PP-LOC (IN at) (NP (NP (NN P) (NNS values)) (ADJP (SYM <) (NP (CD 0.05))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (NN Isolation)) (PP (IN of) (NP (ADJP (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (JJ deficient)) (NNS mice))))) )
( (S (NP-SBJ (DT The) (VBG targeting) (NN construct) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1a)) (-RRB- -RRB-))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT the) (JJ potential) (NN disruption)) (PP (IN of) (NP (JJ normal) (NN splicing)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN loss)) (PP (IN of) (NP (NP (DT some) (VBG coding) (NNS sequences)) (VP (VBG involving) (NP (NNS exons) (NML (CD 3) (CC and) (CD 4)))))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NP (NML (NN ES) (NN cell)) (NN electroporation)) (PP (IN with) (NP (DT the) (VBN linearized) (VBN targeted) (NN plasmid) (NN DNA))))) (, ,) (NP-SBJ-2 (NP (CD two) (JJ homologous) (JJ recombinant) (NN ES) (NNS clones)) (-LRB- -LRB-) (PP (IN out) (PP (IN of) (NP (NP (CD 58) (NN ES) (NNS clones)) (VP (VBN screened) (NP (-NONE- *))))))) (-RRB- -RRB-) (VP (VBD were) (VP (VBN identified) (NP-2 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Blastocyst) (NN injection)) (PP (IN of) (NP (DT these)))) (VP (VBD resulted) (NP-1 (-NONE- *)) (PP (IN in) (NP (CD five) (ADJP (RB highly) (JJ chimeric)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NP (CD three) (NNS males)) (, ,) (NP (CD two) (NNS females))) (-RRB- -RRB-))))) (. .)) )
( (S (S (NP-SBJ (NP (NP (CD One) (NN male)) (CC and) (NP (CD one) (NN female))) (, ,) (RRC (DT both) (PP-PRD (IN from) (NP (DT the) (JJ same) (NN ES) (NN clone))))) (, ,) (VP (VBD showed) (NN germline) (NN transmission))) (CC and) (S (NP-SBJ-1 (DT the) (JJ female) (NN line)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB establish) (NP (NP (DT a) (JJ multi-generational) (NN colony)) (VP (VBN bred) (NP (-NONE- *)) (PP (IN onto) (NP (DT a) (NML (NN C57Bl) (HYPH /) (NN 6J)) (NN background))))))))))) (. .)) )
( (S (NP-SBJ (JJ Heterozygous) (NNS mice)) (VP (VP (VBD were) (ADJP-PRD (JJ fertile))) (CC and) (VP (VBD gave) (NP (NN rise)) (PP (IN to) (NP (JJ normal) (JJ litter) (NNS sizes))))) (. .)) )
( (S (S-NOM-SBJ (NP-SBJ (-NONE- *PRO*)) (VP (VBG Breeding) (NP (JJ heterozygous) (NNS animals)))) (VP (VBD led) (PP (IN to) (NP (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (, ,) (NML (ADJP (JJ heterozygous) (CC and) (JJ homozygous)) (NN knockout))) (NNS mice)) (PP-LOC (IN in) (NP (DT the) (VBN expected) (JJ Mendelian) (NN distribution))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN Although) (FRAG (RB not) (ADJP (JJ quantitative)))) (, ,) (NP-SBJ (NNP Northern) (NNS analyses)) (VP (VBD showed) (SBAR (IN that) (S (SBAR-ADV (IN while) (S (NP-SBJ (DT the) (NN knockout) (NNS mice)) (VP (VBD showed) (NP (NP (DT no) (JJ detectable) (NN mRNA)) (PP (IN for) (NP (NN Abcg8))))))) (, ,) (NP-SBJ-1 (NP (NN expression)) (PP (IN of) (NP (NN Abcg5)))) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ unaltered)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1c)) (-RRB- -RRB-))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB exclude) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (JJ alternative) (NN splicing)) (PP (IN with) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (DT a) (ADJP (JJ non-functional) (CC but) (VBN truncated)) (NML (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (NN protein)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (NN chaperone)) (PP (IN for) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))))))))))))))))))) (, ,) (NP-SBJ-2 (NN RT) (HYPH -) (NN PCR)) (VP (VBD was) (VP (VBN performed) (NP-2 (-NONE- *)) (PP (IN on) (NP (NP (NN cDNA)) (VP (RB reverse) (VBN transcribed) (NP (-NONE- *)) (PP (IN from) (NP (NP (JJ total) (NN liver) (NN RNA)) (PP (IN from) (NP (ADJP (NN Abcg8) (HYPH -) (JJ deficient)) (NNS mice)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (DT No) (NN mRNA)) (PP (IN for) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP-2 (-NONE- *ICH*))) (VP (VBD was) (VP (VBN detected) (NP-1 (-NONE- *)) (VP-2 (VBG containing) (NP (NP (DT any) (NNS sequences)) (ADVP-LOC (RB downstream) (PP (IN of) (NP (NN exon) (CD 4)))))) (PP-LOC (IN in) (NP (DT the) (ADJP (NN Abcg8) (HYPH -) (JJ deficient)) (NNS mice))) (, ,) (SBAR-ADV (IN whether) (S (NP-SBJ-3 (NNS primers)) (VP (VBD were) (VP (VBN located) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS exons) (NML (CD 4) (CC and) (CD 13))) (, ,) (NP (NNS exons) (NML (CD 9) (CC and) (CD 13))) (CC or) (NP (NNS exons) (NML (CD 10) (CC and) (CD 13))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 1d) (, ,) (NN 1e))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ demonstrates) (SBAR (IN that) (S (SBAR-ADV (IN if) (S (NP-SBJ (DT an) (ADJP (RB alternatively) (VBN spliced)) (NN message)) (VP (MD could) (ADVP (RB potentially)) (VP (VB code) (PP (IN for) (NP (DT a) (VBN truncated) (NN protein))))))) (, ,) (NP-SBJ (PRP it)) (VP (VBZ is) (RB not) (ADJP-PRD (JJ detectable)) (PP-LOC (IN in) (NP (DT the) (ADJP (NN Abcg8) (HYPH -) (JJ deficient)) (NNS mice))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (ADJP (NN membrane) (HYPH -) (VBG spanning)) (NNS domains)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VBP are) (VP (VBN encoded) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP-LGS (NNS exons) (NML (NML (CD 9)) (PP (SYM –) (NP (CD 13)))))))) (. .)) )
( (HEADING (NP (NP (NN Sterol) (NNS levels)) (PP-LOC (IN in) (NP (ADJP (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (JJ deficient)) (NNS animals))))) )
( (S (NP-SBJ (NP (JJ Elevated) (NN plant) (NNS sterols)) (PP-LOC (IN in) (NP (NN tissue) (CC and) (NN plasma)))) (VP (VBP are) (ADJP-PRD (JJ diagnostic) (PP (IN of) (NP (NN sitosterolemia))))) (. .)) )
( (S (NP-SBJ-2 (NP (NN Sterol) (NNS levels)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NML (NN gas) (NN chromatography)) (-LRB- -LRB-) (NML (NN GC))) (-RRB- -RRB-) (NN analysis)))))) (, ,) (PP-LOC (IN in) (NP (NP (NN plasma) (CC and) (NNS tissues)) (PP (IN of) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))))) (VP (VBP are) (VP (VBN shown) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NN Table) (CD 2))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD were) (NP-PRD (NP (DT no) (NNS differences)) (PP (IN in) (NP (NN tissue) (NNS weights))) (PP (IN between) (NP (NP (JJ wild) (NNS types)) (, ,) (NP (NNS heterozygotes)) (CC and) (NP (NNS knockouts)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (NN Plasma) (NN cholesterol)) (NNS levels)) (PP (IN of) (NP (DT the) (ADJP (JJ homozygous) (CC and) (JJ heterozygous)) (NNS mice)))) (VP (VBD were) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (NP (CD 52) (NN %)) (CC and) (NP (CD 26) (NN %)))) (, ,) (ADVP (RB respectively)) (, ,) (PP (VBN compared) (PP (IN to) (NP (NP (DT those)) (PP (IN of) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 3)))) (NP (DT all) (NNS groups)) (, ,) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NN Plant) (NNS sterols)) (VP (VP (VBD were) (ADJP-PRD (RB almost) (JJ undetectable)) (PP-LOC (IN in) (NP (UCP (NML (JJ wild) (HYPH -) (NN type)) (CC and) (ADJP (JJ heterozygous))) (NNS mice)))) (, ,) (CC but) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN elevated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))))) (. .)) )
( (S (NP-SBJ (NN Plasma) (NML (NN campesterol) (CC and) (NN sitosterol)) (NNS levels)) (VP (VBD were) (ADJP-PRD (QP (CD eight) (HYPH -) (CC and) (RB 36-fold)) (JJR higher)) (PP-LOC (IN in) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (QP (QP (CD 8.76) (SYM ±) (CD 2.10)) (CC and) (QP (CD 18.52) (SYM ±) (CD 5.03))) (NN mg)) (PP (SYM /) (NP (NN dL)))) (, ,) (ADVP (RB respectively))) (, ,) (CC versus) (NP (NP (QP (QP (CD 1.14) (SYM ±) (CD 0.69)) (CC and) (QP (CD 0.50) (SYM ±) (CD 0.55))) (NN mg)) (PP (SYM /) (NP (NN dL))))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD was) (NP-PRD (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (DT the) (NML (NN plasma) (NML (NN plant) (NN sterol))) (NNS levels)))) (PP (IN between) (NP (UCP (ADJP (JJ heterozygous)) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NNS mice)))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (NN Liver) (NN cholesterol)) (NN content)) (PP (IN of) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))) (VP (VBD was) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (QP (SYM ~) (CD 50)) (NN %))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ relative) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NN liver))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (QP (CD 1202) (SYM ±) (CD 264)) (NN μg)) (PP (SYM /) (NP (NN g) (NML (JJ wet) (NN weight)) (NN tissue)))) (, ,) (CC versus) (NP (NP (QP (CD 2280) (SYM ±) (CD 310)) (NN μg)) (PP (SYM /) (NP (NN g) (NML (JJ wet) (NN weight)) (NN tissue))))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBN reduced) (NN cholesterol) (NN content)) (VP (VBD was) (VP (VBN offset) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (NP (DT a) (RB five-fold) (NN increase)) (PP (IN in) (NP (NN campesterol)))) (CC and) (NP (NP (DT a) (RB 22-fold) (NN increase)) (PP (IN in) (NP (NN sitosterol)))) (PRN (-LRB- -LRB-) (NP (NP (QP (QP (CD 233.9) (SYM ±) (CD 48.1)) (CC and) (QP (CD 376.3) (SYM ±) (CD 96.1))) (NN μg)) (PP (SYM /) (NP (NN g) (NML (JJ wet) (NN weight)) (NN tissue))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (PP-LOC (IN in) (NP (NML (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NN knockout)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))) (PRN (-LRB- -LRB-) (NP (NP (QP (QP (CD 52.2) (SYM ±) (CD 15.0)) (CC and) (QP (CD 16.7) (SYM ±) (CD 8.6))) (NN μg)) (PP (SYM /) (NP (NN g) (NML (JJ wet) (NN weight)) (NN tissue))) (, ,) (ADVP (RB respectively))) (, ,) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD were) (NP-PRD (NP (DT no) (JJ significant) (NNS differences)) (PP (IN of) (NP (NML (NML (NN liver) (NN cholesterol)) (CC or) (NML (NN plant) (NN sterol))) (NNS contents))) (PP (IN between) (NP (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -))) (NNS mice))))) (. .)) )
( (S (NP-SBJ (NML (NN Spleen) (NN sterol)) (NNS contents)) (VP (VBD reflected) (NP (DT the) (NN liver) (NNS profiles)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (DT No) (JJ significant) (NNS differences)) (PP (IN in) (NP (NN brain) (NN sterol) (NNS contents)))) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (MD would) (VP (VB be) (VP (VBN expected) (NP-2 (-NONE- *))))))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ (DT the) (NML (NN blood) (NN brain)) (NN barrier)) (VP (VP (VBZ is) (ADJP-PRD (JJ intact))) (CC and) (VP (VBZ prevents) (NP (NP (NN entry)) (PP (IN of) (NP (DT these) (NNS sterols)))) (PP-LOC (IN in) (NP (NN sitosterolemia))))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD were) (ADVP (RB only)) (NP-PRD (NP (NNS traces)) (PP (IN of) (NP (NN plant) (NNS sterols)))) (PP-LOC (IN in) (NP (NP (DT the) (NNS brains)) (PP (IN from) (NP (NN knockout) (NNS animals))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG reflecting) (NP (NP (NN blood) (NN contamination)) (PP-TMP (IN during) (NP (NN tissue) (NN harvesting))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ (NP (DT the) (NN majority)) (PP (IN of) (NP (DT the) (VBN elevated) (NN tissue) (NN plant) (NNS sterols)))) (VP (VBP are) (ADJP-PRD (JJ unesterified))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS livers)) (PP (IN of) (NP (NML (NN Abcg8) (NML (NML (SYM +) (HYPH /) (SYM +)) (, ,) (NML (SYM +) (HYPH /) (SYM -)) (CC and) (NML (SYM -) (HYPH /) (SYM -)))) (NNS mice)))) (VP (VBP have) (NP (NP (ADJP (RB relatively) (JJ similar)) (NNS levels)) (PP (IN of) (NP (JJ esterified) (NN cholesterol)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2a)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (ADJP (JJ little) (PRN (SBAR (IN if) (FRAG (NP (DT any)))))) (NN esterification)) (PP (IN of) (NP (NN sitosterol) (CC or) (NN campesterol))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 2b) (, ,) (NN 2c))) (-RRB- -RRB-))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (JJ previous) (NNS findings))))) (PRN (-LRB- [) (NP (CD 37) (, ,) (CD 38)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Thus)) (NP-SBJ (NP (DT all)) (PP (IN of) (NP (NP (DT the) (NN expansion)) (PP (IN of) (NP (NN tissue) (NN sterol) (NNS pools)))))) (VP (VBP are) (PP-PRD (IN as) (NP (JJ free) (NNS sterols)))) (. .)) )
( (S (NP-SBJ-1 (NP (NN FPLC) (NNS analyses)) (PP (IN for) (NP (NP (NP (NNS sterols)) (-LRB- -LRB-) (VP (VP (VBN measured) (NP (-NONE- *)) (ADVP (RB enzymatically))) (CC and) (VP (ADVP (RB thus)) (VBG reflecting) (NP (JJ total) (NNS sterols))))) (-RRB- -RRB-) (CC and) (NP (NNS triglycerides))))) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN on) (NP (NP (NN plasma) (NNS samples)) (PP (IN from) (NP (NP (VBN fasted) (NNS animals)) (VP (VBN fed) (NP (-NONE- *)) (NP (DT a) (JJ regular) (NN chow) (NN diet))))))))) (. .)) )
( (S (S (NP-SBJ-1 (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN for) (NP (DT the) (NN sterol) (NNS profiles))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3a)) (-RRB- -RRB-))))) (, ,) (CC but) (S (ADVP (RB surprisingly)) (, ,) (NP-SBJ (DT the) (NML (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NN knockout)) (NNS mice)) (VP (VBD had) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN triglyceride) (NN level)) (PP-LOC (IN in) (NP (DT the) (NML (NN LDL) (NN lipoprotein)) (NNS fractions))) (PP (VBN compared) (PP (IN to) (NP (UCP (NML (JJ wild) (HYPH -) (NN type)) (CC and) (ADJP (JJ heterozygous))) (NNS mice))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3b)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN size)) (PP (IN of) (NP (DT this) (NN peak)))) (VP (VP (VBD was) (ADJP-PRD (JJ variable)) (PP (IN between) (NP (JJ different) (NN littermate) (NNS analyses)))) (, ,) (CC but) (VP (VBZ is) (ADVP (RB always)) (ADJP-PRD (JJ increased)) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NNS animals))))) (. .)) )
( (S (NP-SBJ (NP (JJ Total) (NML (NN plasma) (NN triglyceride)) (NNS levels)) (PP (IN of) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))) (VP (VBD were) (ADJP-PRD (RB slightly) (JJR higher)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 79.2) (SYM ±) (CD 14)) (NN mg)) (PP (SYM /) (NP (NN dL))) (PP (VBN compared) (PP (IN to) (NP (NP (NP (DT the) (NML (JJ wild) (NN type)) (QP (CD 63.4) (SYM ±) (CD 13)) (NN mg)) (PP (SYM /) (NP (NN dL)))) (CC and) (NP (NP (NNS heterozygotes) (QP (CD 46.6) (SYM ±) (CD 12)) (NN mg)) (PP (SYM /) (NP (NN dL)))))))) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 3)) (PP (IN for) (NP (DT all) (NNS genotypes))))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (JJ Preliminary) (NNS analyses)) (PP (IN of) (NP (NP (NN proteins)) (PP (IN in) (NP (DT the) (VBN isolated) (NN FPLC) (NNS fractions)))))) (VP (VBD did) (RB not) (VP (VB show) (NP (NP (DT any) (JJ qualitative) (NNS changes)) (PP-LOC (IN in) (NP (NNS apolipoproteins) (NML (NN B) (, ,) (NN E) (, ,) (NN AI) (, ,) (CC or) (NN AII))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN significance)) (PP (IN of) (NP (DT this) (ADJP (NN triglyceride) (JJ rich)) (NN peak)))) (VP (VBZ remains) (ADJP-PRD (JJ unclear)) (PP-TMP (IN at) (ADJP (JJ present)))) (. .)) )
( (S (NP-SBJ (NN Liver) (NML (NML (NN gene) (NN expression)) (CC and) (NML (NN enzyme) (NN activity)))) (VP (VBP change) (PP-LOC (IN in) (NP (ADJP (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (JJ deficient)) (NNS mice))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT a) (NN deficiency)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))))) (PP (IN on) (NP (NP (DT the) (NNS genes)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP regulate) (NP (NN sterol) (NN metabolism))))))))))) (, ,) (NP-SBJ-2 (JJ quantitative) (NN RT) (HYPH -) (NN PCR)) (VP (VBD was) (VP (VBN performed) (NP-2 (-NONE- *)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG looking) (PP (IN at) (NP (NP (DT the) (NN expression) (NNS levels)) (PP (IN of) (NP (NML (NML (NN Abcg5)) (, ,) (NML (NN Abcg8)) (, ,) (NML (NN Hmgr)) (, ,) (NML (NN Cyp7a1)) (, ,) (NML (NN Abca1)) (, ,) (NML (NN Mdr2)) (, ,) (NML (NN Lxr)) (, ,) (NML (NN Srebp) (HYPH -) (NN 1c)) (, ,) (CC and) (NML (NN Srebp) (HYPH -) (CD 2))) (NN mRNA))) (PP-LOC (IN in) (NP (NP (DT the) (NNS livers)) (PP (IN of) (NP (NP (NNS mice)) (VP (VBN fed) (NP (-NONE- *)) (NP (DT a) (JJ regular) (NN chow) (NN diet))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4a)) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ-2 (NML (NN Abcg8) (NN mRNA)) (NN expression) (NNS levels)) (VP (VP (VBD were) (ADJP-PRD (JJ undetectable)) (PP-LOC (IN in) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))) (CC and) (VP (VBD were) (VP (VBN reduced) (NP-2 (-NONE- *)) (PP-EXT (IN by) (NP (QP (SYM ~) (CD 50)) (NN %))) (PP-LOC (IN in) (NP (DT the) (JJ heterozygous) (NNS mice))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ relative) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (PP-MNR (IN by) (NP (JJ quantitative) (NN RT) (HYPH -) (NN PCR))) (, ,) (NP-SBJ-1 (NP (DT the) (NN mRNA) (NN expression)) (PP (IN of) (NP (NN Abcg5))) (PP-LOC (IN in) (NP (DT the) (ADJP (VB knock) (HYPH -) (RP out)) (NNS mice)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (QP (JJR more) (IN than) (CD 60)) (NN %))) (PP (VBN compared) (PP (IN to) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-2 (DT no) (NNS changes)) (VP (VBD were) (VP (VBN noted) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (JJ heterozygous) (NNS mice))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Expression)) (PP (IN of) (NP (NML (NML (NN HMG) (HYPH -) (NN CoA)) (NN reductase)) (NN mRNA)))) (VP (VBD was) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (NP (QP (SYM ~) (CD 50)) (NN %)) (CC and) (NP (QP (SYM ~) (CD 80)) (NN %)))) (PP-LOC (IN in) (NP (DT the) (NML (NN heterozygote) (CC and) (NN knockout)) (NNS mice))) (ADVP (RB respectively)) (, ,) (PP (IN in) (NP (NP (VBG keeping)) (PP (IN with) (NP (NP (JJ limited) (NNS observations)) (PP-LOC (IN in) (NP (NP (JJ human) (NNS patients)) (PP (IN with) (NP (DT this) (NN disorder))))))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ])))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB verify) (SBAR (IN whether) (S (NP-SBJ (DT the) (NN mRNA) (NNS changes)) (VP (VBD resulted) (PP (IN in) (NP (NP (NN alteration)) (PP (IN of) (NP (DT the) (NML (NN enzyme) (NN activity)) (NNS changes))))))))))) (, ,) (NP-SBJ-1 (NN liver) (NNS samples)) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP (IN for) (NP (NP (NML (NML (NN HMG) (HYPH -) (NN CoA)) (NN reductase)) (NN activity)) (CC and) (NP (NN Cyp7a1) (NN activity)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4b)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NML (NML (NN HMG) (HYPH -) (NN CoA)) (NN reductase)) (NN activity)) (VP (VP (VBD was) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (NP (CD 30) (NN %)) (CC and) (NP (CD 60) (NN %)))) (PP-LOC (IN in) (NP (DT the) (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NNS mice))) (, ,) (ADVP (RB respectively)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4b)) (-RRB- -RRB-)))) (, ,) (CC and) (VP (ADVP (RB thus)) (VBD reflected) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NN mRNA) (NN expression)))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (DT the) (NML (NN Cyp7a1) (NN mRNA)) (NN expression) (NNS levels)) (VP (VBD were) (ADJP-PRD (RB essentially) (JJ unchanged)) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NN mouse)))))) (, ,) (NP-SBJ-1 (NN Cyp7a1) (NN activity)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-EXT (IN by) (NP (CD 37) (NN %))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.01)))) (-RRB- -RRB-)))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (JJ heterozygous) (NNS mice))) (, ,) (NP-SBJ-1 (CC both) (NP (DT the) (NN mRNA)) (CC and) (NP (NP (NN activity)) (PP (IN of) (NP (NN Cyp7a1))))) (VP (VBD were) (VP (VBN decreased) (NP-1 (-NONE- *)))) (. .)) )
( (S (S (NP-SBJ-1 (NN Sitosterol)) (VP (VBZ is) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT a) (JJ direct) (JJ competitive) (NN inhibitor)) (PP (IN of) (NP (NN Cyp7a1)))))))))) (CC and) (S (NP-SBJ (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ likely)) (SBAR-2 (IN that) (S (NP-SBJ (NP (DT the) (JJ elevated) (NN plant) (NNS sterols)) (PP-LOC (IN in) (NP (DT the) (NN liver)))) (VP (VBP are) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN inhibition)) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NN mouse))))))))))) (PRN (-LRB- [) (NP (CD 39)) (-RRB- ])) (. .)) )
( (HEADING (NP (NP (NN Localization)) (PP (IN of) (NP (NN Abcg5) (NN protein))) (PP-LOC (IN in) (NP (NML (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NN knockout)) (NNS mice))))) )
( (SQ (VBZ Does) (NP-SBJ (NP (DT the) (NN loss)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VB result) (PP (IN in) (NP (NP (NN loss)) (PP (IN of) (NP (NML (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN expression))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (MD might) (VP (VB be) (VP (VBN predicted) (NP-1 (-NONE- *)) (PP (PP (IN from) (NP (DT the) (JJ genetic) (NNS studies))) (CC and) (PP (ADVP-TMP (RBR more) (RB recently)) (IN from) (NP (DT the) (ADJP (ADJP (FW in) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NN expression) (NNS studies)))))))))) (. ?)) )
( (S (NP-SBJ (NP (DT A) (JJ robust) (NN antibody)) (PP (IN to) (NP (NN mouse) (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VBZ is) (RB not) (ADVP-TMP (RB currently)) (ADJP-PRD (JJ available))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (CD three) (JJ separate) (NNS groups)) (VP (VBP have) (VP (VBN developed) (NP (NP (NN rabbit) (JJ polyclonal) (NN antibody)) (PP (IN to) (NP (NN mouse) (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (CD three) (NNS antibodies)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNP Western) (NN blotting)) (CC and) (NP (NN immunohistochemistry) (NNS experiments)))) (PP (IN on) (NP (NP (DT the) (NML (NN liver) (CC and) (NN intestine))) (PP (IN of) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice))))))) (. .)) )
( (S (NP-SBJ (NP (NP (NNP Western) (NN blotting)) (PP (IN of) (NP (NN liver) (NML (JJ total) (NN membrane)) (NNS preparations)))) (VP (VBG using) (NP (DT the) (CD three) (ADJP (RB separately) (HYPH -) (VBN developed)) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NNS antibodies)))) (VP (VBD showed) (NP (JJ different) (NNS results))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBZ has) (VP (VBN been) (ADVP (RB previously)) (VP (VBN published) (NP-1 (-NONE- *))))))) (, ,) (NP-SBJ (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (VP (VBZ exists) (PP (IN in) (NP (NP (CD two) (JJ separate) (NNS forms)) (, ,) (NP (NP (DT the) (`` ') (NN immature) ('' ') (NML (CD 75) (NN kDa)) (NN protein)) (CC and) (NP (DT a) (ADJP (RB fully) (VBN glycosylated)) (`` ') (NN mature) ('' ') (NML (CD 93) (NN kDa)) (NN protein))))) (PRN (-LRB- [) (NP (CD 18) (, ,) (CD 30)) (-RRB- ]))) (. .)) )
( (S (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG Using) (NP (DT the) (NML (NN SC) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN peptide)) (NN antibody)))) (, ,) (NP-SBJ-1 (DT a) (NML (CD 75) (NN kDa)) (NN band)) (VP (VBZ is) (VP (VBN detected) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5a)) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ (DT This) (NN antibody)) (VP (VBZ does) (RB not) (VP (VB detect) (NP (DT a) (`` ') (JJ mature) ('' ') (NML (CD 93) (NN kDa)) (NN band)) (PP-LOC (IN in) (NP (CC either) (NML (NML (JJ wild) (HYPH -) (NN type)) (CC or) (NML (NN knockout))) (NNS animals)))))) (CC nor) (SINV (VBZ is) (NP-SBJ (DT the) (NML (CD 75) (NN kDa)) (NN band)) (ADJP-PRD (JJ sensitive) (PP (IN to) (NP (CC either) (NP (NN Endo) (HYPH -) (NN H)) (CC or) (NP (NN PNGaseF)))))) (PRN (-LRB- -LRB-) (S (NP-SBJ (JJ lower) (NN panel)) (VP (VBZ shows) (NP (NP (JJ same) (NNS aliquots)) (VP (VBN probed) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN anti-transferrin))))))) (-RRB- -RRB-)) (. .)) )
( (S (NP-SBJ (DT The) (NN AMC) (NN antibody)) (VP (VBZ detects) (NP (NP (DT the) (`` ') (NN mature) ('' ') (NN form)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (PP-LOC (IN in) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS animals)) (CONJP (CC but) (RB not)) (NP (DT the) (NNS knockouts)))))) (. .)) )
( (S (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ-1 (DT the) (`` ') (JJ immature) ('' ') (NML (CD 75) (NN kDa)) (NN band)) (VP (VBZ is) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (DT this) (NN antibody)))))) (CC but) (S (NP-SBJ (DT the) (NN band)) (VP (VBZ shifts) (PP (IN with) (NP (NML (NML (NN Endo) (HYPH -) (NN H)) (CC and) (NML (NN PNGase) (NN F))) (NN treatment))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5b)) (-RRB- -RRB-)) (. .)) )
( (S (NP-SBJ (DT The) (NN UTSW) (NN antibody)) (VP (VP (VBZ detects) (NP (NP (DT the) (`` ') (ADJP (JJ mature) ('' ') (CC and) (`` ') (JJ immature)) ('' ') (NNS forms)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))) (PP-LOC (IN in) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS animals)))) (CC but) (VP (VBZ detects) (NP (DT no) (NNS forms)) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NN mouse)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5c)) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-NOM-SBJ (WHNP-1 (WP What)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ does) (VP (VB hold) (ADJP-PRD (JJ true)) (PP (IN for) (NP (NP (DT all) (NNS antibodies)) (VP (VBN used) (NP (-NONE- *)) (PP (IN against) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))))))))) (VP (VBZ is) (NP-PRD (NP (DT the) (NN detection)) (PP (IN of) (NP (DT a) (NML (CD 75) (NN kDa)) (NN band))))) (. .)) )
( (S (NP-SBJ-1 (NN Immunohistochemistry) (NNS experiments)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT all) (CD three) (NNS antibodies)))))) (. .)) )
( (S (PP-LOC (IN In) (NP (JJ acute) (NN transfection) (NNS studies))) (, ,) (NP-SBJ (DT the) (NN SC) (NN antibody)) (VP (VBD recognized) (NP (NP (NP (VBN over-expressed) (NN mouse) (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (PP-LOC (IN in) (NP (NML (NN COS) (HYPH -) (CD 1)) (NNS cells)))) (, ,) (CONJP (CC but) (RB not)) (NP (NN mouse) (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 6b) (, ,) (NN 6c))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (NN Co-transfection)) (PP (IN of) (NP (NML (NN COS) (HYPH -) (CD 1)) (NNS cells))) (PP (IN with) (NP (NML (CC both) (NN Abcg5) (CC and) (NN Abcg8)) (NNS cDNAs)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NN pattern)) (PP (IN of) (NP (NN immunofluorescence)))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-1 (PRP we)) (VP (VBP are) (RB not) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB confirm) (NP (NP (JJ simultaneous) (NN expression)) (PP (IN of) (NP (NN Abcg8))) (PP-LOC (IN in) (NP (NP (NNS cells)) (VP (VBG expressing) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))))))))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (PRP we)) (VP (VBP have) (NP (NP (DT no) (JJ suitable) (NN antibody)) (PP (IN for) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6d)) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Nevertheless)) (, ,) (NP-SBJ (DT this) (NN experiment)) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ (DT the) (NN SC) (NN antibody)) (VP (VP (MD can) (VP (VB recognize) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))) (CC but) (VP (VBZ does) (RB not) (VP (VB cross-react) (PP (IN with) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Serial) (NNS sections)) (PP (IN of) (NP (JJ intestinal) (NN tissue)))) (VP (VBD were) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ cellular) (NN location)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN pattern)) (PP (IN of) (NP (NN staining))) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (PP-LOC (IN in) (NP (DT the) (JJ intestinal) (NNS sections)))) (VP (VBZ is) (ADJP-PRD (ADJP (RB clearly) (JJ apical)) (CC and) (ADJP (JJ localized) (PP (IN to) (NP (NP (DT the) (NNS villi)) (PP (IN of) (NP (DT the) (NNS enterocytes))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 6g) (, ,) (NN 6h) (, ,) (NN 6i))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Loss)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VBZ does) (RB not) (VP (VB seem) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB affect) (NP (NP (DT this) (NN pattern)) (PP (IN of) (NP (NN staining))))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (ADVP (RB further)) (VP (VB confirm) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN antibody)) (VP (VBN used) (NP (-NONE- *)))) (VP (VBZ recognizes) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))))))) (: ;) (NP-SBJ-1 (DT this) (NN pattern)) (VP (VBZ is) (VP (VBN blocked) (NP-1 (-NONE- *)) (SBAR-ADV (IN if) (S (NP-SBJ-2 (DT the) (NN antibody)) (VP (VBZ is) (VP (VBN pre-incubated) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT the) (NN peptide)) (SBAR (WHPP-3 (IN to) (WHNP (WDT which))) (S (NP-SBJ-4 (PRP it)) (VP (VBD was) (VP (VBN raised) (NP-4 (-NONE- *)) (PP-3 (-NONE- *T*)))))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6f)) (-RRB- -RRB-)))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (ADVP (RB further)) (VP (VB confirm) (SBAR (IN that) (S (NP-SBJ-1 (NML (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN expression)) (VP (VP (VBZ is) (VP (VBN preserved) (NP-1 (-NONE- *)))) (CC and) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ apical)))))))))) (, ,) (NP-SBJ-2 (NN immunohistochemistry)) (VP (VBD was) (VP (VBN performed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NN Amsterdam))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NN AMC) (NN antibody)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB stain) (NP (NP (NN liver) (NNS sections)) (PP (IN from) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN knockout))) (NNS mice))))))))) (PRN (-LRB- [) (NP (CD 30)) (-RRB- ])))) (. .)) )
( (S (PP (IN As) (NP (DT a) (NN control))) (, ,) (NP-SBJ-2 (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN Abcb11)) (, ,) (NP (NP (DT an) (NN ABC) (NN transporter)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN export)) (PP (IN of) (NP (NN bile) (NNS salts)))))))))))))) (, ,) (VP (VBD was) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (NP (DT that)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 6j) (, ,) (NN 6k))) (-RRB- -RRB-)))) (. .)) )
( (S (S (ADVP (RB Again)) (, ,) (NP-SBJ-1 (DT both) (NN proteins)) (VP (VBP are) (ADVP (RB apically)) (VP (VBN localized) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN liver) (NNS sections)) (PP (IN from) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))))) (CC and) (S (NP-SBJ (DT this) (NN pattern)) (VP (VBZ is) (ADJP-PRD (RB essentially) (JJ unperturbed)) (PP-LOC (IN in) (NP (NP (NN liver)) (PP (IN from) (NP (NN knockout) (NNS mice))))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-2 (NP (DT the) (NN expression) (NN level)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))) (VP (VBZ seems) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (RBR less) (JJ robust)) (ADVP (RB qualitatively)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 6l) (, ,) (NN 6m))) (-RRB- -RRB-)) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (ADVP (RB further)) (VP (VB confirm) (NP (NP (DT the) (JJ apical) (NN expression)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NNS mice))))))) (, ,) (NP-SBJ-1 (DT the) (NN UTSW) (NN antibody)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB stain) (NP (NP (NN liver) (NNS sections)) (PP (IN of) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN knockout))) (NNS mice))))))))) (. .)) )
( (S (ADVP (RB Again)) (, ,) (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (JJ apical) (NN expression)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))) (PP-LOC (IN in) (NP (NML (CC both) (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN knockout))) (NNS livers))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 7a) (, ,) (NN 7b))) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NP (JJ Biliary) (NN secretion)) (PP (IN of) (NP (NN bile) (NML (NNS salts) (, ,) (NN sterol) (CC and) (NNS phospholipids)))) (PP-LOC (IN in) (NP (ADJP (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (JJ deficient)) (NNS mice))))) )
( (S (NP-SBJ (JJ Sitosterolemic) (NNS individuals)) (VP (VBP have) (NP (DT an) (JJ impaired) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NP (NN cholesterol)) (CC and) (NP (NN plant) (NNS sterols))) (PP-DIR (IN into) (NP (NN bile))))))) (PRN (-LRB- [) (NP (CD 40) (, ,) (CD 41)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD analyzed) (NP (DT the) (NN knockout) (NNS mice)) (PP (IN for) (NP (NP (DT any) (NNS alterations)) (PP (IN in) (NP (NML (JJ biliary) (NN sterol)) (NN handling)))))) (. .)) )
( (S (NP-SBJ (NP (NNS Analyses)) (PP (IN of) (NP (DT the) (JJ initial) (JJ basal) (NN bile) (NN secretion)))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NML (NN sterol) (CC and) (NN phospholipid)) (NNS contents)) (PP-LOC (IN in) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))) (VP (VBD were) (VP (VBN reduced) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))))))) (, ,) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 8a) (, ,) (NN 8b) (, ,) (NN 8c))) (, ,) (S (FRAG (NP-SBJ (NML (NN bile) (NN salt)) (NN secretion)) (ADJP-PRD (RB not) (RB statistically) (JJ significant))) (, ,) (S (S-FRM (PP (IN for) (NP (NN sterol) (NN secretion))) (NP-SBJ (NN P)) (VP (SYM =) (NP (CD 0.01)))) (CC and) (S-FRM (PP (IN for) (NP (NN phospholipid) (NN secretion))) (NP-SBJ (NN P)) (VP (SYM =) (NP (CD 0.03)))))) (-RRB- -RRB-))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB investigate) (SBAR (IN whether) (S (NP-SBJ-1 (NP (DT the) (NN defect)) (PP (IN in) (NP (JJ biliary) (NN sterol) (NN secretion)))) (VP (MD could) (VP (VB be) (-LRB- -LRB-) (ADVP (RB partly)) (-RRB- -RRB-) (VP (VBN restored) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (VBN forced) (NML (JJ biliary) (NN sterol)) (NN secretion))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD infused) (NP (NNS mice)) (PP-MNR (IN with) (NP (NP (ADJP (JJ stepwise) (VBG increasing)) (NNS doses)) (PP (IN of) (NP (NP (JJ tauroursodeoxycholic) (NN acid)) (-LRB- -LRB-) (NP (NN TUDC))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VP (VBD were) (ADVP-TMP (RB first)) (VP (VBN depleted) (NP-1 (-NONE- *)) (PP (IN of) (NP (PRP$ their) (JJ endogenous) (NML (NN bile) (NN salt)) (NNS pools))) (PP-TMP (IN for) (NP (CD 90) (NN min))))) (CC and) (VP (ADVP-TMP (RB subsequently)) (VBN infused) (NP-1 (-NONE- *)) (PP-LOC (IN via) (NP (DT the) (JJ jugular) (NN vein))) (PP-MNR (IN with) (NP (NP (VBG increasing) (NNS doses)) (PP (IN of) (NP (NN TUDC))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN Figure) (NN 8d)))))) (, ,) (NP-SBJ (NML (NN bile) (NN salt)) (NN secretion)) (VP (VBD was) (ADJP-PRD (RB no) (JJ different)) (PP (IN between) (NP (DT the) (JJ different) (NNS genotypes))) (PP-TMP (IN during) (NP (NP (NP (DT the) (NN depletion) (NML-2 (-NONE- *RNR*))) (CC or) (NP (DT the) (NN TUDC) (NN infusion) (NML-2 (-NONE- *RNR*))) (NML-2 (NNS phases))) (PP (IN of) (NP (DT the) (NN experiment)))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (DT a) (JJ different) (NN pattern)) (VP (VBD emerged) (PP (IN for) (NP (NP (DT the) (NN secretion)) (PP (IN of) (NP (NN phospholipid))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8f)) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (EX There)) (VP (VBD was) (NP-PRD (NP (DT no) (NN difference)) (PP (IN between) (NP (UCP (NML (JJ wild) (HYPH -) (NN type)) (CC and) (ADJP (JJ heterozygous))) (NNS mice)))))) (, ,) (CC but) (S (NP-SBJ (NN knockout) (NNS mice)) (VP (VBD showed) (NP (NP (DT a) (NN trend)) (PP (IN of) (NP (JJR lower) (NN phospholipid) (NN secretion)))) (PP-TMP (IN during) (NP (CC both) (DT the) (NML (NN depletion) (CC and) (NN infusion)) (NN phase))))) (. .)) )
( (SINV (ADJP-TPC-4 (ADVP (RB Even) (RBR more)) (JJ dramatic)) (VP (VBD was) (ADJP-PRD-4 (-NONE- *T*))) (NP-SBJ (NP (DT the) (NN effect)) (PP (IN on) (NP (NML (JJ biliary) (NN sterol)) (NN secretion)))) (SBAR-ADV (IN although) (S (S (NP-SBJ-1 (DT the) (NN sterol) (NNS contents)) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (ADVP-MNR (RB enzymatically))))) (CC and) (S (NP-SBJ-2 (NP (DT no) (NN distinction)) (PP-3 (-NONE- *ICH*))) (VP (VBZ is) (VP (VBN made) (NP-2 (-NONE- *)) (PP-3 (IN as) (PP (IN to) (SBAR-NOM (IN whether) (S (NP-SBJ (DT this)) (VP (VBZ is) (NP-PRD (NN sitosterol) (CC or) (NN cholesterol)))))))))))) (PRN (-LRB- -LRB-) (UCP (NP (NN Figure) (NN 8e)) (, ,) (CC but) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (ADVP (RB below))))) (-RRB- -RRB-)) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (NN knockout) (NNS mice))) (, ,) (NP-SBJ-1 (RB almost) (DT no) (VBN stimulated) (NN sterol) (NN secretion)) (VP (VBD was) (VP (VBN noted) (NP-1 (-NONE- *)) (, ,) (PP (IN with) (NP (NP (DT an) (JJ intermediate) (NN phenotype)) (PP-LOC (IN in) (NP (DT the) (JJ heterozygous) (NNS mice))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (JJ heterozygous) (NNS mice))) (, ,) (NP-SBJ (NN sterol) (NN secretion)) (VP (VBD increased) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB reach) (NP (NP (DT a) (JJ maximal) (NN level)) (PP (IN of) (NP (NP (QP (IN about) (CD 50)) (NN %)) (PP (IN of) (NP (DT the) (JJ wild) (NN type))))))))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (VP (VBZ is) (NP-PRD (NP (DT a) (ADJP (NN rate) (HYPH -) (VBG limiting)) (NN step)) (PP (IN for) (NP (JJ biliary) (`` ') (NN cholesterol) ('' ') (NN secretion)))))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (NN knockout) (NNS mice))) (, ,) (NP-SBJ (NN sterol) (NN secretion)) (VP (VP (VBD remained) (S-CLR (NP-SBJ (-NONE- *PRO*)) (PP-PRD (IN at) (NP (DT a) (JJ constant) (NN level)))) (PP-TMP (IN during) (NP (DT the) (NN depletion) (NN phase)))) (CC and) (VP (VBN increased) (ADVP (RB minimally)) (PP-TMP (IN upon) (NP (NP (NN infusion)) (PP (IN of) (NP (NN TUDC))))))) (. .)) )
( (S (SBAR-PRP (IN Since) (S (NP-SBJ (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (ADVP-TMP (RB still)) (VP (VBD secreted) (NP (DT some) (NNS sterols))))) (NP-SBJ (PRP we)) (VP (VBD were) (ADJP-PRD (JJ interested) (PP (IN in) (SBAR-NOM (WHNP-1 (WDT which) (NML (JJ biliary) (NN sterol)) (NNS species)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBG being) (VP (VBN secreted) (NP-1 (-NONE- *)))))))))) (. .)) )
( (S (ADVP (RB Therefore)) (NP-SBJ-1 (NN bile)) (VP (VBD was) (VP (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN from) (NP (NNS mice))) (PP-TMP (IN during) (NP (NP (DT a) (JJ constant) (NN infusion)) (PP (IN of) (NP (NN TUDC)))))) (CC and) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN GC)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VP (ADVP-TMP (RB first)) (VBN depleted) (NP-1 (-NONE- *)) (PP (IN of) (NP (PRP$ their) (JJ endogenous) (NML (NN bile) (NN acid)) (NNS pools))) (PP-TMP (IN for) (NP (CD 30) (NNS minutes)))) (VP (ADVP-TMP (RB then)) (VBN infused) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (JJ continuous) (NN dose)) (PP (IN of) (NP (NN TUDC)))))) (PRN (-LRB- -LRB-) (NP (NP (CD 1,200) (NN nmol)) (PP (SYM /) (NP (NN min))) (PP (SYM /) (NP (NML (NN 100) (NN g)) (NN body) (NN weight)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT The) (NN knockout) (NNS mice)) (VP (VP (VP (VBD showed) (NP (DT a) (ADJP (RB significantly) (VBN diminished)) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN cholesterol))))))) (, ,) (CC yet) (VP (ADVP (RB still)) (VBD maintained) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN sitosterol) (CC and) (NN campesterol)))))))) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 9)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Surprisingly)) (, ,) (NP-SBJ-1 (DT the) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD tended) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB show) (NP (DT an) (VBN increased) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (DT all) (NNS sterols)) (PP (IN above) (NP (NP (DT the) (NNS levels)) (VP (VBN seen) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))))))))))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (DT this)) (VP (VBD was) (RB not) (ADJP-PRD (RB statistically) (JJ significant)))))) (. .)) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ-1 (NP (NP (DT The) (NN mechanism)) (SBAR (WHPP-4 (IN by) (WHNP (WDT which))) (S (S (S (NP-SBJ-2 (JJ dietary) (NN cholesterol)) (VP (VBZ is) (ADVP (RB specifically)) (VP (VBN absorbed) (NP-2 (-NONE- *))))) (CC and) (S (NP-SBJ-3 (JJ dietary) (NN non-cholesterol) (NNS sterols)) (ADVP (RB primarily)) (VP (VBD excluded) (NP-3 (-NONE- *))))) (PP-MNR-4 (-NONE- *T*))))) (CC or) (NP (NP (DT the) (NN mechanism) (-LRB- -LRB-) (AFX s) (-RRB- -RRB-)) (SBAR (WHPP-5 (IN by) (WHNP (WDT which))) (S (NP-SBJ (DT the) (NN liver)) (VP (MD can) (ADVP (RB selectively)) (VP (VB secrete) (NP (NNS sterols)) (PP-MNR-5 (-NONE- *T*)))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN elucidated) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ (NP (NN Identification)) (PP (IN of) (NP (NP (DT the) (JJ genetic) (NN defect) (-LRB- -LRB-) (AFX s) (-RRB- -RRB-)) (PP-LOC (IN in) (NP (NP (NP (DT a) (JJ rare) (JJ human) (NN disorder)) (, ,) (NP (NN sitosterolemia))) (, ,) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ-2 (DT these) (NNS processes)) (VP (VBP are) (ADVP (RB specifically)) (VP (VBN disrupted) (NP-2 (-NONE- *)) (ADVP-LOC-1 (-NONE- *T*))))))))))) (, ,) (VP (MD may) (ADVP-TMP (RB finally)) (VP (VB have) (VP (VBN led) (PP (IN to) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (DT the) (`` ') (NNS transporters) ('' ')) (ADJP (JJ responsible) (PP (IN for) (NP (DT these) (NNS processes))))))))))) (. .)) )
( (S (NP-SBJ (NP (NP (JJ Complete) (NNS defects)) (PP (IN in) (NP (NP (QP (CD one) (IN of) (CD two)) (NNS genes)) (-LRB- -LRB-) (CONJP (CC but) (RB not)) (NP (DT both))))) (-RRB- -RRB-) (, ,) (VP (VBN organized) (NP (-NONE- *)) (PP-MNR (IN in) (NP (DT a) (NML (NML (NN head)) (HYPH -) (PP (IN to) (HYPH -) (NP (NN head)))) (NN configuration))) (PP-LOC (IN at) (NP (DT the) (NN STSL) (NN locus))))) (, ,) (VP (VBZ causes) (NP (NN sitosterolemia))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN mouse) (NN model)) (PP (IN of) (NP (NN sitosterolemia))) (, ,) (PP (IN with) (NP (NP (DT a) (ADJP (JJ selective) (, ,) (CC but) (JJ complete)) (, ,) (NN defect)) (PP-LOC (IN in) (NP (NP (NP (CD one)) (PP (IN of) (NP (DT these) (NNS genes)))) (, ,) (NP (NN Abcg8)))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN mouse)) (VP (VBZ reflects) (NP (NP (DT the) (JJ known) (NNS defects)) (VP (VBN described) (NP (-NONE- *)) (PP-LOC (IN in) (NP (JJ human) (NN sitosterolemia))))) (PRN (-LRB- [) (NP (CD 5) (, ,) (CD 7) (, ,) (CD 42)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (NN Plasma)) (CC and) (NP (NP (DT all) (NNS tissues)) (, ,) (ADVP (RB apart) (PP (IN from) (NP (DT the) (NN brain)))))) (, ,) (VP (VBP have) (NP (ADJP (RB significantly) (VBN elevated)) (NN sitosterol) (NNS levels))) (. .)) )
( (S (NP-SBJ (JJ Homozygous) (NN knockout) (NNS mice)) (VP (VBP are) (ADJP-PRD (JJ viable) (, ,) (JJ fertile) (CC and) (JJ sitosterolemic))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (NN fertility)) (VP (VBZ seems) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN reduced) (NP-1 (-NONE- *)) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (JJ homozygous) (NNS mice)) (VP (VBP are) (VP (VBN bred) (NP-2 (-NONE- *)) (ADVP (RB together)) (ADVP-TMP-3 (-NONE- *T*)))))) (CIT (-LRB- -LRB-) (NNP S) (NNP Patel) (CC and) (NNP J) (NNP Oatis) (, ,) (JJ unpublished) (NN observation) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN model)) (VP (VBZ reflects) (NP (NP (JJ many) (JJ other) (VBN observed) (NNS changes)) (VP (VBN described) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (JJ limited) (NNS studies)) (PP-LOC (IN in) (NP (NNS humans)))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (PP-LOC (IN in) (NP (NNS humans))) (, ,) (NP-SBJ-1 (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NML (NN HMG) (HYPH -) (NN CoA)) (NN reductase)) (CC and) (NP (NN CYP7a1))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ low))))) (PRN (-LRB- [) (NP (CD 7) (, ,) (CD 39)) (-RRB- ]))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NML (NML (NN mRNA)) (CC and) (NML (NN enzyme) (NNS activities)))) (PP-LOC (IN in) (NP (NP (DT the) (NNS livers)) (PP (IN from) (NP (NN knockout) (NNS animals)))))) (VP (VBP are) (ADVP (RB also)) (ADVP (RB significantly)) (VP (VBN reduced) (NP-1 (-NONE- *))))))) (. .)) )
( (S (ADVP (RB Additionally)) (, ,) (NP-SBJ-1 (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NP (DT the) (ADJP (NN rate) (HYPH -) (VBG limiting)) (NN enzyme)) (PP (IN for) (NP (NML (NN bile) (NN acid)) (NN synthesis)))) (, ,) (NP (NN CYP7a1))))) (, ,) (VP (VBZ is) (VP (VBN reduced) (NP-1 (-NONE- *)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-2 (NP (DT no) (NNS changes)) (PP-LOC (IN at) (NP (DT the) (NN mRNA) (NN level)))) (VP (VBP are) (VP (VBN noted) (NP-2 (-NONE- *)))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ is) (ADVP (RB also)) (PP-PRD (IN in) (NP (NP (VBG keeping)) (PP (IN with) (NP (NP (JJ previous) (NNS studies)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NN sitosterol)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ direct) (NN inhibitor)) (PP (IN of) (NP (DT this) (NN enzyme)))) (ADVP (FW in) (FW vitro)))))))))))) (PRN (-LRB- [) (NP (CD 39)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (JJ Biliary) (NNS sterols)) (PP (IN of) (NP (ADJP (NN Abcg8) (HYPH -) (JJ deficient)) (NNS mice)))) (VP (VBD were) (ADJP-PRD (RB dramatically) (JJ different)) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))) (. .)) )
( (S (NP-SBJ (NP (NN Measurement)) (PP (IN of) (NP (NP (NML (JJ biliary) (NN sterol)) (NN secretion) (NNS rates)) (PP-LOC (IN in) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))))) (VP (VBD demonstrated) (NP (NP (DT a) (NN failure) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB increase) (NP (NP (NN sterol) (NN secretion)) (PP (IN into) (NP (NN bile)))))))) (PP (IN despite) (NP (NP (JJ exogenous) (NN infusion)) (PP (IN of) (NP (NN bile) (NNS acids))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NP (JJ complete) (NN loss)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VBZ results) (PP (IN in) (NP (DT an) (NN inability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN cholesterol)) (PP-DIR (IN into) (NP (NN bile)))))))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (NP (NN secretion)) (PP (IN of) (NP (NN sitosterol)))) (VP (VBD seemed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN preserved) (NP-1 (-NONE- *)))))))))) (. .)) )
( (S (ADVP (RB Arguably)) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ (NP (NP (DT the) (NN body) (NNS pools)) (CC and) (NP (NML (NN plasma) (NN sitosterol)) (NNS levels))) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NNS mice)))) (VP (VBP are) (ADVP (RB so) (RB considerably)) (ADJP-PRD (JJ elevated))))) (, ,) (ADVP (RB perhaps)) (NP-SBJ-1 (DT the) (NML (JJ biliary) (NN sitosterol)) (NNS levels)) (VP (MD could) (VP (VB be) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (RB inappropriately) (JJ low)))))))) (. .)) )
( (S (PP (IN Despite) (NP (DT this) (NN reservation))) (, ,) (NP-SBJ (DT the) (NN finding) (SBAR (IN that) (S (NP-SBJ (NN sitosterol)) (VP (VBZ is) (ADJP-PRD (JJ present) (PP-LOC (IN in) (NP (DT the) (NN bile)))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ-1 (NN plant) (NNS sterols)) (VP (MD may) (VP (VB be) (VP (VBN secreted) (NP-1 (-NONE- *)) (ADVP (RB independent) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN ability) (S-3 (-NONE- *ICH*))) (PP (IN of) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (S-3 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN bile) (NML (NN salt) (CC and) (NN phospholipid))) (PP-DIR (IN into) (NP (NN bile))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN compared) (NP-2 (-NONE- *)) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))))))) (VP (VBD was) (RB not) (ADVP (RB significantly)) (VP (VBN impaired) (NP-1 (-NONE- *)))) (. .)) )
( (S (ADVP (RB Collectively)) (NP-SBJ (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (VP (VBZ is) (ADJP-PRD (JJ necessary) (PP (IN for) (NP (NP (JJ hepatobiliary) (NN cholesterol) (NN secretion)) (PP-LOC (IN in) (NP (NNS mice)))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ normal) (CC and) (JJ healthy))) (S-ADV (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN maintained) (NP-2 (-NONE- *)) (PP (IN on) (NP (DT a) (JJ regular) (NML (NN rodent) (NN chow)) (NN diet)))))) (. .)) )
( (S (NP-SBJ (PRP$ Their) (JJ phenotypic) (NNS features)) (VP (VBP are) (ADJP-PRD (RB very) (JJ similar) (PP (IN to) (NP (NP (DT those)) (VP (ADVP-TMP (RB recently)) (VBN reported) (NP (-NONE- *)) (PP (IN for) (NP (NP (DT a) (NN mouse)) (ADJP (JJ deficient) (PP (IN in) (NP (NP (DT both) (NNS sterolins)) (ADVP-TMP (RB simultaneously))))))))))) (PRN (-LRB- [) (NP (CD 7) (, ,) (CD 20)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (NP (UCP (NN Plasma) (CC and) (JJ hepatic)) (NML (NN plant) (NN sterol)) (NNS levels)) (PP-LOC (IN in) (NP (NP (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (CC and) (NP (NML (NN Abcg5) (HYPH /) (NN Abcg8)) (NN knockout))))) (VP (VBP are) (VP (VBN increased) (NP-1 (-NONE- *)) (ADVP (RB similarly)) (PP (IN with) (NP (NP (JJ marked) (NNS decreases)) (PP (IN in) (NP (NN cholesterol) (NNS levels))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (S (NP-SBJ (NP (NML (NN plasma) (NN triglyceride)) (NNS levels)) (PP (IN of) (NP (DT the) (NML (NN Abcg8) (NML (SYM -) (HYPH /) (SYM -))) (NNS mice)))) (VP (VBD were) (ADJP-PRD (ADJP (RB slightly) (JJR higher)) (PP (IN than) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS animals)))))) (CC and) (S (NP-SBJ-1 (DT this) (VBN increased) (NN triglyceride)) (VP (VBZ is) (VP (VBN carried) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN LDL) (NN fraction)) (NN range))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN measured) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NN FPLC))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN significance)) (PP (IN of) (NP (DT this)))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ clear)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-1 (NP (JJ preliminary) (NML (NN SDS) (HYPH -) (NN PAGE)) (NNS analyses)) (PP (IN of) (NP (PDT all) (DT the) (NNS fractions)))) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB reveal) (NP (NP (DT any) (NNS differences)) (PP (IN between) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN knockout))) (NNS samples))))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (JJ Hepatic) (NNS levels)) (PP (IN of) (NP (ADJP (NN GC) (HYPH -) (VBN measured)) (NN cholesterol)))) (VP (VBD were) (ADVP (RB greatly)) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Abcg8) (NML (SYM -) (HYPH /) (SYM -))) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))))) (, ,) (CC yet) (S (NP-SBJ-2 (NP (NP (NN mRNA) (NNS levels)) (PP (IN of) (NP (NML (NN HMG) (HYPH -) (NN CoA)) (NN reductase)))) (CC and) (NP (NN enzyme) (NN activity))) (VP (VBP are) (ADVP (RB also)) (VP (VBN reduced) (NP-2 (-NONE- *)) (PP (IN without) (NP (NP (DT any) (JJ significant) (NN change)) (PP (IN in) (NP (NP (NN mRNA)) (PP (IN of) (NP (DT the) (NNS Srebps)))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN basis)) (PP (IN for) (NP (DT this)))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ clear)) (PP-TMP (IN at) (ADJP (JJ present))) (, ,) (SBAR-ADV (IN unless) (S (NP-SBJ (NP (DT the) (NN increase)) (PP (IN in) (NP (JJ non-plant) (NNS sterols)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT a) (NN suppression)) (PP (IN of) (NP (NN SREBP) (NN activation))))))))) (. .)) )
( (S (S (NP-SBJ-1 (NN Sitosterol)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (ADVP (RB directly)) (VP (VB inhibit) (NP (NN Cyp7a1) (NN activity)) (ADVP-LOC (FW in) (FW vitro))))))))) (CC and) (S (NP-SBJ (PRP we)) (VP (VBP presume) (SBAR (-NONE- *0*) (S (NP-SBJ (DT this)) (VP (MD may) (VP (VB account) (PP (IN for) (NP (DT the) (VBN reduced) (NN enzyme) (NN activity))))))))) (PRN (-LRB- [) (NP (CD 39)) (-RRB- ])) (. .)) )
( (S (PP-LOC (IN In) (NP (JJ preliminary) (NNS studies))) (, ,) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-1 (NN knockout) (NNS mice)) (VP (VBP are) (VP (VBN placed) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (JJ low) (NN sitosterol)) (NN diet))) (ADVP-TMP-3 (-NONE- *T*)))))) (, ,) (NP-SBJ-2 (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN enzyme)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN mRNA) (NNS levels))) (VP (VBP are) (VP (VBN increased) (NP-2 (-NONE- *)) (CIT (-LRB- -LRB-) (NNP E) (NNP Klett) (CC and) (NNP S) (NNP Patel) (, ,) (JJ unpublished) (NNS observations) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT Another) (NN prediction)) (, ,) (PP (VBN based) (PP (IN upon) (NP (NP (DT the) (NML (NN enzyme) (CC and) (NN mRNA)) (NNS levels)) (PP-LOC (IN in) (NP (NN knockout) (NNS mice))))))) (, ,) (VP (VBZ is) (SBAR-PRD (IN that) (S (SBAR-ADV (IN if) (S (NP-SBJ-1 (DT these) (NNS mice)) (VP (VBP are) (VP (VBN placed) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (NML (JJ high) (NN cholesterol)) (HYPH /) (NML (JJ high) (NN sitosterol))) (NN diet))))))) (, ,) (NP-SBJ (PRP they)) (VP (MD may) (VP (VB show) (NP (NP (JJ significant) (NN accumulation)) (PP (IN of) (NP (DT both) (NNS sterols))) (PP-LOC (IN in) (NP (DT the) (NN body))))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (ADJP-PRD (JJ relevant) (PP (IN to) (NP (NP (DT the) (JJ human) (NN disorder)) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (DT some) (PRN (, ,) (SBAR (IN although) (FRAG (RB not) (NP (DT all))))) (VBN affected) (NNS individuals)) (, ,) (VP (VBP manifest) (NP (JJ premature) (NML (JJ coronary) (NN artery)) (NN disease)) (ADVP-LOC-1 (-NONE- *T*)))))))))) (. .)) )
( (S (NP-SBJ (ADJP (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (JJ deficient)) (NNS mice)) (ADVP (RB also)) (VP (VBP allow) (S (NP-SBJ (PRP us)) (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT this) (NN protein))) (PP (IN in) (NP (NML (JJ biliary) (NN sterol)) (NN secretion)))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (NN bile)) (VP (VBZ is) (ADJP-PRD (NN sterol) (JJ poor)))) (CC and) (S (PP-TMP (IN upon) (NP (NP (NN stimulation)) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG increasing) (NP (NML (NN bile) (NN salt)) (NN excretion))))))) (, ,) (NP-SBJ (ADJP (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (JJ deficient)) (NNS mice)) (VP (MD can) (RB not) (VP (VB respond) (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (IN to) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (VP (VBZ is) (ADJP-PRD (ADJP (JJ necessary) (PP (IN for) (NP (NN cholesterol) (NN secretion)))) (CONJP (CC but) (RB not)) (ADJP (JJ necessary) (PP (IN for) (NP (NML (NN plant) (NN sterol)) (NN secretion)))))) (. .)) )
( (S (NP-SBJ-1 (NP (PRP It)) (SBAR (-NONE- *EXP*))) (VP (MD could) (VP (VB be) (VP (VBN argued) (NP-1 (-NONE- *)) (SBAR (IN that) (SBAR (SBAR-ADV (IN although) (S (NP-SBJ (DT the) (NML (JJ biliary) (NN sterol)) (NN output)) (VP (VBZ is) (ADJP-PRD (JJ comparable) (PP (IN to) (NP (NP (DT that)) (VP (VBN seen) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))))))) (IN that) (S (NP-SBJ (DT this)) (VP (VBZ is) (ADJP-PRD (RB inappropriately) (JJ low)))))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ (NP (DT the) (NML (NN tissue) (CC and) (NN plasma)) (NNS pools)) (PP (IN of) (NP (NN sitosterol)))) (VP (VBP are) (ADJP-PRD (RB so) (JJ elevated)) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NNS mice))))))))) (. .)) )
( (S (PP (IN Despite) (NP (DT this) (NN caveat))) (, ,) (NP-SBJ (NP (DT the) (NNS findings)) (PP (IN of) (NP (NP (NN sitosterol)) (PP (IN in) (NP (JJ significant) (NNS quantities))) (PP-LOC (IN in) (NP (DT the) (NN bile)))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NP (NNS mechanisms)) (ADJP (JJ other) (PP (IN than) (PP (IN via) (NP (DT the) (NNS sterolins)))))) (VP (MD can) (`` ') (VP (VB export) ('' ') (NP (NP (DT some)) (PP (IN of) (NP (DT these) (NNS sterols))))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-2 (NP (NNS humans)) (SBAR (WHNP-1 (WP who)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ heterozygous) (PP (IN for) (NP (NP (JJ genetic) (NNS defects)) (PP-LOC (IN in) (NP (CC either) (NN ABCG5) (CC or) (NN ABCG8)))))))))) (VP (VBP seem) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (RB phenotypically) (JJ normal)))))))) (, ,) (NP-SBJ (NP (NNS mice)) (ADJP (JJ heterozygous) (PP (IN for) (NP (NML (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (NN deficiency))))) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NN sterol) (NN secretion)) (VP (VBZ is) (ADJP-PRD (JJ impaired) (, ,) (CONJP (CC but) (RB not)) (JJ absent)))))) (. .)) )
( (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (PP (IN under) (NP (NML (JJ steady) (HYPH -) (NN state)) (NNS conditions))) (PP (IN on) (NP (DT a) (NML (NN rodent) (NN chow)) (NN diet))) (, ,) (NP-SBJ (JJ heterozygous) (NNS animals)) (VP (VBP show) (NP (NP (DT no) (JJ significant) (NNS elevations)) (PP (IN in) (NP (NML (NML (NN plasma) (CC or) (NN tissue)) (NN sitosterol)) (NNS levels)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN activity)) (PP (IN of) (NP (DT these) (NN proteins)))) (VP (MD may) (RB not) (VP (VB be) (ADJP-PRD (NN rate) (VBG limiting)))))))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (DT the) (JJ heterozygous) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD showed) (NP (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (JJ biliary) (NN sitosterol)))) (ADJP (JJ relative) (PP (IN to) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-1 (NP (DT the) (NN rate)) (PP (IN of) (NP (JJ total) (NML (JJ biliary) (NN sterol)) (NN secretion)))) (VP (VBZ is) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ (DT the) (JJ heterozygous) (NNS mice)) (VP (VBP are) (RB not) (ADJP-PRD (JJ sitosterolemic))))))))) (, ,) (CC either) (S (NP-SBJ (NP (DT the) (NN activity)) (PP (IN of) (NP (DT these) (NN proteins)))) (VP (VBZ is) (RB not) (ADJP-PRD (NN rate) (VBG limiting)))) (CC or) (S (NP-SBJ (JJ other) (NNS mechanisms)) (VP (MD can) (VP (VB compensate) (PP (IN for) (NP (NP (DT a) (NML (CD 50) (NN %)) (NN loss)) (PP (IN of) (NP (NN activity)))))))) (. .)) )
( (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ (NN feeding)) (VP (VBZ is) (ADJP-PRD (JJ intermittent))))) (, ,) (NP-SBJ (NP (DT a) (ADJP (JJ slow) (, ,) (CC but) (JJ continuous)) (NN secretion)) (PP-TMP (IN during) (NP (JJ post-prandial) (NNS periods)))) (VP (MD could) (ADVP (RB easily)) (VP (VB negate) (NP (NP (DT any) (JJ mild) (JJ temporary) (NN increase)) (PP (IN in) (NP (NML (NN tissue) (CC and) (NN plasma)) (NML (NN plant) (NN sterol)) (NNS levels))) (PP-LOC (IN in) (NP (JJ heterozygous) (NNS animals)))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ amenable) (PP (IN to) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG testing) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG placing) (NP (DT these) (NNS animals)) (PP (IN on) (NP (DT a) (NML (JJ high) (NN plant) (NN sterol)) (NN diet)))) (CC and) (VP (VBG measuring) (NP (DT the) (NML (NN plasma) (NN sterol)) (NNS levels)))))))))))) (. .)) )
( (S (ADVP-TMP (RB Recently)) (, ,) (NP-SBJ (NP (NNP Kosters)) (ADVP-ETC (FW et) (FW al.))) (VP (VBD reported) (SBAR (IN that) (S (NP-SBJ (NP (NML (NML (NN Abcg5) (HYPH /) (NN Abcg8)) (NN mRNA)) (NN expression)) (PP-LOC (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ different) (NN mouse) (NNS strains)))))) (VP (VBD correlated) (PP (IN with) (NP (NML (NML (JJ biliary) (NN cholesterol)) (NN secretion)) (NNS rates)))))) (PRN (-LRB- [) (NP (CD 30)) (-RRB- ]))) (. .)) )
( (S (PP-LOC (IN In) (NP (PRP$ their) (NNS studies))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (ADJP (NN diosgenin) (HYPH -) (VBN fed)) (NNS mice)) (VP (VBD showed) (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (JJ biliary) (NN cholesterol) (NN output))))))) (, ,) (NP-SBJ-1 (NP (NN mRNA) (NNS levels)) (PP (IN of) (NP (NN Abcg5) (CC and) (NN Abcg8)))) (VP (VBD were) (RB not) (VP (VBN altered) (NP-1 (-NONE- *)))) (. .)) )
( (S (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG Using) (NP (NML (NNP Western) (NN blot)) (NNS analyses)))) (, ,) (NP-SBJ-1 (NP (DT the) (NN protein) (NN level)) (PP (IN of) (NP (NN Abcg5)))) (VP (VBD was) (ADVP (RB also)) (RB not) (VP (VBN altered) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN diosgenin))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-2 (NN Abcg8)) (VP (VBD was) (VP (RB not) (VP (VBN measured) (NP-2 (-NONE- *))))))))) (. .)) )
( (S (NP-SBJ (PRP They)) (VP (VBD concluded) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (JJ parallel) (NN route)) (PP (IN for) (NP (NML (JJ biliary) (NN cholesterol)) (NN secretion)))) (VP (MD might) (VP (VB be) (ADJP-PRD (JJ operational)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ independent) (PP (IN of) (NP (DT the) (NNS sterolins)))))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ (NML (JJ biliary) (NN cholesterol)) (NN secretion)) (VP (VBZ is) (RB not) (ADJP-PRD (RB completely) (JJ absent)) (PP-LOC (IN in) (NP (DT the) (ADJP (NN Abcg8) (HYPH -) (JJ deficient)) (NNS mice)))))) (NP-SBJ (PRP it)) (VP (MD would) (VP (VB appear) (SBAR (IN that) (S (NP-SBJ (NN sterolin) (HYPH -) (CD 2)) (VP (VBZ plays) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (DT this) (NN process)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (DT a) (JJ genetic) (NN screen)) (PP (IN of) (NP (NN plasma) (NML (NN plant) (NN sterol)) (NNS levels))))) (, ,) (S (S (NP-SBJ (NP (NNP Sehayek)) (ADVP-ETC (FW et) (FW al.))) (VP (VBD identified) (NP (NP (CD three) (NNS loci)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ responsible) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG controlling) (NP (NN plasma) (NML (NN plant) (NN sterol)) (NNS levels))))))))))))) (CC and) (S (NP-SBJ (NP (RB not) (CD one)) (PP (IN of) (NP (DT these) (NNS loci)))) (VP (VBN mapped) (PP (IN to) (NP (DT the) (JJ murine) (NN STSL) (NN region)))))) (PRN (-LRB- [) (NP (CD 43)) (-RRB- ])) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (NN support)) (PP (IN for) (NP (NP (QP (RB at) (RBS least) (CD four)) (NNS loci)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB be) (VP (VBN involved) (NP-1 (-NONE- *)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG regulating) (NP (NN plasma) (NML (NN plant) (NN sterol)) (NNS levels)))))))))))))) (. .)) )
( (S (PP-TMP (IN To) (NP (NN date))) (S (S (NP-SBJ (DT the) (NN STSL) (NN locus)) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ only) (CD one)) (VP (VBN proven) (NP-1 (-NONE- *)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB be) (VP (VBN involved) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (JJ dietary) (NN sterol)) (NN trafficking))))))))))) (CC and) (S (NP-SBJ-2 (NP (DT the) (NN identity)) (PP (IN of) (NP (DT the) (NNS others)))) (VP (VBZ remains) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN elucidated) (NP-2 (-NONE- *))))))))) (. .)) )
( (S (NP-SBJ (PRP We) (, ,) (CONJP (RB as) (RB well) (IN as)) (NNS others)) (, ,) (VP (VBP have) (VP (VBN proposed) (NP-1 (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (CC and) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB function) (PP (IN as) (NP (JJ obligate) (NNS heterodimers)))))))) (. .)) )
( (S (ADVP (RB Thus)) (S-NOM-SBJ (NP-SBJ (-NONE- *PRO*)) (VP (VBG knocking) (PRT (RP out)) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2) (RB alone)))) (VP (VBZ is) (ADJP-PRD (JJ equivalent) (PP (IN to) (NP (NP (DT a) (JJ functional) (NN loss)) (PP (IN of) (NP (DT both) (NNS sterolins))))))) (. .)) )
( (S (NP-SBJ-1 (NP (PRP It)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ-3 (NML (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (NN expression)) (VP (VBZ is) (VP (VBN required) (NP-3 (-NONE- *)) (PP-PRP (IN for) (NP (NP (JJ correct) (JJ apical) (NN trafficking)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (PP (IN to) (NP (DT the) (JJ apical) (NN surface))) (UCP (PP-LOC (IN in) (NP (DT a) (NML (VBN polarized) (NN cell)) (NN line))) (CC and) (ADVP (ADVP-TMP (RBR more) (RB recently)) (FW in) (FW vivo))) (PP (IN by) (NP (NN over-expression) (NNS experiments))))))))) (PRN (-LRB- [) (NP (CD 18) (, ,) (CD 19)) (-RRB- ]))))) (. .)) )
( (S (PP (IN In) (NP (NP (NNS experiments)) (VP (VBN shown) (NP (-NONE- *)) (ADVP-LOC (RB here))))) (, ,) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (CD three) (ADJP (RB separately) (VBN developed)) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NNS antibodies)))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBP have) (VP (VBN obtained) (NP-1 (-NONE- *)) (NP (NP (JJ inconsistent) (NNS data)) (PP (VBG regarding) (NP (NP (DT the) (NN trafficking)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (PP-LOC (IN in) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))))))) (. .)) )
( (S (PP-PRP (VBN Based) (PP (IN upon) (NP (JJ classical) (NML (NN N) (HYPH -) (NN glycosylation)) (NN maturation)))) (NP-SBJ (PRP it)) (VP (MD would) (VP (VB appear) (SBAR (IN that) (S (NP-SBJ (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (, ,) (PP-LOC (IN in) (NP (DT the) (NML (NN Abcg8) (NML (SYM -) (HYPH /) (SYM -))) (NNS mice)))) (, ,) (VP (VBZ does) (RB not) (VP (VB exit) (NP (DT the) (JJ endoplasmic) (NN reticulum)))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP-MNR (IN by) (NP (NN immunohistochemistry))) (NP-SBJ (PRP it)) (VP (VBZ appears) (SBAR (IN that) (S (NP-SBJ-2 (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (VP (VBZ is) (ADVP (RB apically)) (VP (VBN expressed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (ADJP (NN Abcg8) (HYPH -) (JJ deficient)) (NNS mice))) (ADVP (RB regardless) (PP (IN of) (NP (NP (DT the) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN antibody)) (VP (VBN used) (NP (-NONE- *))))))))))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (PP-LOC (IN in) (NP (NP (DT a) (NN report)) (PP (IN of) (NP (NP (NML (NN Abcg5) (HYPH /) (NN Abcg8)) (NN localization)) (PP-LOC (IN in) (NP (NML (JJ canine) (NN gallbladder)) (JJ epithelial) (NNS cells))))))) (, ,) (NP-SBJ-1 (DT these) (CD two) (NN proteins)) (VP (VBD were) (VP (VBN found) (NP-1 (-NONE- *)) (ADVP (RB intracellularly)) (PP (IN under) (NP (NN baseline) (NNS conditions))) (PRN (-LRB- [) (NP (CD 44)) (-RRB- ])))) (. .)) )
( (S (CC But) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN given) (NP-1 (-NONE- *)) (NP (NML (NML (NN liver) (NN X) (NN receptor) (NN alpha)) (-LRB- -LRB-) (NML (NN LXRα))) (-RRB- -RRB-) (NN agonist)) (ADVP-TMP-3 (-NONE- *T*))))) (, ,) (NP-SBJ-2 (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (CC and) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))) (VP (VBD appeared) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN expressed) (NP-2 (-NONE- *)) (PP-LOC (IN at) (NP (DT the) (JJ apical) (NN surface)))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT these) (NNS studies))) (NP-SBJ-1 (DT the) (NN UTSW) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN antibody)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ apparent)) (PP (IN with) (NP (DT these) (VBG conflicting) (NNS data))) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT the) (NN trafficking)) (PP (IN of) (NP (DT these) (NNS transporters)))) (VP (VBZ is) (RB not) (ADJP-PRD (RB as) (JJ clear) (HYPH -) (JJ cut)))))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT a) (JJ recent) (NN paper))) (, ,) (NP-SBJ (NP (NNP Mangrivite)) (ADVP-ETC (FW et) (FW al.))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ apical) (NN sorting)) (PP (IN of) (NP (NN rat) (NN SPNT))) (PP-LOC (IN in) (NP (VBN polarized) (JJ renal) (JJ epithelial) (NNS cells)))) (VP (VBD was) (ADJP-PRD (JJ independent) (PP (IN of) (NP (NN N) (HYPH -) (NN glycosylation))))))) (PRN (-LRB- [) (NP (CD 45)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (PP-TMP (IN at) (NP (DT this) (NN time))) (, ,) (S (S (NP-SBJ (PRP we)) (VP (MD can) (RB neither) (VP (VB exclude) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP-SBJ (NML (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN expression)) (VP (VBZ is) (ADJP-PRD (JJ functional)) (PP-LOC (IN in) (NP (PRP$ our) (ADJP (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (JJ deficient)) (NNS mice)))))))))) (CC nor) (SINV (MD can) (NP-SBJ (PRP we)) (VP (VB rule) (NP (PRP it)) (PRT (RP out))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (NP (NP (DT no) (JJ functional) (NN assay)) (PP (IN for) (NP (DT these) (NN proteins)))) (PP-TMP (IN at) (ADJP (JJ present)))) (. .)) )
( (S (NP-SBJ (ADJP (RBR More) (JJ extensive)) (NN fractionation) (NNS experiments) (S-1 (-NONE- *ICH*))) (VP (VBP are) (ADJP-PRD (JJ underway)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (ADVP (RBR better)) (VP (VB determine) (NP (NP (DT the) (JJ exact) (JJ compartmental) (NN location)) (PP (IN of) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (PP-LOC (IN in) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN context))) (, ,) (NP-SBJ (NP (NNP Plösch)) (ADVP-ETC (FW et) (FW al.))) (VP (VBP have) (VP (VBN described) (NP (NP (DT an) (ADJP (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (JJ deficient)) (NN mouse)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VP (VBZ maintains) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (JJ biliary) (NN cholesterol)) (PP (IN to) (NP (NP (DT the) (JJ same) (NN extent)) (PP (IN as) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))))))) (CC and) (, ,) (VP (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN fed) (NP-2 (-NONE- *)) (NP (DT a) (NN LXR) (NN agonist)) (ADVP-TMP-1 (-NONE- *T*))))) (, ,) (VP (VBD had) (NP (JJR higher) (NML (NN Abcg8) (NN mRNA)) (NN expression))) (CC and) (VP (VBD tended) (S (NP-SBJ-3 (-NONE- *)) (VP (TO to) (VP (VB secrete) (NP (NP (JJR more) (JJ biliary) (NN cholesterol)) (PP (IN than) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))))))))))) (PRN (-LRB- [) (NP (CD 46)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (PRP It)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ has) (VP (VBN been) (VP (VBN argued) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (CC and) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))) (VP (VBP are) (ADJP-PRD (JJ dependent) (PP (IN upon) (NP (DT each) (JJ other)))) (PP (IN for) (NP (NP (NN secretion)) (PP (IN of) (NP (JJ hepatic) (NNS sterols))) (PP (IN into) (NP (NN bile)))))))) (PRN (-LRB- [) (NP (CD 19)) (-RRB- ]))))) (. .)) )
( (S (PP (PP (VBN Given) (NP (NP (DT the) (NNS data)) (VP (VBN presented) (NP (-NONE- *)) (ADVP-LOC (RB here))))) (CC and) (PP (IN from) (NP (DT the) (ADJP (NN Abcg5) (HYPH -) (JJ deficient)) (NN mouse)))) (NP-SBJ-1 (DT this)) (VP (VBZ does) (RB not) (VP (VB appear) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (DT the) (NN case))))))) (. .)) )
( (S (ADVP (RB Perhaps)) (PP-LOC (IN in) (NP (DT the) (ADJP (RB previously) (VBN published)) (NN model))) (NP-SBJ-1 (NP (DT a) (JJ non-physiologic) (NN state)) (SBAR-2 (-NONE- *ICH*))) (VP (VBZ has) (VP (VBN been) (VP (VBN made) (NP-1 (-NONE- *)) (SBAR-2 (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ generates) (NP (DT these) (NNS data)))))))) (. .)) )
( (S (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN Taken) (NP-1 (-NONE- *)) (ADVP (RB together)))) (, ,) (NP-SBJ (DT these) (NN animal) (NNS models)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP-SBJ (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (CC and) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))) (VP (VBP have) (NP (JJ independent) (NN function)) (ADVP (FW in) (FW vivo))))) (CC or) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (NP (NN proteins)) (ADJP (JJ other) (PP (IN than) (NP (DT the) (NNS sterolins))))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (MD can) (VP (VB secrete) (NP (JJ biliary) (NNS sterols)))))))))))) (. .)) )
( (HEADING (NP (NNS Conclusions))) )
( (S (NP-SBJ (NP (DT The) (JJ major) (NNS findings)) (PP-LOC (IN in) (NP (DT this) (NN study)))) (VP (VBP are) (: :) (UCP-PRD (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP-SBJ-2 (NP (NN disruption)) (PP (IN of) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (NP (DT the) (CD two) (NNS genes)) (VP (VBG comprising) (NP (DT the) (NN STSL) (NN locus)))))))) (VP (VBZ is) (ADJP-PRD (JJ necessary) (CC and) (JJ sufficient) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB cause) (NP (NN sitosterolemia)))))))) (, ,) (SBAR (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (IN that) (S (NP-SBJ (NP (DT the) (NN loss)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VBZ leads) (PP (IN to) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (JJ biliary) (NN cholesterol) (NN secretion)))))))) (CC and) (SBAR (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (-NONE- *0*) (S (NP-SBJ-1 (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADVP-TMP (RB still)) (ADVP (RB apically)) (HYPH -) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN despite) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))))))))))))) (. .))) )
( (S (NP-SBJ (DT These) (NNS data)) (ADVP (RB strongly)) (VP (VBP support) (NP (NP (DT the) (JJ direct) (NN role)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))) (PP (IN as) (NP (NP (DT a) (JJ key) (NN player)) (PP (IN in) (NP (NML (JJ biliary) (NN cholesterol)) (NN secretion)))))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-1 (NML (JJ biliary) (NN sitosterol)) (NN secretion)) (VP (VBD was) (ADVP (RB apparently)) (VP (VBN preserved) (NP-1 (-NONE- *))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (NP (NNS mechanisms)) (ADJP (JJ other) (PP (IN than) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP allow) (PP (IN for) (NP (NP (DT the) (NN secretion)) (PP (IN of) (NP (NN sitosterol))) (PP (IN into) (NP (NN bile))))))))))))) (. .)) )
( (HEADING (NP (VBG Competing) (NNS interests))) )
( (FRAG (NP-SBJ-1 (NN None)) (VP (VBD declared) (NP-1 (-NONE- *))) (. .)) )
( (HEADING (NP (NP (NNS Authors) (POS ')) (NNS contributions))) )
( (S (NP-SBJ (NN ELK)) (VP (VBD carried) (PRT (RP out)) (NP (NP (NML (JJ molecular) (NN genetics)) (NNS studies)) (, ,) (NP (JJ quantitative) (NN RT) (HYPH -) (NN PCR)) (, ,) (CC and) (NP (JJ dynamic) (NN bile) (NN collection))) (PP (IN for) (NP (NN Figure) (CD 9)))) (. .)) )
( (S (NP-SBJ (NN KL)) (VP (VP (VBD carried) (PRT (RP out)) (NP (JJ molecular) (JJ genetic) (NNS studies))) (CC and) (VP (VBD made) (NP (DT the) (NN targeting) (NN construct)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN knockout) (NNS mice)) (VP (VBD were) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NNP NM) (NN laboratory))))) (. .)) )
( (S (NP-SBJ (NNP HY)) (VP (VBD performed) (NP (NNP Northern) (NN blotting))) (. .)) )
( (S (NP-SBJ (NNP ELK) (, ,) (NNP AK) (, ,) (NNP EV) (CC and) (NNP MHL)) (VP (VBD performed) (NP (NP (NNP Western) (NN blotting)) (CC and) (NP (NN immunohistochemistry) (NNS experiments)))) (. .)) )
( (S (NP-SBJ (NNP AK) (CC and) (NNP NL)) (VP (VBD performed) (NP (NP (NP (NML (NN bile) (NN collection)) (NNS experiments)) (CC and) (NP (NN bile) (NN characterization))) (PP (IN for) (NP (NN Figure) (CD 8))))) (. .)) )
( (S (NP-SBJ (NNP MA)) (VP (VBN performed) (NP (NN FPLC) (NN analysis))) (. .)) )
( (S (NP-SBJ (NNP SS) (, ,) (NNP AK) (CC and) (NNP RK)) (VP (VBD performed) (NP (NN GC) (NN sterol) (NNS analyses))) (. .)) )
( (S (NP-SBJ (NNP JC)) (VP (VBN assisted) (PP (IN with) (NP (NP (JJ dynamic) (NN bile) (NN collection)) (CC and) (NP (NN mouse) (NN surgery))))) (. .)) )
( (S (NP-SBJ (NNP ROE) (, ,) (NNP AG) (, ,) (NNP NM) (, ,) (NNP GS) (CC and) (NNP SBP)) (VP (VBD were) (ADJP-PRD (JJ responsible) (PP (PP (IN for) (NP (NP (NN supervision)) (, ,) (NP (NP (NNS data) (NNS analyses)) (PP (IN of) (NP (NNS experiments)))))) (CC and) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG providing) (NP (NP (NN funding)) (PP (IN of) (NP (DT these) (NNS experiments)))))))))) (. .)) )
( (S (NP-SBJ (NNP ELK) (CC and) (NNP SBP)) (VP (VBD wrote) (NP (DT the) (NN paper))) (. .)) )
( (HEADING (NP (JJ Pre-publication) (NN history))) )
( (S (NP-SBJ-1 (NP (DT The) (JJ pre-publication) (NN history)) (PP (IN for) (NP (DT this) (NN paper)))) (VP (MD can) (VP (VB be) (VP (VBN accessed) (NP-1 (-NONE- *)) (ADVP-LOC (RB here))))) (: :)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ-1 (PRP We)) (VP (MD would) (VP (VB like) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VP (VB thank) (NP=2 (NNP Dr) (NNP B) (NNP Stieger)) (PP=3 (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (ADVP (RB kindly)) (VP (VBG providing) (NP (JJ anti-Bsep) (NN antibody)))))) (CC and) (VP (NP=2 (NNP Dr) (NNP H) (NNP Hobbs)) (PP=3 (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG providing) (NP (DT the) (NN UTSW) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN antibody))))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (MD would) (ADVP (RB also)) (VP (VB like) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB thank) (NP (NNP John) (NNP Oatis) (, ,) (CD III)) (PP-PRP (IN for) (NP (PRP$ his) (JJ excellent) (NN animal) (NN husbandry)))))))) (. .)) )
( (S (NP-SBJ (NP (NP (NNS Grants)) (PP (IN from) (NP (DT the) (NNP American) (NNP Heart) (NNP Association)))) (, ,) (NP (JJ Beginning) (NML (NML (NN Grant)) (HYPH -) (PP (IN In) (HYPH -) (NP (NN Aid)))) (JJ Mid-Atlantic) (NN Affiliate) (PRN (-LRB- -LRB-) (NP (NNP KL)) (-RRB- -RRB-))) (, ,) (NP (NP (NNP NIH) (NML (JJ Postdoctoral) (NN Training)) (NN Grant) (NML (NN T32) (NN HL07260))) (-LRB- -LRB-) (NP (NNP ELK))) (-RRB- -RRB-) (, ,) (NP (NP (NP (NP (DT the) (NNP Netherlands) (NNP Organization)) (PP (IN for) (NP (NNP Scientific) (NNP Research)))) (-LRB- -LRB-) (NP (NN NOW))) (-RRB- -RRB-) (NML (NML (CD 902) (HYPH -) (CD 23) (HYPH -) (CD 193)) (-LRB- -LRB-) (NML (NNP AK)))) (-RRB- -RRB-) (CONJP (RB as) (RB well) (IN as)) (NP (NML (NML (DT the) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health)))) (NN Grant) (NML (NML (NML (NN HL60613)) (-LRB- -LRB-) (NML (NNP SBP))) (-RRB- -RRB-) (CC and) (NML (NML (NN DK56830)) (-LRB- -LRB-) (NML (NNP GS)))))) (-RRB- -RRB-) (VP (VBD supported) (NP (DT this) (NN work))) (. .)) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (NP (NP (NN Generation)) (PP (IN of) (NP (NP (NNS mice)) (ADJP (JJ deficient) (PP (IN in) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NML (VBN targeted) (NN disruption)) (NN strategy)) (PP (IN of) (NP (NN Abcg8)))) (VP (VBZ is) (SBAR-PRD (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN a)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NN BamHI)))) (VP (VBD digested) (NP (NP (NN mouse) (JJ genomic) (NN DNA)) (, ,) (VP (VBN probed) (NP (-NONE- *)) (PP-MNR (IN with) (NP (-LRB- [) (NN 32P) (-RRB- ]) (HYPH -) (ADJP (RB randomly) (VBN labelled)) (NN probe))))) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (NP (DT a) (NML (CD 6.0) (NN kb)) (NN band)) (PP (IN for) (NP (JJ wild) (NN type)))) (, ,) (NP (NP (DT a) (NML (CD 2.7) (NN kb)) (NN band)) (PP (IN for) (NP (JJ homozygous)))) (CC and) (NP (NP (CD two) (NNS bands)) (PP (IN of) (NP (CD 5.9) (CC and) (CD 2.6) (NN kb))) (PP (IN for) (NP (DT the) (NN heterozygote)))))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN b)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (NNP Northern) (NN blot)) (NN analysis)) (PP (IN of) (NP (JJ hepatic) (NN RNA)))) (VP (VP (VP (VBD showed) (NP (NP (DT a) (NN loss)) (PP (IN of) (NP (NML (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (NN mRNA)))) (PP-LOC (IN in) (NP (DT the) (NN homozygote)))) (CC and) (VP (VBD decreased) (NP (NML (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (NN mRNA)) (PP-LOC (IN in) (NP (DT the) (NN heterozygote))))) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ-1 (NML (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN mRNA)) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (RB relatively) (JJ unaffected))) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NNS mice)))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN c)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Probes)) (VP (VBD were) (NP-PRD (NP (NP (QP (RB approximately) (CD 1.9)) (NN kb)) (PP (IN for) (NP (NN Abcg5)))) (CC and) (NP (NP (CD 2) (NN kb)) (PP (IN for) (NP (NN Abcg8))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Methods)) (PP-PRP (IN for) (NP (JJR more) (NN detail))))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (NN RT) (HYPH -) (NN PCR)) (NNS analyses)) (PP (IN of) (NP (JJ hepatic) (NN cDNA)))) (VP (VBD showed) (NP (NP (DT no) (NML (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)) (NN message)) (, ,) (ADVP-LOC (RB downstream) (PP (IN of) (NP (NN exon) (CD 4)))) (PP-LOC (IN in) (NP (DT the) (NML (NN Abcg8) (NML (SYM -) (HYPH /) (SYM -))) (NNS mice)))) (, ,) (SBAR-ADV (IN whether) (S (NP-SBJ-1 (NNS primers)) (VP (VBD were) (VP (VBN located) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS exons) (NML (CD 4) (CC and) (CD 13)) (PRN (-LRB- -LRB-) (NP (NN panel) (NN d)) (-RRB- -RRB-))) (, ,) (NP (NNS exons) (NML (CD 9) (CC and) (CD 13))) (CC or) (NP (NNS exons) (NML (CD 10) (CC and) (CD 13)) (PRN (-LRB- -LRB-) (NP (NN panel) (NN e)) (-RRB- -RRB-)))))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NP (NML (ADJP (JJ Free) (CC versus) (JJ esterified)) (NN sterol)) (NNS levels)) (PP-LOC (IN in) (NP (NP (DT the) (NNS livers)) (PP (IN of) (NP (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +)) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NP (NN Sterol) (NNS contents)) (PP (IN of) (NP (NP (NN liver) (NNS extracts)) (PP (IN of) (NP (NP (ADJP (NP (CD 12) (HYPH -) (NN week)) (HYPH -) (JJ old)) (JJ female) (NNS mice)) (VP (VBN fed) (NP (-NONE- *)) (NP (DT a) (NML (JJ regular) (NN chow)) (NN diet)))))))) (, ,) (VP (VBN determined) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NN GC) (NN analysis))))) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (NNS sterols)) (PP-LOC (IN in) (NP (DT all) (NNS genotypes)))))) (VP (VBP are) (ADJP-PRD (JJ unesterified)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Esterified) (NN cholesterol) (PRN (-LRB- -LRB-) (NP (NN panel) (NN a)) (-RRB- -RRB-))) (VP (VBZ remains) (ADJP-PRD (RB relatively) (JJ constant)) (PP (IN for) (NP (DT each) (NN genotype)))) (. .))) )
( (CAPTION (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (NP (NP (DT no) (VBN esterified) (NN sitosterol)) (PP-LOC (IN in) (NP (NP (DT the) (NNS livers)) (PP (IN from) (NP (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +)) (CC and) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -))) (NNS mice)))))) (CC and) (NP (NP (RB very) (JJ little)) (PP (IN from) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice))))) (VP (VBD was) (VP (VBN detected) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN panel) (NN b)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (JJ Small) (NNS amounts)) (PP (IN of) (NP (VBN esterified) (NN campesterol)))) (VP (VBD were) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (NNS genotypes))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN c)) (-RRB- -RRB-)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (NN Lipid) (NNS profiles)) (PP (IN of) (NP (NP (DT the) (NN plasma)) (PP (IN of) (NP (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +)) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Lipoproteins)) (VP (VBD were) (VP (VBN separated) (NP-1 (-NONE- *)) (PP (IN from) (NP (VBN pooled) (NML (NN mouse) (NN plasma)) (NNS samples))) (PP-MNR (IN by) (NP (NN FPLC))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NML (NML (JJ Total) (NNS sterols) (PRN (-LRB- -LRB-) (NP (NN panel) (DT a)) (-RRB- -RRB-))) (CC and) (NML (NN triglyceride) (PRN (-LRB- -LRB-) (NP (NN panel) (NN b)) (-RRB- -RRB-)))) (NNS profiles)) (PP (IN of) (NP (DT the) (NNS fractions)))) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (S (NP-SBJ (EX There)) (VP (VBD was) (NP-PRD (NP (DT no) (NN difference)) (PP (IN of) (NP (NN cholesterol) (NNS profiles))) (PP-LOC (IN in) (NP (DT the) (NNS groups)))))) (, ,) (CC but) (S (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (NP (DT a) (JJ small) (NN triglyceride) (NN peak)) (PP-LOC (IN in) (NP (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (PP (IN in) (NP (NNS fractions) (NML (NML (CD 21)) (PP (SYM –) (NP (CD 25))))))) (, ,) (VP (VBG corresponding) (PP (IN to) (NP (NP (DT the) (NML (NN LDL) (HYPH -) (NN size)) (NN range)) (, ,) (SBAR (WHNP-1 (NP (DT the) (NN significance)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (RB not) (VP (VBN known) (NP-1 (-NONE- *)) (PP-TMP (IN at) (ADJP (JJ present))))))))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (NP (NP (NNS Analyses)) (PP (IN of) (NP (NP (NP (NN mRNA) (NN expression)) (CC and) (NP (NN enzyme) (NN activity))) (PP-LOC (IN in) (NP (NN mouse) (NNS livers))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Panel) (-LRB- -LRB-) (NN a) (-RRB- -RRB-)) (VP (VBZ shows) (NP (NP (NML (NN RT) (HYPH -) (NN PCR)) (NN quantitation)) (PP (IN of) (NP (NN mRNA) (NNS levels))) (PP (IN for) (NP (NP (NN Abcg5)) (, ,) (NP (NN Abcg8)) (, ,) (NP (NN Hmgr)) (, ,) (NP (NN Cyp7a1)) (, ,) (NP (NN Abca1)) (, ,) (NP (NN Mdr2)) (, ,) (NP (NN Lxr)) (, ,) (NP (NN Srebp) (HYPH -) (NN 1c)) (CC and) (NP (NN Srebp) (HYPH -) (CD 2)))) (PP-LOC (IN in) (NP (NP (NN mouse) (NNS livers)) (PP (IN from) (NP (NP (NN Abcg8) (SYM +) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (NP (JJ open) (NNS bars)) (-RRB- -RRB-))) (, ,) (NP (HYPH Abcg8) (SYM +) (HYPH /) (SYM -) (PRN (-LRB- -LRB-) (NP (VBN hatched) (NNS bars)) (-RRB- -RRB-))) (CC and) (NP (NN Abcg8) (SYM -) (HYPH /) (SYM -) (PRN (-LRB- -LRB-) (NP (VBN filled) (NNS bars)) (-RRB- -RRB-))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Knockout) (NNS mice)) (VP (VBD showed) (NP (NP (NP (DT an) (NML (QP (SYM ~) (CD 60)) (NN %)) (NN reduction)) (PP (IN in) (NP (NP (NN mRNA)) (PP (IN for) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)))))) (CC and) (NP (NP (DT an) (NML (CD 80) (NN %)) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN message)) (PP (IN for) (NP (NN HMG) (NN CoA) (NN reductase)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (RB Relatively) (DT no) (NN message)) (PP (IN for) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2)))) (VP (VBD was) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Panel) (-LRB- -LRB-) (NN b) (-RRB- -RRB-)) (VP (VBZ shows) (NP (NP (DT the) (NN enzyme) (NNS activities)) (PP (IN for) (NP (NP (NML (NN HMG) (HYPH -) (NN CoA)) (NN reductase)) (CC and) (NP (NN CYP7a1)))) (PP-LOC (IN in) (NP (NP (NNS livers)) (PP (IN from) (NP (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +)) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NNS mice))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NNS Activities)) (PP (IN of) (NP (NP (NML (NN HMG) (HYPH -) (NN CoA)) (NN reductase)) (CC and) (NP (NN CYP7a1))))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NN mouse) (NN liver))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN text)) (PP-PRP (IN for) (NP (NN discussion))))) (-RRB- -RRB-)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (HEADING (NP (NP (NN N) (HYPH -) (NN glycosylation)) (PP (IN of) (NP (NML (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NNS analyses))) (PP-LOC (IN in) (NP (NML (HYPH Abcg8) (SYM -) (HYPH /) (SYM -)) (NN mouse) (NN liver))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (NN Mouse) (NN liver)) (NN homogenate)) (VP (VBN stained) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN SC) (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (PP-TMP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NN Endo) (HYPH -) (NN H)) (CC or) (NP (NN PNGaseF)))))))) (VP (VBZ shows) (NP (NP (NP (DT a) (NML (CD 75) (NN kDa)) (NN band)) (RRC (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (DT both) (NNS genotypes))))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (JJ resistant) (PP (IN to) (NP (NN deglycosylation)))))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN a)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Staining)) (PP (IN of) (NP (NML (JJ wild) (HYPH -) (NN type)) (NN liver) (NN homogenate))) (PP (IN with) (NP (JJ preimmune) (NN serum)))) (VP (VBD showed) (NP (DT no) (JJ detectable) (NNS bands))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (JJR Lower) (NN portion)) (PP (IN of) (NP (NN panel) (-LRB- -LRB-) (NN a) (-RRB- -RRB-)))) (VP (VBZ shows) (NP (NP (NP (DT the) (JJ same) (NNS aliquots)) (VP (VBN stained) (NP (-NONE- *)) (PP (IN for) (NP (NN anti-transferrin))))) (PP (IN as) (NP (NP (DT a) (NN control)) (PP (IN for) (NP (NN deglycosylation))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN AMC) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN staining)) (PP (IN of) (NP (NML (NN mouse) (NN liver)) (NN homogenate)))) (VP (VBZ shows) (NP (NP (DT a) (`` ') (JJ mature) ('' ') (NML (QP (SYM ~) (CD 90)) (NN kDa)) (NN band)) (PP-LOC (PP (IN in) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN b)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT A) (NML (CD 75) (NN kDa)) (NN form)) (SBAR-1 (-NONE- *ICH*))) (VP (VBZ is) (ADJP-PRD (JJ present)) (SBAR-1 (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (JJ sensitive) (PP (IN to) (NP (NN deglycosylation)))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (NP (NML (NN Mouse) (NN liver)) (NN homogenate)) (VP (VBN stained) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN UTSW) (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))))) (VP (VBZ shows) (NP (NP (NP (DT a) (`` ') (JJ mature) ('' ') (NML (QP (SYM ~) (CD 90)) (NN kDa)) (NN band)) (CC and) (NP (DT an) (`` ') (JJ immature) ('' ') (NML (CD 75) (NN kDa)) (NN band))) (PP-LOC (IN in) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))) (CC but) (S (NP-SBJ-1 (DT no) (NN signal)) (VP (VBZ is) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Treatment)) (PP (IN with) (NP (NP (NN Endo) (HYPH -) (NN H)) (CC or) (NP (NN PNGaseF))))) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJR lower) (NML (JJ molecular) (NN weight)) (NN protein)) (PP-LOC (IN in) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))) (. .))) )
( (CAPTION (NP (NP (NML (NML (NN Abcg5) (HYPH /) (NN Abcg8)) (SYM -) (HYPH /) (SYM -)) (NN liver) (NN homogenate)) (VP (VBN used) (NP (-NONE- *)) (PP-PRP (IN for) (NP (JJ negative) (NN control)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (HEADING (NP (NP (JJ Immunohistochemical) (NN evaluation)) (PP (IN of) (NP (NP (NML (NN mouse) (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN expression)) (PP-LOC (IN in) (NP (NN liver) (CC and) (NN intestine))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (NN COS) (HYPH -) (CD 1)) (NNS cells)) (VP (VBD were) (VP (VP (ADVP (RB transiently)) (VBN transfected) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (NML (NML (NN pCMV) (HYPH -) (NN mouse)) (NN Abcg5)) (CC or) (NML (NML (NN pCMV) (HYPH -) (NN mouse)) (NN Abcg8))) (NNS constructs)))) (, ,) (VP (VBN allowed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB express) (PP (IN for) (NP (CD 48) (NNS hours))))))) (VP (ADVP-TMP (RB then)) (VBN fixed) (CC and) (VBN incubated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN antibody)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (ADJP (NP (NN pCMV) (JJ empty) (NN vector)) (VBN transfected)) (NML (NN COS) (HYPH -) (CD 1)) (NNS cells)) (VP (VBN incubated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN SC) (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))))) (VP (VBD showed) (NP (DT no) (JJ significant) (NN fluorescence)) (PRN (-LRB- -LRB-) (NP (NN panel) (NN a)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (ADJP (NN Abcg5) (VBN transfected)) (NML (NN COS) (HYPH -) (CD 1)) (NNS cells)) (VP (VBN incubated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN SC) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN antibody))))) (VP (VBD showed) (NP (DT a) (NN membrane) (NN distribution)) (PRN (-LRB- -LRB-) (NP (NN panel) (NN b)) (-RRB- -RRB-)) (, ,) (SBAR-ADV (RB where) (IN as) (S (NP-SBJ (NP (ADJP (NN Abcg8) (VBN transfected)) (NNS cells)) (VP (VBN incubated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN SC) (NN anti-Abcg5) (NN antibody))))) (VP (VBD showed) (NP (DT no) (JJ significant) (NN fluorescence)) (PRN (-LRB- -LRB-) (NP (NN panel) (NN c)) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (ADJP (NP (NN Abcg5) (CC and) (NN Abcg8)) (JJ co-transfected)) (NML (NN COS) (HYPH -) (CD 1)) (NNS cells)) (VP (VBN incubated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN SC) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN antibody))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (NN fluorescence) (NN pattern)) (ADJP (JJ similar) (PP (IN to) (NP (NN Abcg5) (RB alone)))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN d)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJ yellow) (NN bar)) (VP (VBZ represents) (NP (CD 20) (NN μm))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NP (NML (JJ Wild) (HYPH -) (NN type)) (NN intestine)) (VP (VBN incubated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN SC) (NN pre-immune) (NN serum)))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN e)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN SC) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN antibody)) (VP (VBN pre-incubated) (NP (-NONE- *)) (PP (IN with) (NP (DT the) (VBG blocking) (NN peptide)))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN f)) (-RRB- -RRB-)))) (VP (VBD showed) (NP (DT no) (JJ specific) (NNS signals))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (NML (JJ Wild) (HYPH -) (NN type)) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NN intestine) (PRN (-LRB- -LRB-) (NP (NNS panels) (NML (NN g) (, ,) (NN h) (CC and) (NN i))) (ADVP (RB respectively)) (-RRB- -RRB-))) (VP (VBN incubated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN SC) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN antibody))))) (, ,) (VP (VBD showed) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NN expression) (NNS patterns)))) (, ,) (PP (IN despite) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN Abcg8) (HYPH /) (NN sterolin) (HYPH -) (CD 2))) (PP-LOC (IN in) (NP (DT the) (NN knockout) (NNS mice)))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (JJ Single) (NN arrowhead)) (VP (VBZ shows) (NP (JJ intestinal) (NN villus)))) (CC and) (S (NP-SBJ (JJ double) (NN arrowhead)) (VP (VBZ shows) (NP (NN crypt)))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJ yellow) (NN bar)) (VP (VBZ represents) (NP (CD 50) (NN μm))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NN Antibody) (NN staining)) (PP (IN of) (NP (NN liver) (NNS sections)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-LOC (IN at) (NP (DT the) (NNP AMC) (NNP Liver) (NNP Center))))) (. .))) )
( (CAPTION (S (PP (IN As) (NP (DT a) (NN control))) (, ,) (NP-SBJ-1 (NP (DT an) (NN antibody)) (PP (IN to) (NP (NN Bsep) (HYPH /) (NN Abcb11)))) (VP (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)))) (CC and) (VP (VBD showed) (NP (DT a) (JJ clear) (JJ apical) (NN distribution)) (PP-LOC (IN in) (NP (NML (CC both) (NML (JJ wild) (HYPH -) (NN type) (PRN (-LRB- -LRB-) (NP (NN panel) (NN j)) (-RRB- -RRB-))) (CC and) (NML (NN Abcg8) (NN knockout))) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN panel) (NN k)) (-RRB- -RRB-)))))) (. .))) )
( (CAPTION (S (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG Using) (NP (NN AMC) (NN antibody)) (PP (IN against) (NP (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN text)))) (-RRB- -RRB-)) (, ,) (PP-LOC (IN in) (NP (NML (CC both) (NML (JJ wild) (HYPH -) (NN type) (PRN (-LRB- -LRB-) (NP (NN panel) (NN l)) (-RRB- -RRB-))) (CC and) (NML (NN Abcg8) (NN knockout))) (NN liver) (PRN (-LRB- -LRB-) (NML (NN panel) (NN m)) (-RRB- -RRB-)))))) (, ,) (NP-SBJ (NP (DT the) (NN pattern)) (PP (IN of) (NP (NN expression)))) (VP (VBD was) (ADVP (RB also)) (ADJP-PRD (JJ apical) (CC and) (JJ unchanged)) (SBAR-ADV (IN although) (S (NP-SBJ (DT the) (NN signal)) (VP (VBZ is) (ADJP-PRD (JJR fainter)) (PP (VBN compared) (PP (IN to) (NP (NP (DT that)) (PP (IN for) (NP (NN Bsep) (HYPH /) (NN Abcb11))))))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NP (NN text)) (PP (IN for) (NP (NN discussion)))))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Arrows)) (VP (VBP indicate) (NP (NN bile) (NNS canaliculi))) (. .))) )
( (HEADING (NP (NN Figure) (CD 7))) )
( (HEADING (NP (NP (JJ Immunohistochemical) (NN evaluation)) (PP (IN of) (NP (NP (NN mouse) (NML (NN Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN expression)) (PP-LOC (IN in) (NP (NN liver))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (JJ Wild) (HYPH -) (NN type)) (NN liver)) (VP (VBN incubated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN UTSW) (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1))))) (VP (VBD resulted) (PP (IN in) (NP (JJ apical) (NN expression))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN a)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (NP-SBJ (VBN Merged) (NN image)) (ADVP (RB clearly)) (VP (VBZ shows) (NP (DT the) (JJ apical) (NN distribution))) (. .))) )
( (CAPTION (S (ADVP (RB Likewise)) (NP-SBJ (NP (NML (NN Abcg8) (NML (SYM -) (HYPH /) (SYM -))) (NN liver)) (VP (VBN incubated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (DT the) (JJ same) (NN UTSW) (ADJP (NN anti-Abcg5) (HYPH /) (NN sterolin) (HYPH -) (CD 1)) (NN antibody))))) (VP (VBD resulted) (PP (IN in) (NP (DT a) (JJ similar) (NML (JJ apical) (NN expression)) (NN pattern))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ relative) (PP (IN to) (NP (DT the) (JJ wild) (NN type))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN b)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (S (NP-SBJ (JJ White) (NNS arrows)) (VP (VBP indicate) (NP (NN bile) (NNS canaliculi)))) (CC and) (S (NP-SBJ (NN asterisk)) (VP (VBZ indicates) (NP (DT a) (NN bile) (NN duct)))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJ yellow) (NN bar)) (VP (VBZ represents) (NP (CD 50) (NN μm))) (. .))) )
( (HEADING (NP (NN Figure) (CD 8))) )
( (HEADING (NP (NML (JJ Biliary) (NML (NML (NN sterol)) (, ,) (NML (NN phospholipid)) (CC and) (NML (NN bile) (NN salt)))) (NNS analyses) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NML (NN Bile) (NML (NN salt) (, ,) (NN sterol) (CC and) (NN phospholipid))) (NNS contents)) (PP (IN from) (NP (JJ male) (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 8)))) (-RRB- -RRB-))) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 7)))) (-RRB- -RRB-))) (, ,) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 5)))) (-RRB- -RRB-)))) (NNS mice)))) (VP (VBD were) (VP (VBN examined) (NP-1 (-NONE- *)) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NNS Methods)))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (NP (NML (NN Bile) (NN salt)) (NN secretion)) (PP-TMP (VBG following) (NP (DT a) (NML (CD 10) (NN minute)) (NN collection)))) (VP (VBD was) (ADJP-PRD (JJR lower)) (PP (IN in) (NP (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -)) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -))) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (JJ wild) (NN type)))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN a)) (-RRB- -RRB-)))) (, ,) (CC but) (S (NP-SBJ (DT these) (NNS differences)) (VP (VBD were) (RB not) (ADJP-PRD (RB statistically) (JJ significant)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Biliary) (NML (NN sterol) (CC and) (NN phospholipid))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (DT the) (JJ wild) (HYPH -) (NN type)))) (PRN (-LRB- -LRB-) (NP (NNS panels) (NML (NN b) (CC and) (NN c))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (JJR lower) (NN panel)) (VP (VBZ shows) (NP (NP (NP (NML (NML (JJ biliary) (NN bile) (NML (NN salt) (, ,) (NN sterol) (CC and) (NN phospholipid))) (NN secretion)) (NNS rates)) (PP (IN from) (NP (JJ female) (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 5)))) (-RRB- -RRB-))) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 4)))) (-RRB- -RRB-))) (, ,) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 3)))) (-RRB- -RRB-)))) (NNS mice)))) (VP (VBN measured) (NP (-NONE- *)) (PP-TMP (VBG following) (NP (NP (NML (CD 90) (HYPH -) (NN minute)) (NML (NN bile) (NN salt)) (NN depletion)) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (JJ stepwise) (NN TUDC) (NN infusion)))))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN described) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN text))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Bars)) (VP (VBP represent) (NP (NML (NML (NN phase) (NN TUDC)) (NN infusion)) (NNS rates))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (DT No) (NNS differences)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN ability) (S-2 (-NONE- *ICH*))) (PP (IN of) (NP (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice))) (S-2 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN bile) (NNS salts))))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN d)) (-RRB- -RRB-))))) (, ,) (CC but) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (NP (DT a) (JJ marked) (NN inability) (S-4 (-NONE- *ICH*))) (PP (IN of) (NP (DT the) (NN knockout) (NNS mice))) (S-4 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NNS sterols)) (PRN (-LRB- -LRB-) (NP (NN panel) (NN e)) (-RRB- -RRB-)))))) (CC and) (NP (NP (DT a) (NN trend)) (PP (IN towards) (NP (DT a) (VBN reduced) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN phospholipid)) (PRN (-LRB- -LRB-) (NP (NN panel) (NN f)) (-RRB- -RRB-))))))))) (PP (VBN compared) (PP (IN to) (NP (JJ wild) (NN type)))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 9))) )
( (HEADING (NP (JJ Biliary) (NML (NN cholesterol) (CC and) (NN sitosterol)) (NN secretion) (. .))) )
( (CAPTION (S (NP-SBJ-1 (JJ Biliary) (NNS sterols)) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN GC) (NNS analyses))) (PP-LOC (IN in) (NP (NML (NML (NN Abcg8) (SYM +) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 4)))) (-RRB- -RRB-))) (, ,) (NML (NN Abcg8) (SYM +) (HYPH /) (SYM -) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP-PRD (CD 3)))) (-RRB- -RRB-))) (CC and) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 4)))) (-RRB- -RRB-)))) (NNS mice))) (PP-TMP (VBG following) (NP (NP (NML (CD 30) (HYPH -) (NN minute)) (NML (NN bile) (NN salt)) (NN depletion)) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (JJ continuous) (NN TUDC) (NN infusion)))))) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NNS Methods)))))))) (. .))) )
( (S (NP-SBJ-1 (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD were) (ADJP-PRD (JJ unable) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (NN cholesterol)) (PP-DIR (IN into) (NP (NN bile))) (PP (IN with) (NP (VBN forced) (NN TUDC) (NN administration))))))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ relative) (PP (IN to) (NP (DT the) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))) (PRN (-LRB- -LRB-) (NP (NN panel) (NN a)) (, ,) (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (. .)) )
( (CAPTION (S (ADVP (RB Interestingly)) (, ,) (NP-SBJ-1 (DT the) (NML (NN Abcg8) (SYM -) (HYPH /) (SYM -)) (NNS mice)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (ADVP-TMP (RB still)) (VP (VB secrete) (NP (NP (NN sitosterol) (PRN (-LRB- -LRB-) (NP (NN panel) (NN b)) (-RRB- -RRB-))) (CC and) (NP (NN campesterol) (PRN (-LRB- -LRB-) (NP (NN panel) (NN c)) (-RRB- -RRB-))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Heterozygous) (NNS mice)) (VP (VBD showed) (NP (DT an) (VBN increased) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB secrete) (NP (DT all) (NNS sterols)) (PP-MNR (IN with) (NP (VBN forced) (NN TUDC) (NN administration))) (ADVP-MNR-1 (-NONE- *T*)) (, ,) (SBAR-ADV (IN although) (S (NP-SBJ (DT the) (NNS results)) (VP (VBD were) (RB not) (ADJP-PRD (RB statistically) (JJ significant)))))))))) (. .))) )
( (HEADING (NP (NN Table) (CD 1))) )
( (HEADING (NP (NP (NN Oligonucleotide) (NNS primers)) (VP (VBN used) (NP (-NONE- *)) (PP-PRP (IN for) (NP (JJ quantitative) (NN RT) (HYPH -) (NN PCR)))))) )
( (HEADING (NP (NN Table) (CD 2))) )
( (HEADING (NP (NML (NN Mouse) (NML (NN plasma) (CC and) (NN tissue))) (NN sterol) (NNS analyses))) )
( (S (NP-SBJ-1 (NP (NNS Animals)) (VP (VBN used) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT these) (NNS studies))))) (VP (VBD were) (UCP-PRD (NP (NP (CD 12) (NNS weeks)) (PP (IN of) (NP (NN age)))) (, ,) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (JJ male) (CC and) (JJ female)))) (CC and) (VP (VBN fed) (NP-1 (-NONE- *)) (NP (DT a) (NML (JJ regular) (NN chow)) (NN diet))))) (. .)) )
( (S-FRM (NP-SBJ (NN *P)) (VP (SYM <) (NP (CD 0.05)) (PP (IN for) (NP (NP (NP (SYM -) (HYPH /) (SYM -)) (CC versus) (NP (SYM +) (HYPH /) (SYM +))) (CC and) (NP (NP (SYM -) (HYPH /) (SYM -)) (CC versus) (NP (SYM +) (HYPH /) (SYM -)))))) (. .)) )
( (FRAG (NP (NN ND)) (, ,) (FRAG (RB not) (ADJP (JJ detectable))) (. .)) )
